http://www.pharmajournalist.com/roche-lymphoma-drug-drives-high-remission-rate-longer-survival/ 2017-12-12T06:43:56+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/gilead-sciences-kite-acquire-cell-design-labs-2/ 2017-12-12T06:46:24+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/gilead1.jpg http://www.pharmajournalist.com/aerogen-lyomark-partner-develop-inhaled-surfactant-begin-phase-2-clinical-trial/ 2017-12-12T06:50:20+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/Aerogen-logo.png http://www.pharmajournalist.com/carmot-enters-multi-year-drug-discovery-collaboration-amgen-2/ 2017-12-12T06:51:50+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/amgen.jpg http://www.pharmajournalist.com/meiragtx-receives-rare-pediatric-disease-designation-gene-therapy-a001/ 2017-12-12T06:55:54+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/MeiraGTx-logo.jpg http://www.pharmajournalist.com/abzena-secures-adc-manufacturing-services-contract/ 2017-12-12T07:02:59+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/abzena-image.jpg https://pharmajournalist.com/wp-content/uploads/2017/12/abzena-image.jpg http://www.pharmajournalist.com/sgs-launches-new-large-molecule-bioanalytical-services/ 2017-12-12T07:06:41+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/sgs-logo.jpg http://www.pharmajournalist.com/storm-therapeutics-joins-smis-9th-annual-rna-therapeutics/ 2017-12-12T12:28:49+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/SMi-Group-Ltd-Logo.png http://www.pharmajournalist.com/fda-grants-orphan-drug-designation-zytoprotecs-novel-dialysis-fluid/ 2017-12-14T15:26:27+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/pfizer-announces-fda-approval-xeljanz-tofacitinib-xeljanz-xr/ 2017-12-15T07:22:00+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/biovectra-keryx-biopharmaceuticals-enter-agreement-ferric-citrate-production-expansion/ 2017-12-15T07:25:56+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/bioVectra.jpg http://www.pharmajournalist.com/medicure-acquires-exclusive-license-sell-market-branded-cardiovascular-drug-u-s/ 2017-12-15T07:29:04+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/Medicure-Inc-Logo.gif http://www.pharmajournalist.com/aprecia-cycle-pharmaceuticals-partner-develop-3d-printed-orphan-drugs/ 2017-12-15T07:33:27+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/Aprecia-Logo.png http://www.pharmajournalist.com/cmc-biologics-announces-development-manufacturing-agreement-harpoon-therapeutics/ 2017-12-15T07:42:50+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/CMC-Biologics-logo.jpg http://www.pharmajournalist.com/fda-grants-fast-track-designation-renova-therapeutics-rt-100-ac6-gene-transfer/ 2017-12-15T07:46:39+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/renova-logo.png http://www.pharmajournalist.com/amris-ssci-announces-plans-expand-spectroscopy-capabilities/ 2017-12-15T07:51:35+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/AMRI_SSCI_Spectroscopy.jpg http://www.pharmajournalist.com/wp-content/uploads/2017/12/AMRI_SSCI_Spectroscopy.jpg http://www.pharmajournalist.com/parexel-launches-perceptive-cloud-life-sciences-industry/ 2017-12-15T07:54:21+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/parexel-clinical.jpg http://www.pharmajournalist.com/aldevron-provide-new-gmp-cas9-nuclease-agreement-integrated-dna-technologies/ 2017-12-15T07:57:44+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/Michael-Chambers-Aldevron-CEO.jpg https://pharmajournalist.com/wp-content/uploads/2017/12/Michael-Chambers-Aldevron-CEO.jpg http://www.pharmajournalist.com/regeneron-isa-pharmaceuticals-announce-strategic-immuno-oncology-collaboration/ 2017-12-19T12:26:56+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/regeneron.jpg http://www.pharmajournalist.com/pixarbio-corporation-announces-signed-agreement-lubrizols-division/ 2017-12-19T12:29:42+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/pixarbio-logo.png http://www.pharmajournalist.com/celltrion-receives-positive-chmp-opinion-herzuma-trastuzumab-biosimilar/ 2017-12-19T12:31:36+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/celltrion-logo.jpg http://www.pharmajournalist.com/teva-announces-exclusive-launch-generic-viread-united-states/ 2017-12-19T12:32:34+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/TEVA-Pharma.jpg http://www.pharmajournalist.com/aratana-therapeutics-announces-study-results-016/ 2017-12-19T12:34:38+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/aratana-therapeutics-logo.png http://www.pharmajournalist.com/biolife-solutions-executes-supply-agreement-iovance-biotherapeutics/ 2017-12-19T12:39:05+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/biolife-solutions-logo.jpg http://www.pharmajournalist.com/avista-pharma-solutions-expands-drug-product-cgmp-manufacturing-colorado-site/ 2017-12-19T12:44:45+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/Avista-Pharma-Solutions.jpg http://www.pharmajournalist.com/dice-molecules-announce-multi-year-research-collaboration-genentech/ 2017-12-19T12:50:15+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/Genentech-Image.jpg http://www.pharmajournalist.com/confo-therapeutics-enters-drug-discovery-collaboration-roche/ 2017-12-19T12:56:55+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/Confo-Therapeutics-logo.png http://www.pharmajournalist.com/nanobiotixs-first-immuno-oncology-trial-approved-u-s-fda/ 2018-01-03T14:22:58+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/roche-ignyta-reach-definitive-merger-agreement/ 2018-01-03T14:24:02+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/recipharm-acquires-remaining-shares-nitin-lifesciences-ltd/ 2018-01-03T14:30:38+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/recipharm.jpg http://www.pharmajournalist.com/u-s-subsidiary-cannimed-therapeutics-bids-state-michigan-license-produce-process-medical-cannabis/ 2018-01-04T12:09:15+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/cannimed-logo.png http://www.pharmajournalist.com/circulogenes-molecular-genetics-testing-ventures-international-licensing-agreement-turkey-based-circulogene-saglik/ 2018-01-04T12:28:40+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/circulogene-logo.png http://www.pharmajournalist.com/symbiotix-biotherapies-declares-agreement-paragon-bioservices-process-development-manufacturing/ 2018-01-04T12:35:04+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/logo_symbiotix-biotherapies.png http://www.pharmajournalist.com/aruna-biomedical-commences-new-class-exosome-biologics-cure-central-nervous-system-neurodegenerative-disorders/ 2018-01-04T12:58:36+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/aruna-biomedical-logo.png http://www.pharmajournalist.com/glaukos-submits-ide-application-fda-seeking-examine-istent-infinite-trabecular-micro-bypass-system/ 2018-01-04T13:29:11+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/soligenix-announces-us-patent-issuance-use-dusquetide-oral-mucositis/ 2018-01-04T13:46:16+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Soligenix-Logo.jpg http://www.pharmajournalist.com/teva-announces-exclusive-launch-generic-version-reyataz-u-s/ 2018-01-04T13:46:16+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/TEVA-Pharma.jpg http://www.pharmajournalist.com/mallinckrodt-acquire-sucampo-pharmaceuticals-approximately-1-2-billion/ 2018-01-04T13:46:16+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/mallinckrodt-pharma.jpg http://www.pharmajournalist.com/mab-biopharma-signs-licensing-agreement-hyleukin-genexine/ 2018-01-04T13:46:16+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/I-Mab-Biopharma.jpg http://www.pharmajournalist.com/wp-content/uploads/2018/01/I-Mab-Biopharma.jpg http://www.pharmajournalist.com/ani-pharmaceuticals-acquires-four-ndas-astrazeneca-46-5-million/ 2018-01-04T13:46:16+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/ppd-appoints-colin-hill-board-directors/ 2018-01-04T13:46:16+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Colin-Hill-PPD.jpg https://pharmajournalist.com/wp-content/uploads/2018/01/Colin-Hill-PPD.jpg http://www.pharmajournalist.com/asana-biosciences-confirms-acceptance-ind-application-asn007-erk1-2-inhibitor/ 2018-01-04T13:46:16+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/asana-biosciences-logo.png http://www.pharmajournalist.com/genecentric-therapeutics-signify-research-collaboration-assess-cancer-subtype-platform/ 2018-01-04T13:46:16+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/GeneCentric-Logo.png http://www.pharmajournalist.com/novaquest-capital-set-obtain-viamet-pharma-vt-1161-product-candidate/ 2018-01-04T13:46:16+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/viamet-pharma-logo.png http://www.pharmajournalist.com/foresee-pharma-enters-license-distribution-agreement-megapharm/ 2018-01-05T12:37:25+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Foresee-Pharma-Logo.png http://www.pharmajournalist.com/indivior-collaborates-addex-enhance-gabab-pams-modulators/ 2018-01-05T12:49:16+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Indivior-logo.png http://www.pharmajournalist.com/pharmamar-pronounces-distribution-license-agreement-megapharm/ 2018-01-05T13:14:27+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/pharmamar1.jpg http://www.pharmajournalist.com/soligenix-grants-usage-us-patent-treatment-oral-mucositis/ 2018-01-05T13:20:02+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/soligenix-logo.jpg http://www.pharmajournalist.com/aurinia-pharmaceuticals-applies-fresh-introductory-base-shelf-prospectus/ 2018-01-05T13:23:34+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Aurinia-Pharma-Logo.jpg http://www.pharmajournalist.com/rocket-pharmaceuticals-finally-merges-inotek-pharmaceuticals/ 2018-01-05T13:28:07+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/rocket-pharmaceuticals-logo.jpg http://www.pharmajournalist.com/avantgen-announces-completion-first-cancer-therapeutic-antibody-discovery-program-trl/ 2018-01-05T13:31:30+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/AvantGen-Logo.jpg http://www.pharmajournalist.com/brian-roberts-appointed-chief-financial-officer-tarveda-therapeutics/ 2018-01-05T13:36:38+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Tarveda-Therapeutics-logo.png http://www.pharmajournalist.com/xcell-biosciences-endeavors-tap-new-market-opportunities-immunotherapy-drug-research-development/ 2018-01-05T13:41:44+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/drug.jpg http://www.pharmajournalist.com/innovate-uk-offers-grant-bicycle-therapeutics-develop-next-generation-novel-antibiotics/ 2018-01-05T13:43:47+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/Bicycle-Therapeutics.jpg http://www.pharmajournalist.com/9-reasons-attend-paediatric-clinical-trials-2018-conference/ 2018-01-08T10:17:28+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/SMi-Group-Ltd-Logo.png http://www.pharmajournalist.com/harbour-biomed-licenses-h2l2-transgenic-mouse-platform-beigene/ 2018-01-08T13:22:29+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Harbour-Biomed-logo.png http://www.pharmajournalist.com/jiangsu-hengrui-medicine-partners-arcutis-develop-hengruis-shr0302-drug-treating-dermatology-disorders/ 2018-01-08T13:25:40+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/drug-discovery.jpg http://www.pharmajournalist.com/kala-pharma-application-new-drug-inveltystm-set-evaluated-fda/ 2018-01-08T13:29:54+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Kala-pharma-logo.png http://www.pharmajournalist.com/semnur-initiates-phase-3-clinical-trial-assess-sp-102-lumbar-radicular-pain-sciatica-afflicted-patients/ 2018-01-08T13:34:04+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/semnur-pharma-logo.jpg http://www.pharmajournalist.com/leading-pharma-acquires-growth-capital-40-million/ 2018-01-08T13:38:49+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Leading-Pharma-Logo.png http://www.pharmajournalist.com/celgene-impact-biomedicines-accede-collaborate/ 2018-01-08T13:42:14+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/celgene-corporation.jpg http://www.pharmajournalist.com/takeda-denali-therapeutics-ventures-combat-neurodegenerative-diseases/ 2018-01-08T13:44:03+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/sssb-f1-oncology-foray-development-manufacturing-supply-agreements/ 2018-01-08T13:47:23+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/F1_Oncology_logo.jpg http://www.pharmajournalist.com/alveo-technologies-curates-economically-viable-disease-diagnostic-devices/ 2018-01-08T13:51:00+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/alveo-logo.jpg http://www.pharmajournalist.com/acercus-entitled-commercialize-urivarx-canada/ 2018-01-08T13:53:26+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Acerus-Pharma-Logo.jpg http://www.pharmajournalist.com/christian-pangratz-appointed-ceo-sterna-biologicals/ 2018-01-08T13:56:09+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/sterna-biologicals-logo.jpg http://www.pharmajournalist.com/medivir-ab-initiate-phase-1-clinical-trials-miv-818-2018/ 2018-01-08T14:01:58+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Medivir-AB-Logo.png http://www.pharmajournalist.com/liquidia-technologies-undertakes-phase-3-clinical-trial-liq861-diagnosing-pah/ 2018-01-08T14:25:54+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Liquidia-Technologies.jpg https://pharmajournalist.com/wp-content/uploads/2018/01/Liquidia-Technologies.jpg http://www.pharmajournalist.com/novaliq-enrols-dry-eye-disease-patients-seecase-phase-2-clinical-trial-nov03/ 2018-01-09T13:28:35+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Novaliq-Logo.jpg http://www.pharmajournalist.com/neil-herson-appointed-senior-vp-national-accounts-market-access-octapharma-usa/ 2018-01-09T13:34:18+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/NeilHerson-octapharma.jpg http://www.pharmajournalist.com/wp-content/uploads/2018/01/NeilHerson-octapharma.jpg http://www.pharmajournalist.com/guangdong-lewwin-pharmaceutical-purchases-provantis-preclinical-software-solution-suite/ 2018-01-09T13:39:21+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Instem-logo.png http://www.pharmajournalist.com/aimmune-plans-declare-results-phase-3-palisade-trial-ar101-peanut-allergy/ 2018-01-09T13:44:26+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Aimmune-Therapeutics-logo.png http://www.pharmajournalist.com/attune-medical-receives-us-fdas-clearance-new-ensoetmtm/ 2018-01-09T13:53:25+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/attune-medicallogo.png http://www.pharmajournalist.com/tai-diagnostics-closes-10-million-series-preferred-equity-financing/ 2018-01-09T13:56:43+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/TAI-Diagnostics-logo.png http://www.pharmajournalist.com/miraca-life-sciences-changes-name-inform-diagnostics/ 2018-01-09T13:59:24+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Inform_Diagnostics_Logo.jpg http://www.pharmajournalist.com/mitochondrial-organizations-create-mitochondrial-care-network/ 2018-01-09T14:03:36+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/news.jpg http://www.pharmajournalist.com/bell-biosystems-announce-latest-pre-clinical-safety-study-results/ 2018-01-09T16:28:26+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/bell-biosystems-logo.gif http://www.pharmajournalist.com/esn-group-rolls-ceramedx-brand-natural-ceramide-therapy-products/ 2018-01-09T16:33:06+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/ceramedx.jpg https://pharmajournalist.com/wp-content/uploads/2018/01/ceramedx.jpg http://www.pharmajournalist.com/novo-nordisk-tries-disposal-program-patients-california/ 2018-01-09T16:38:42+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/novo-nordisk-logo.jpg http://www.pharmajournalist.com/4-key-questions-new-experimental-technologies-answered-smis-drug-discovery-conference-2018/ 2018-01-09T17:03:21+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/SMi-Group-Ltd-Logo.png http://www.pharmajournalist.com/aerin-rollout-vivaer-overcoming-nasal-airway-obstruction/ 2018-01-10T13:56:35+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Aerin-Medical-Image.png http://www.pharmajournalist.com/wp-content/uploads/2018/01/Aerin-Medical-Image.png http://www.pharmajournalist.com/emotional-brain-declares-successful-phase-2b-trials-fsiad-products-lybrido-lybridos/ 2018-01-10T13:59:31+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/clinical-trial.jpg http://www.pharmajournalist.com/wuxi-nextcode-partners-rhythm-treat-rare-obesity-genetic-disorders/ 2018-01-10T14:02:48+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/WeXi-NextCODE-logo.png http://www.pharmajournalist.com/gt-biopharma-completes-dosing-phase-1-clinical-trial-gtp-004-treat-myasthenia-gravis/ 2018-01-10T14:06:07+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/GTBiopharma-Image.jpg https://pharmajournalist.com/wp-content/uploads/2018/01/GTBiopharma-Image.jpg http://www.pharmajournalist.com/cepheid-granted-fda-clearance-xpert-xpress-flu-test/ 2018-01-10T14:09:25+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/u-s-fda-enlists-clearbridge-biomedics-clearcell-fx1-system/ 2018-01-10T14:11:59+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/clearbridge-biomedics-logo.png http://www.pharmajournalist.com/tpc-declares-strategic-agreement-vizient/ 2018-01-10T14:15:20+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Vizient_Logo.jpg http://www.pharmajournalist.com/cofactor-genomics-declares-results-fred-hutchinson-cancer-research-center/ 2018-01-10T14:19:04+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/confactor-genomics-logo.png http://www.pharmajournalist.com/omron-healthcare-launches-avail-enabling-drug-free-pain-relief/ 2018-01-10T14:24:48+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Avial-Omron-Healthcare.jpg https://pharmajournalist.com/wp-content/uploads/2018/01/Avial-Omron-Healthcare.jpg http://www.pharmajournalist.com/john-l-tonkinson-appointed-chief-business-development-officer-dcn-dx/ 2018-01-10T14:28:01+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/John-L.-Tokinson.jpg https://pharmajournalist.com/wp-content/uploads/2018/01/John-L.-Tokinson.jpg http://www.pharmajournalist.com/gynesonics-declares-ide-trial-results-incision-free-treatment-uterine-fibroids/ 2018-01-10T14:34:42+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/gynesonics-logo.jpg http://www.pharmajournalist.com/sab-biotherapeutics-announces-phase-1-clinical-trial-results-anti-mers-immunotherapy/ 2018-01-11T06:12:20+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/SAB-Biotherapeutics-logo.jpg http://www.pharmajournalist.com/viz-ai-declares-ce-mark-direct-intervention-system-contact/ 2018-01-11T06:19:52+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Viz.ai-logo.jpg http://www.pharmajournalist.com/astrazeneca-declared-availability-bydureon-bcise-type-2-diabetes/ 2018-01-11T09:10:01+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/AstraZeneca.jpg http://www.pharmajournalist.com/wp-content/uploads/2018/01/AstraZeneca.jpg http://www.pharmajournalist.com/bioprotect-launches-clinical-trial-post-ide-approval-fda/ 2018-01-11T09:18:08+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/BioProtect.png http://www.pharmajournalist.com/lipocine-divulges-tlando-profile-examined-advisory-committees-fda-hypogonadism/ 2018-01-11T09:32:00+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/LIPOCINE.jpg http://www.pharmajournalist.com/alk-introduces-odactra-house-dust-mite-hdm-induced-allergic-rhinitis-patients/ 2018-01-11T09:45:46+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/alk-abello-big.jpg http://www.pharmajournalist.com/braeburn-pharmaceuticals-invests-110-million-led-wellington-capital-management/ 2018-01-11T09:46:22+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Braeburn-pharma.png http://www.pharmajournalist.com/armando-moncada-entitled-chief-medical-officer-aeon-global-health/ 2018-01-11T10:06:26+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Armando-Moncada.jpg http://www.pharmajournalist.com/target-pharmasolutions-novartis-enters-alliance-target-nash/ 2018-01-11T12:29:38+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/adimab-partners-boehringer-ingelheim-optimize-antibodies-targets/ 2018-01-11T12:31:29+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/boehringer-ingelheim.jpg http://www.pharmajournalist.com/us-fda-accepts-morphoteks-ind-application-morab-202/ 2018-01-11T12:32:31+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/syndax-pharmaceuticals-collaborates-genentech-examine-entinostat/ 2018-01-11T12:33:53+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Syndax-Logo-1.png http://www.pharmajournalist.com/kalorama-escalates-ivd-innovations-combat-sepsis/ 2018-01-11T12:34:42+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/SEPSIS.jpg http://www.pharmajournalist.com/us-fda-sanctions-boston-scientific-corporations-spectra-wavewriter-scs-system/ 2018-01-12T07:02:26+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Boston-scientific-logo.png http://www.pharmajournalist.com/skincure-oncology-delivers-46th-image-guided-superficial-radiation-therapy-system/ 2018-01-12T07:10:19+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/SkinCure-Oncology-SRT.png https://pharmajournalist.com/wp-content/uploads/2018/01/SkinCure-Oncology-SRT.png http://www.pharmajournalist.com/xcede-patch-clinical-trial-dossier-submitted-mrec-begin-first-human-clinical-trial/ 2018-01-12T07:11:44+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/clinical-trials.jpg http://www.pharmajournalist.com/livanova-plc-commences-believe-aortic-heart-valve-study/ 2018-01-12T07:14:33+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/livaNova-Logo.jpg http://www.pharmajournalist.com/waveform-technologies-finishes-four-human-clinical-trials-cgm-system/ 2018-01-12T12:56:20+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/clinical-trial.jpg http://www.pharmajournalist.com/dr-johanna-c-bendell-entitled-chief-development-officer-sarah-cannon/ 2018-01-12T13:06:11+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Johanna-C.-Bendell.jpg https://pharmajournalist.com/wp-content/uploads/2018/01/Johanna-C.-Bendell.jpg http://www.pharmajournalist.com/alliance-healthcare-services-purchases-stock-ecancercare/ 2018-01-12T13:08:54+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/ecancer-logo.jpg http://www.pharmajournalist.com/ligand-pharmaceuticals-glenmark-pharmaceuticals-enters-license-agreement/ 2018-01-12T13:11:56+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Glenmark-Pharma-Image.jpg http://www.pharmajournalist.com/shiseido-obtains-innovative-technology-olivo-laboratories/ 2018-01-12T13:15:35+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Shiseido-Company-logo.jpg http://www.pharmajournalist.com/rgenix-declares-clinical-pre-clinical-results/ 2018-01-12T13:17:34+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Rgenix-Logo.jpg http://www.pharmajournalist.com/review-successes-2017-look-future-amr-superbugs-superdrugs-event-london/ 2018-01-15T11:17:59+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/SMi-Group-Ltd-Logo.png http://www.pharmajournalist.com/adaptimmune-therapeutics-manufactures-spear-t-cells/ 2018-01-15T11:31:34+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Adaptimmune-Therapeutics-logo.png http://www.pharmajournalist.com/celgene-set-obtain-impact-biomedicines-develop-fedratinib/ 2018-01-15T11:34:17+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/celgene-corporation.jpg http://www.pharmajournalist.com/optimapharm-obtains-czech-mks-research/ 2018-01-15T11:36:27+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Optimapharm-2.png http://www.pharmajournalist.com/richard-paulson-appointed-vice-president-ceo-ipsen-north-america/ 2018-01-15T11:40:07+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Ipsen-Logo.jpg http://www.pharmajournalist.com/fast-track-designation-granted-concert-pharmaceuticals-ctp-543-alopecia-areata/ 2018-01-15T11:42:54+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/fresenius-kabi-launches-bortezomib-injection-u-s/ 2018-01-15T11:45:29+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Bortezomib_FK_63323-721-10_-1.jpg https://pharmajournalist.com/wp-content/uploads/2018/01/Bortezomib_FK_63323-721-10_-1.jpg http://www.pharmajournalist.com/fda-approves-gsks-fluarix-quadrivalent/ 2018-01-15T11:48:16+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/gsk.jpg http://www.pharmajournalist.com/u-s-fda-sanctions-use-lynparza-treat-breast-cancer-inherited-genetic-mutation/ 2018-01-15T11:49:21+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/dr-chiang-syin-appointed-chief-quality-officer-wuxi-biologics/ 2018-01-15T11:50:12+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/wuxi-biologics-logo.png http://www.pharmajournalist.com/boston-scientific-declares-affirmative-outcomes-whisper-rct/ 2018-01-15T11:51:25+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Boston-scientific-logo.png http://www.pharmajournalist.com/sci-engi-medco-solutions-secures-sbir-phase-1-contract/ 2018-01-15T11:54:56+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/NCI.png http://www.pharmajournalist.com/hear-janssen-antikor-biopharma-smis-adc-conference-may-2018/ 2018-01-15T13:23:04+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/SMi-Group-Ltd-Logo.png http://www.pharmajournalist.com/fda-sanctions-teva-pharmaceuticals-trisenox-acute-promyelocytic-leukemia-treatment/ 2018-01-16T05:51:43+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/ccp-confirms-testification-iga-scale-treating-ebs/ 2018-01-16T07:51:47+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Castlecreekpharma.jpg http://www.pharmajournalist.com/wp-content/uploads/2018/01/Castlecreekpharma.jpg http://www.pharmajournalist.com/usrm-alleges-10000-kit-sales-adipocell-product/ 2018-01-16T07:55:12+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/US-Steam-Cell-Logo.jpg https://pharmajournalist.com/wp-content/uploads/2018/01/US-Steam-Cell-Logo.jpg http://www.pharmajournalist.com/dawn-barry-declared-president-luna-dna/ 2018-01-16T07:57:36+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Dawn-Barry.jpg https://pharmajournalist.com/wp-content/uploads/2018/01/Dawn-Barry.jpg http://www.pharmajournalist.com/bio-techne-offers-reagents-kits-vector-laboratories/ 2018-01-16T08:02:02+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Bio-Techne-Logo.jpg http://www.pharmajournalist.com/bd-check-points-attains-ce-mark-next-generation-molecular-screening-test/ 2018-01-16T08:06:50+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/bd-logo1.png http://www.pharmajournalist.com/diplomat-pharmacy-offers-cabometyx-treatment-rcc/ 2018-01-16T08:10:38+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Diplomat-Pharmacy-Logo.png http://www.pharmajournalist.com/us-diagnostics-declares-availability-infinity-blood-glucose-monitoring-system-across-western-africa/ 2018-01-16T08:13:36+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/INFINITY.jpg https://pharmajournalist.com/wp-content/uploads/2018/01/INFINITY.jpg http://www.pharmajournalist.com/challenges-development-drug-device-combination-products-discussion-pre-filled-syringes-east-coast-2018/ 2018-01-16T08:18:26+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/SMi-Group-Ltd-Logo.png http://www.pharmajournalist.com/ge-healthcare-roche-partners-develop-digital-clinical-solutions/ 2018-01-16T10:32:13+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/raymond-kaczmarek-appointed-president-nitto-avecia-pharma/ 2018-01-16T10:34:43+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Nitto-Avecia-Pharma-Services.jpg http://www.pharmajournalist.com/lustgarten-foundation-claimed-22-million-funding-pancreatic-cancer-research/ 2018-01-16T10:37:21+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Lustgarten-Foundation-logo.png http://www.pharmajournalist.com/biotech-executive-heinz-schwer-appointed-amcure/ 2018-01-16T11:45:38+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/amcure-logo.jpg http://www.pharmajournalist.com/edwin-miranda-entitled-vp-cytovances-quality-biologics/ 2018-01-16T13:10:25+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Cytovance-Biologics-logo.jpg http://www.pharmajournalist.com/avantgen-completes-first-cancer-therapeutic-antibody-program-trl/ 2018-01-17T05:38:11+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/AvantGen-Logo.jpg http://www.pharmajournalist.com/ipsen-exelixis-proclaims-phase-3-celestial-trial-results-patients-hcc/ 2018-01-17T05:54:24+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Ipsen-Logo.jpg http://www.pharmajournalist.com/fda-issues-510k-clearance-centric-medical-cannulated-screw-internal-fixation-system/ 2018-01-17T07:05:41+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/start-collaborates-sarah-cannon-accelerate-phase-drug-development-programs/ 2018-01-17T07:18:52+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Sarah-Cannon-Image.jpg https://pharmajournalist.com/wp-content/uploads/2018/01/Sarah-Cannon-Image.jpg http://www.pharmajournalist.com/vccn-alliance-cancer-specialists-aspire-offer-oncology-care-across-philadelphia/ 2018-01-17T07:22:36+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Alliance-Cancer-Care-Image.jpg https://pharmajournalist.com/wp-content/uploads/2018/01/Alliance-Cancer-Care-Image.jpg http://www.pharmajournalist.com/new-york-state-department-health-grants-approval-counsyl-prelude-prenatal-screen/ 2018-01-17T07:25:48+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Counsyl-Logo.jpg http://www.pharmajournalist.com/fda-commissioner-scott-gottliebm-d-vows-enhance-clarity-clinical-trial-information/ 2018-01-17T08:17:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/aprinoia-therapeutics-finances-us11-1-million-series-b-developing-imaging-diagnostic-therapeutic-pipelines/ 2018-01-17T09:50:02+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/APRINOIA-Therapeutics-logo.png http://www.pharmajournalist.com/compleware-ventures-agreement-yprime-offer-enhanced-ecoa-irt/ 2018-01-17T09:56:39+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/CompleWare-Logo.png http://www.pharmajournalist.com/nils-hauptmann-appointed-aerie-pharmaceuticals-director-regulatory-affairs-pharmacovigilance/ 2018-01-17T10:00:48+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Aerie-Pharmaceuticals.jpg http://www.pharmajournalist.com/ophthotech-enlists-first-patient-phase-2b-clinical-trial-zimura-treat-stgd1/ 2018-01-17T12:06:29+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/ophthotech-corp-logo.png http://www.pharmajournalist.com/gc-pharma-conducts-phase-2-3-clinical-trial-gc1102-forbidding-hepatitis-b-virus/ 2018-01-18T06:30:49+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/GC-Pharma-Logo.jpg http://www.pharmajournalist.com/mimedx-enrolls-first-patients-phase-3-ind-clinical-trial-treating-achilles-tendonitis/ 2018-01-18T06:31:59+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/MiMedx-Group-Inc-logo.jpg http://www.pharmajournalist.com/neurim-pharmaceuticals-grants-rights-biocodex-market-neurims-pedprm/ 2018-01-18T06:34:11+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Neurim-Pharma.jpg http://www.pharmajournalist.com/wp-content/uploads/2018/01/Neurim-Pharma.jpg http://www.pharmajournalist.com/obi-pharma-confirms-fdas-clearance-ind-phase-1-study-monoclonal-antibody-cancer-immunotherapy/ 2018-01-18T06:52:02+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/marina-biotech-enters-agreement-autotelic-bio-developing-marinaas-103-clinical-program/ 2018-01-18T08:16:07+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/marina-biotech1.jpg https://pharmajournalist.com/wp-content/uploads/2018/01/marina-biotech1.jpg http://www.pharmajournalist.com/daniel-j-castillo-appointed-chief-executive-officer-wisercare/ 2018-01-18T08:19:59+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/WiserCare-Logo.png http://www.pharmajournalist.com/eiger-biopharmaceuticals-disappointed-negative-results-phase-2-liberty-study-pah/ 2018-01-18T08:23:11+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Eiger.png https://pharmajournalist.com/wp-content/uploads/2018/01/Eiger.png http://www.pharmajournalist.com/transgene-dosed-first-patient-phase-1-clinical-trial-china/ 2018-01-18T08:27:24+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Transgene-Logo.png http://www.pharmajournalist.com/ipsen-set-present-five-new-sub-analyses-pivotal-phase-3-napoli-1-trial/ 2018-01-18T08:32:01+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Ipsen-Logo.jpg http://www.pharmajournalist.com/fda-grants-priority-review-novartis-kymriah-treating-r-r-dlbcl/ 2018-01-18T08:32:58+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/biolinerx-declares-partial-results-bl-8040s-phase-2a-combat-study/ 2018-01-18T08:35:57+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/BioLineRx-Logo.jpg http://www.pharmajournalist.com/avion-pharmaceuticals-sought-approval-nda-oral-contraceptive-balcoltra/ 2018-01-18T16:08:34+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/avion-pharmaceuticals-logo.png http://www.pharmajournalist.com/relmada-therapeutics-obtained-global-rights-market-dextromethadone-treating-cns-diseases/ 2018-01-18T16:10:21+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Relmada-Therapeutics-logo.png http://www.pharmajournalist.com/x-chem-extends-drug-discovery-collaboration-astrazeneca/ 2018-01-18T16:10:58+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/kite-pfizer-extend-clinical-trial-collaboration-assess-yescarta-large-b-cell-lymphoma/ 2018-01-19T05:50:32+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/concept-life-sciences-partners-alderley-analytical-ensuring-bioanalytical-dmpk-study-services/ 2018-01-19T08:46:12+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Concept-Life-Sciences-logo.png http://www.pharmajournalist.com/alberto-garotti-appointed-chief-financial-officer-selexis-sa/ 2018-01-19T08:49:50+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Selexis-SA-logo.jpg http://www.pharmajournalist.com/biohaven-initiates-clinical-investigation-bhv-5000-directed-fda/ 2018-01-19T08:52:48+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Biohaven-Pharma-Logo.png http://www.pharmajournalist.com/fda-accepts-aquestive-therapeutics-nda-clobazam-osf-treating-lgs-patients/ 2018-01-19T08:54:11+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/qiagen-sought-fda-approval-qiagens-therascreen-egfr-rgq-pcr-kit-nsclc/ 2018-01-19T08:54:59+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/bluegrass-vascular-declares-enrollment-first-patients-save-us-pivotal-trial/ 2018-01-19T08:58:42+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Bluegrass-Vascular-logo.png http://www.pharmajournalist.com/oncosec-medical-proclaims-preliminary-clinical-observations-oms-1140-clinical-trial-immunopulse-tnbc-patients/ 2018-01-19T09:01:28+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/OncoSec.jpg https://pharmajournalist.com/wp-content/uploads/2018/01/OncoSec.jpg http://www.pharmajournalist.com/laminate-medical-technologies-rolled-fda-pivotal-trial-vasq-device/ 2018-01-19T09:51:34+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/VasQ-device-Laminate-Medical.jpg https://pharmajournalist.com/wp-content/uploads/2018/01/VasQ-device-Laminate-Medical.jpg http://www.pharmajournalist.com/box-pronounced-box-gxp-validation-life-sciences/ 2018-01-19T09:52:50+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Box.png http://www.pharmajournalist.com/ligand-pharmaceuticals-initiates-program-develop-contrast-agents-diagnostic-imaging/ 2018-01-19T10:02:37+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Ligand-Pharmaceuticals-logo.png http://www.pharmajournalist.com/pandion-therapeutics-sought-58-million-series-funding-advance-drug-programs-autoimmune-inflammatory-diseases/ 2018-01-19T10:05:03+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Pandion-therapeutics-logo.png http://www.pharmajournalist.com/symbio-commences-phase-clinical-trial-oral-treakisym/ 2018-01-22T07:56:49+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/SymBio.png http://www.pharmajournalist.com/astrazeneca-merck-asserted-approval-lynparza-tablets-patients-ovarian-cancer/ 2018-01-22T08:44:46+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/astrazeneca.jpg http://www.pharmajournalist.com/fda-sanctions-clearance-medrobotics-transabdominal-transthoracic-robotic-scope/ 2018-01-22T08:56:42+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/pfizer-presents-opening-keynote-smis-adc-conference-2018/ 2018-01-22T09:00:33+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/SMi-Group-Ltd-Logo.png http://www.pharmajournalist.com/positive-results-amgens-phase-3b-liberty-study-assessing-efficacy-aimovig/ 2018-01-23T06:00:43+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/amgen.jpg https://pharmajournalist.com/wp-content/uploads/2017/04/amgen.jpg http://www.pharmajournalist.com/fda-grants-orphan-drug-designation-bergs-candidate-bpm31510/ 2018-01-23T06:34:12+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/pulmatrix-sought-approval-clinical-trial-application-mhra-pulmazole/ 2018-01-23T06:36:09+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Pulmatrix-Logo.jpg http://www.pharmajournalist.com/agenus-launches-clinical-trial-combination-anti-ctla4-agen1884-anti-pd1-agen2034-antibodies/ 2018-01-23T06:38:26+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/agenus-logo.jpg http://www.pharmajournalist.com/fda-approves-ready-use-cardiovascular-medication-bivalirudin-baxter/ 2018-01-23T07:36:34+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/baxter-logo.jpg https://pharmajournalist.com/wp-content/uploads/2017/06/baxter.jpg http://www.pharmajournalist.com/fda-offers-supplementary-clearances-bio-rads-ih-system-gel-reagents-blood-typing-products/ 2018-01-23T07:41:54+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Bio-Rad-Lab.jpg http://www.pharmajournalist.com/fda-extends-orphan-drug-designation-enzychem-lifesciencess-ec-18-treatment-ars/ 2018-01-23T07:44:28+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/astellas-pharma-vical-asserts-negative-phase-3-clinical-trial-results-asp0113-cmv-hsct-recipients/ 2018-01-23T07:45:30+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astellas.jpg http://www.pharmajournalist.com/opdivo-along-yervoy-displays-treatment-dmmr-msi-h-patients-mcrc/ 2018-01-23T08:25:04+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/bristol-myers-squibb.jpg http://www.pharmajournalist.com/celgene-juno-therapeutics-sign-definitive-merger-agreement/ 2018-01-23T08:27:04+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/celgene-corporation.jpg http://www.pharmajournalist.com/seattle-genetics-asserted-ecs-extension-marketing-authorization-adcetris/ 2018-01-23T08:29:42+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/seattle-genetics_logo.png http://www.pharmajournalist.com/enzo-biochem-testifies-cervical-cancer-biomarker-detection-test/ 2018-01-23T08:32:00+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Enzo-logo.jpg http://www.pharmajournalist.com/deborah-dunsire-md-appointed-alexion-board-directors/ 2018-01-23T08:36:23+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Alexion-Pharma-Logo.png http://www.pharmajournalist.com/tabuk-pharmaceuticals-enters-licensing-supply-agreement-red-otc-development-gmbh/ 2018-01-23T09:12:03+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/TabukPharma-Logo.jpg http://www.pharmajournalist.com/cerus-affirms-positive-results-phase-3-transfusion-study-assessing-intercept-rbcs-thalassemia-patients/ 2018-01-24T08:26:06+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Cerus-Logo.jpg http://www.pharmajournalist.com/ligand-ventures-omniab-platform-license-agreement-ferring-pharmaceuticals/ 2018-01-24T08:27:41+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Ligand-Pharmaceuticals-logo.png http://www.pharmajournalist.com/chmp-ema-conveyed-negative-trend-vote-pumas-ma-neratinib-treating-her2-positive-breast-cancer/ 2018-01-24T08:31:41+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Puma-Biotechnology-logo.jpg http://www.pharmajournalist.com/dr-nalini-murdter-appointed-ceo-mbli-jsr-life-sciences/ 2018-01-24T08:33:20+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/jsr-life-sciences-image.jpg http://www.pharmajournalist.com/mary-t-szela-appointed-ceo-president-surefire-medical/ 2018-01-24T08:34:56+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Szela.jpg https://pharmajournalist.com/wp-content/uploads/2018/01/Szela.jpg http://www.pharmajournalist.com/fda-grants-clearance-qiagens-ipsogen-jak2-rgq-pcr-kit-detecting-mpns/ 2018-01-24T08:35:41+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/biomarck-initiates-phase-2-clinical-study-nsclc/ 2018-01-24T08:38:07+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/biomarck-pharma-logo.png http://www.pharmajournalist.com/promis-neurosciences-claimed-results-previously-claimed-preclinical-program-alzheimers-disease/ 2018-01-24T08:43:05+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/promis-neurosciences-logo.jpg http://www.pharmajournalist.com/fda-concedes-sobis-ind-application-sobi003-along-fast-track-status-treating-mps-iiia/ 2018-01-24T09:53:45+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/sobi.jpg http://www.pharmajournalist.com/shannon-bledsoe-appointed-executive-director-wcg/ 2018-01-24T09:56:25+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/WCG-logo.png http://www.pharmajournalist.com/astellas-obtains-mitobridge/ 2018-01-24T09:57:47+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astellas.jpg http://www.pharmajournalist.com/sillajen-abl-europe-extends-strategic-manufacturing-collaboration/ 2018-01-24T10:01:26+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/sillajen-logo.jpg http://www.pharmajournalist.com/evofem-biosciences-enrolls-first-patient-phase-2b-3-clinical-trial-assessing-amphoras-ability-foil-ucg-women/ 2018-01-24T12:04:19+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/evofem-biosciences-logo.jpg http://www.pharmajournalist.com/cde-assents-expansion-aggrastat-cardiome/ 2018-01-24T12:46:05+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/cardiome-logo.png http://www.pharmajournalist.com/japans-mhlw-extended-marketing-manufacturing-authorization-regenerons-dupixent/ 2018-01-24T12:47:48+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/regeneron.jpg https://pharmajournalist.com/wp-content/uploads/2017/08/regeneron.jpg http://www.pharmajournalist.com/3d-cell-culture-market-expected-expand-2020-experts-gather-smisevent-february/ 2018-01-25T15:13:26+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/SMi-Group-Ltd-Logo.png http://www.pharmajournalist.com/perrigo-rolls-ab-rated-generic-version-epiduo-gel/ 2018-01-26T11:32:43+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/perrigo-logo.jpg http://www.pharmajournalist.com/perrigo-asserted-fdas-approval-generic-version-estrace-cream/ 2018-01-26T11:33:28+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/spectris-plc-acquires-concept-life-sciences/ 2018-01-26T11:34:27+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Concept-Life-Sciences-logo.png http://www.pharmajournalist.com/liquidia-proclaimed-positive-phase-1-preclinical-results-liq861-treatment-pah/ 2018-01-26T11:35:08+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Liquidia-Technologies.jpg https://pharmajournalist.com/wp-content/uploads/2018/01/Liquidia-Technologies.jpg http://www.pharmajournalist.com/pixium-vision-confirms-human-implantation-activation-prima/ 2018-01-26T11:40:43+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Pixium-Vision-logo.jpg http://www.pharmajournalist.com/compass-trial-results-advocate-penumbras-frontline-thrombectomy-approach-acute-ischemic-stroke/ 2018-01-26T11:44:29+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Penumbra-Image.jpg https://pharmajournalist.com/wp-content/uploads/2018/01/Penumbra-Image.jpg http://www.pharmajournalist.com/epo-extends-intent-grant-notice-onxeo-asidna-patent/ 2018-01-26T11:47:47+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/onxeo-logo.jpg http://www.pharmajournalist.com/ema-concedes-alnylams-maa-treatment-attr-amyloidosis/ 2018-01-26T11:50:54+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/alnylam-pharmaceuticals_logo.jpg http://www.pharmajournalist.com/paragon-international-initiates-fresh-brand-logo-corporate-name/ 2018-01-26T17:19:22+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Paragon-Global-Crs-logo.png http://www.pharmajournalist.com/fda-assents-bioatlas-ind-ba3011/ 2018-01-26T17:21:35+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/bioalta-logo.png http://www.pharmajournalist.com/fda-grants-510-k-clearance-market-techlabs-campylobacter-quik-chek-campylobacter-chek-tests/ 2018-01-26T17:23:47+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/techcare-signs-distribution-agreement-mwmedical-bv-novokid-lice-treatment-device/ 2018-01-26T17:29:40+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/TechCare-Novokid-Lice-Treatment-Device.png https://pharmajournalist.com/wp-content/uploads/2018/01/TechCare-Novokid-Lice-Treatment-Device.png http://www.pharmajournalist.com/novartis-ventures-licensing-agreement-spark-therapeutics/ 2018-01-26T17:30:42+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/fda-grants-tentative-approval-perrigos-onexton-gel/ 2018-01-29T06:28:43+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/perrigo-logo.jpg http://www.pharmajournalist.com/araclon-biotech-partners-tfs-international-advance-ad-vaccine-abvac40-phase-ii/ 2018-01-29T13:11:42+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/drug.jpg http://www.pharmajournalist.com/chmp-elicits-positive-response-chugais-hemlibra/ 2018-01-29T13:15:39+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/chugai-logo.png http://www.pharmajournalist.com/iris-appoints-chris-belmont-interim-ceo-revamps-leadership-team/ 2018-01-29T13:20:17+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Iris-logo.png http://www.pharmajournalist.com/aradigm-sought-crl-fda-pertaining-nda-linhaliq-treating-ncfbe-patients/ 2018-01-29T13:21:32+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Aradigm-1.jpg https://pharmajournalist.com/wp-content/uploads/2018/01/Aradigm-1.jpg http://www.pharmajournalist.com/sterling-pharma-solutions-surges-visibility-japan/ 2018-01-29T13:23:10+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Sterling-pharma-solutions.jpg https://pharmajournalist.com/wp-content/uploads/2018/01/Sterling-pharma-solutions.jpg http://www.pharmajournalist.com/solid-form-solutions-obtained-avista-pharma-solutions/ 2018-01-29T13:23:57+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/Avista-Pharma-Solutions.jpg http://www.pharmajournalist.com/theradex-oncology-appointed-cro-alligator-biosciencess-ator-1015-phase-study/ 2018-01-29T13:26:27+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/alligator-bioscience-logo.jpg http://www.pharmajournalist.com/regenxbio-forays-strategic-partnership-fujifilm-diosynth-biotechnologies/ 2018-01-29T13:29:09+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/REGENXBIO-logo.png http://www.pharmajournalist.com/casi-pharmaceuticals-acquired-25-u-s-fda-approved-andas-sandoz/ 2018-01-29T13:35:25+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/casi-pharmaceuticals-logo.png http://www.pharmajournalist.com/sacred-oak-medical-center-revokes-agreement-redshift-healthcare-management-llc/ 2018-01-29T13:38:13+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/sacredoakmedical-logo.jpg http://www.pharmajournalist.com/veracyte-undertook-100000-afirma-genomic-tests-thwart-unwanted-surgeries-diagnosed-thyroid-cancer/ 2018-01-29T13:41:33+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/veracyte-logo.jpg http://www.pharmajournalist.com/strykers-weave-trial-testifies-endovascular-treatment-icad-patients/ 2018-01-29T15:40:24+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/stryker-logo.png http://www.pharmajournalist.com/novartis-fda-approval-nda-lutathera/ 2018-01-30T05:39:41+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg https://pharmajournalist.com/wp-content/uploads/2018/01/Lutathera-Novartis.jpg http://www.pharmajournalist.com/nj-bariatric-center-bmi-weight-loss-surgery-study/ 2018-01-30T06:48:16+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/NJ-Bariatric-Center.jpg http://www.pharmajournalist.com/wp-content/uploads/2018/01/NJ-Bariatric-Center.jpg http://www.pharmajournalist.com/sillajen-initiates-phase-1-2-clinical-trial-pexastimogene-devacirepvec/ 2018-01-30T10:25:43+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Silajen-Clinical-Trials.jpg https://pharmajournalist.com/wp-content/uploads/2018/01/Silajen-Clinical-Trials.jpg http://www.pharmajournalist.com/prometic-life-sciences-fda-meet-pbi-4050/ 2018-01-30T10:35:06+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Prometic-Life-Sciences.jpg https://pharmajournalist.com/wp-content/uploads/2018/01/Prometic-Life-Sciences.jpg http://www.pharmajournalist.com/wuxi-biologics-aravive-biologics-biologics-collaboration-avb-s6-500/ 2018-01-30T10:44:08+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Aravive-Biologics-logo.png http://www.pharmajournalist.com/medtronic-acquires-qt-vascular-chocolate-pta-balloon-catheter/ 2018-01-30T10:49:59+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Chocolate-PTA-Balloon-Catheter.jpg https://pharmajournalist.com/wp-content/uploads/2018/01/Chocolate-PTA-Balloon-Catheter.jpg http://www.pharmajournalist.com/letco-medical-arl-bio-pharma-quality-savings-program/ 2018-01-30T11:15:09+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Lecto-Medical-LLC-Logo.png http://www.pharmajournalist.com/emerald-health-information-systems-changes-harris-healthcare-clinical-solutions/ 2018-01-30T11:18:53+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/harris-healthcare-logo.png http://www.pharmajournalist.com/dr-jean-marie-cuillerot-md-cmo-dragonfly-therapeutics/ 2018-01-30T11:35:56+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Dragonfly-Therapeutics-logo.png http://www.pharmajournalist.com/cutispharma-confirms-fdas-sanction-firvanq-clostridium-difficile/ 2018-01-30T11:51:50+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/FIRVANQ-CutisPharma.png https://pharmajournalist.com/wp-content/uploads/2018/01/FIRVANQ-CutisPharma.png http://www.pharmajournalist.com/biocardia-fda-approval-ide-cmi-trial-treating-ra/ 2018-01-30T11:55:30+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/biocardia-logo.gif http://www.pharmajournalist.com/fda-extends-510k-clearance-electrocores-gammacore-nvns/ 2018-01-30T11:56:00+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/gammacore-usage.jpg https://pharmajournalist.com/wp-content/uploads/2018/01/gammacore-usage.jpg http://www.pharmajournalist.com/fda-theravance-biopharma-mylan-nda-revefenacin/ 2018-01-30T12:17:19+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Theravance-biopharma-logo.png http://www.pharmajournalist.com/sanofi-acquire-ablynx-e3-9-billion/ 2018-01-30T13:27:26+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Sanofi.jpg http://www.pharmajournalist.com/synteract-appoints-chief-commercial-officer-jack-shannon/ 2018-01-31T05:57:50+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Jack-Shannon.jpg https://pharmajournalist.com/wp-content/uploads/2018/01/Jack-Shannon.jpg http://www.pharmajournalist.com/medshape-declares-successful-performance-first-surgeries-dynanail-xl/ 2018-01-31T08:00:04+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/MedShape.jpg http://www.pharmajournalist.com/wp-content/uploads/2018/01/MedShape.jpg http://www.pharmajournalist.com/agilent-technologies-science-exchange-partner-ensuring-access-agilent-enabled-service/ 2018-01-31T12:42:30+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/agilent-logo.png http://www.pharmajournalist.com/cel-sci-patent-leaps-vaccine-platform-technology-permitted/ 2018-01-31T12:47:09+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/celsci-logo.jpg http://www.pharmajournalist.com/puma-biotechnology-medison-pharma-partner-commercialize-nerlynx/ 2018-01-31T12:50:13+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/puma-biotechnology.jpg http://www.pharmajournalist.com/foundation-medicine-eortc-collaborate-specta/ 2018-01-31T12:53:52+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/foundation-medicine-logo.png http://www.pharmajournalist.com/u-s-fda-grants-fast-track-designation-takedas-tak-426/ 2018-01-31T12:56:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/fda-clears-multi-radiance-medicals-mr4-laser-technology-neck-shoulder-pain/ 2018-01-31T12:57:43+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/mallinckrodt-enrolls-first-patient-phase-4-trial-h-p-acthar-gel/ 2018-01-31T13:06:17+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/mallinckrodt-pharma.jpg http://www.pharmajournalist.com/upsher-smith-sought-fda-approval-bumetanide-tablets/ 2018-01-31T13:15:29+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Bumetanide-Tablets.jpg https://pharmajournalist.com/wp-content/uploads/2018/01/Bumetanide-Tablets.jpg http://www.pharmajournalist.com/aldeyra-therapeutics-enrolls-first-patient-phase-2b-clinical-trial-ded/ 2018-01-31T13:19:05+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/aldeyra-therapeutics-logo.png http://www.pharmajournalist.com/biomx-licenses-jsr-corporation-treating-ibd/ 2018-01-31T13:21:47+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/biomx-logo.png http://www.pharmajournalist.com/investors-group-acquired-corepharma/ 2018-01-31T13:24:09+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/corepharmallc-logo.png http://www.pharmajournalist.com/perrigo-sought-tentative-fda-approval-soolantra-cream1/ 2018-01-31T13:27:49+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/soolantra-cream.jpg http://www.pharmajournalist.com/introducing-6th-annual-adc-summit-2018/ 2018-02-01T06:44:47+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Antibodies-Antibody-Drug-Conjugates-Banner.jpg http://www.pharmajournalist.com/wp-content/uploads/2018/01/Antibodies-Antibody-Drug-Conjugates-Banner.jpg http://www.pharmajournalist.com/highlights-years-asthma-copd-conference/ 2018-02-01T06:47:12+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Asthma-COPD-SMi-Pharma-Journalist-Banner.jpg http://www.pharmajournalist.com/wp-content/uploads/2018/01/Asthma-COPD-SMi-Pharma-Journalist-Banner.jpg http://www.pharmajournalist.com/parallel-trade-conference-next-week-london/ 2018-02-01T06:54:35+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/Parallel-Trade-2018-SMi-Banner.jpg http://www.pharmajournalist.com/wp-content/uploads/2017/10/Parallel-Trade-2018-SMi-Banner.jpg http://www.pharmajournalist.com/puma-biotechnology-declares-results-phase-ii-basket-clinical-trial/ 2018-02-01T07:59:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/puma-biotechnology.jpg https://pharmajournalist.com/wp-content/uploads/2017/04/puma-biotechnology.jpg http://www.pharmajournalist.com/novartis-declares-results-eliana-clinical-trial-kymriah/ 2018-02-01T14:15:17+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/skylinedx-collaborates-mayo-clinic-curate-diagnostic-tests-melanoma/ 2018-02-01T14:23:42+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/mayo-clinic.jpg https://pharmajournalist.com/wp-content/uploads/2018/02/mayo-clinic.jpg http://www.pharmajournalist.com/r-michael-gendreau-appointed-chief-medical-officer-intec-pharma/ 2018-02-01T14:31:24+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/intec-pharma-logo.png http://www.pharmajournalist.com/medidata-partners-syapse-transform-oncology-clinical-trials/ 2018-02-01T14:32:19+00:00 https://pharmajournalist.com/wp-content/uploads/2017/07/medidata-logo.jpg http://www.pharmajournalist.com/authentidate-holding-announced-corporate-name-change-aeon-global-health-corp/ 2018-02-01T14:34:50+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Aeon-Global-health-image.jpg https://pharmajournalist.com/wp-content/uploads/2018/02/Aeon-Global-health-image.jpg http://www.pharmajournalist.com/qiagen-n-v-obtains-stat-dx/ 2018-02-01T14:38:15+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/qiagen-image.jpg https://pharmajournalist.com/wp-content/uploads/2018/02/qiagen-image.jpg http://www.pharmajournalist.com/fda-approval-sought-ferring-pharmaaceuticals-zomacton/ 2018-02-01T14:43:50+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Ferring-Pharmaceuticals-Singapore.jpg http://www.pharmajournalist.com/vertex-pharmaceuticals-selects-vx-659-vx-445-phase-3-cf/ 2018-02-01T14:51:38+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/vertex-pharma-logo.png http://www.pharmajournalist.com/hisamitsu-noven-pharma-declares-transdermal-patch-schizophrenia/ 2018-02-01T14:58:36+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/hisamitsu-pharma-logo.png http://www.pharmajournalist.com/ceterix-orthopedics-enrollment-stitch-horizontal-meniscus-tears/ 2018-02-01T15:09:18+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/ceterix-orthopaedics.jpg https://pharmajournalist.com/wp-content/uploads/2018/02/ceterix-orthopaedics.jpg http://www.pharmajournalist.com/seattle-genetics-merges-cascadian-therapeutics/ 2018-02-01T15:10:03+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/seattle-genetics_logo.png http://www.pharmajournalist.com/nuvox-pharma-concedes-fdas-approval-phase-ii-clinical-trial/ 2018-02-01T15:13:14+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/nuvox-pharma-image.jpg http://www.pharmajournalist.com/wp-content/uploads/2018/02/nuvox-pharma-image.jpg http://www.pharmajournalist.com/ambry-genetics-partners-invicro-extend-customized-genomics-imaging-services/ 2018-02-01T15:17:34+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/ambry-Genetics-exterior.jpg https://pharmajournalist.com/wp-content/uploads/2018/02/ambry-Genetics-exterior.jpg http://www.pharmajournalist.com/recent-advances-artificial-intelligence-systems-now-providing-basis-introduction-greater-automation/ 2018-02-02T14:30:31+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/Drug-Discovery-2018-SMi-Banner.jpg http://www.pharmajournalist.com/wp-content/uploads/2017/10/Drug-Discovery-2018-SMi-Banner.jpg http://www.pharmajournalist.com/tva-medicals-everlinq-endoavf-system-exhibits-positive-clinical-results/ 2018-02-02T14:48:08+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/TVA-Medical-Logo.png http://www.pharmajournalist.com/chinas-transcatheter-mitralstitch-mitral-valve-repair-system-completed/ 2018-02-02T14:57:16+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/MitralStitch-mitral-valve-repair-system.jpg https://pharmajournalist.com/wp-content/uploads/2018/02/MitralStitch-mitral-valve-repair-system.jpg http://www.pharmajournalist.com/panacea-pharmaceuticals-enrolls-patient-pan-301-1-phase-1-clinical-trial/ 2018-02-02T15:04:42+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/panacea-pharma-logo.png http://www.pharmajournalist.com/syndax-pharmaceuticals-affirms-oncology-clinical-trial-venture-astrazeneca/ 2018-02-02T15:06:04+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/astrazeneca.jpg https://pharmajournalist.com/wp-content/uploads/2017/04/astrazeneca.jpg http://www.pharmajournalist.com/lazarex-states-new-fda-guidance-issued/ 2018-02-02T15:08:59+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Lazarex-Cancer-Foundation-logo.jpg http://www.pharmajournalist.com/allergan-asserts-fdas-approval-ssnda-avycaz/ 2018-02-02T15:10:01+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/select-medical-holdings-dignity-health-asserts-integration-concentra-healthworks/ 2018-02-02T15:21:27+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/select-medical-logo.png http://www.pharmajournalist.com/apha-ncpo-join-hands-combat-opioid-abuse/ 2018-02-02T15:25:53+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/apha-logo.png http://www.pharmajournalist.com/fda-commissioner-vows-initiatives-tackle-saline-shortages/ 2018-02-02T15:31:33+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Scott-Gottlieb-FDA.jpg http://www.pharmajournalist.com/wp-content/uploads/2018/02/Scott-Gottlieb-FDA.jpg http://www.pharmajournalist.com/puma-biotechnology-licenses-canbridge-life-sciences-commercialize-nerlynx-china/ 2018-02-02T15:37:03+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Puma-Biotechnology-logo.jpg http://www.pharmajournalist.com/anika-therapeutics-collaborates-iib-develop-msc-therapy-osteoarthritis/ 2018-02-02T15:43:49+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Anika-Therapeutics-office.jpg https://pharmajournalist.com/wp-content/uploads/2018/02/Anika-Therapeutics-office.jpg http://www.pharmajournalist.com/cobra-biologics-symbiosis-clinched-2-5m-usd-collaborative-grant/ 2018-02-02T15:47:24+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Cobra-Biologics-image.jpg https://pharmajournalist.com/wp-content/uploads/2018/02/Cobra-Biologics-image.jpg http://www.pharmajournalist.com/fda-concedes-ind-imago-biosciences-img-7289-u-s/ 2018-02-02T15:48:41+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/imago-biosciences-logo.png http://www.pharmajournalist.com/exciting-developments-3d-cell-culture-world-full-thickness-human-skin-chip-research-first-stem-cells-using-crispr-genome-activation/ 2018-02-05T08:43:50+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/3D-Cell-Culture-2018.jpg http://www.pharmajournalist.com/wp-content/uploads/2017/10/3D-Cell-Culture-2018.jpg http://www.pharmajournalist.com/exclusive-speaker-interview-janssen-smis-adc-conference-2018/ 2018-02-05T08:51:24+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Antibodies-Antibody-Drug-Conjugates-Banner.jpg http://www.pharmajournalist.com/wp-content/uploads/2018/01/Antibodies-Antibody-Drug-Conjugates-Banner.jpg http://www.pharmajournalist.com/matthew-m-walsh-appointed-executive-vice-president-cfo-allergan/ 2018-02-05T13:00:02+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/allergan.jpg http://www.pharmajournalist.com/ema-accepts-tevas-fremanezumab-marketing-authorization-application/ 2018-02-05T13:06:09+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/TEVA-Pharma.jpg http://www.pharmajournalist.com/ver-pharma-adopts-veeva-opendata-veeva-crm-transform-customer-engagement/ 2018-02-06T12:43:10+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/veeva-crm.jpg https://pharmajournalist.com/wp-content/uploads/2018/02/veeva-crm.jpg http://www.pharmajournalist.com/kevin-gordon-president-cfo-liquidia/ 2018-02-06T12:50:27+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Kevin-Gordon-Liquidia.jpg https://pharmajournalist.com/wp-content/uploads/2018/02/Kevin-Gordon-Liquidia.jpg http://www.pharmajournalist.com/netvation-dl-medicine-announces-research-collaboration-pfizer-inc/ 2018-02-06T12:53:35+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/fda-clears-oricula-therapeutics-investigational-new-drug-application-clinical-trials/ 2018-02-06T13:01:11+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/capricor-receives-fda-rmat-designation-duchenne-muscular-dystrophy-therapy/ 2018-02-06T13:06:27+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/capricor-therapeutics-logo.jpg http://www.pharmajournalist.com/xcovery-initiates-phase-2-clinical-trial-ensartinib-melanoma-patients-alk-alternations/ 2018-02-07T13:23:46+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/xcovery-logo.png http://www.pharmajournalist.com/roivant-sciences-arqule-enter-license-agreement-derazantinib-china/ 2018-02-07T13:26:42+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Roivant_Logo.png http://www.pharmajournalist.com/major-research-project-launched-crack-aspirins-anti-cancer-properties/ 2018-02-07T13:30:00+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/aspirin-hero_1.jpg https://pharmajournalist.com/wp-content/uploads/2018/02/aspirin-hero_1.jpg http://www.pharmajournalist.com/sosei-provides-update-immuno-oncology-clinical-program-astrazeneca/ 2018-02-08T15:10:11+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/astrazeneca.jpg http://www.pharmajournalist.com/novo-nordisk-launches-rebinyn-united-states-people-hemophilia-b/ 2018-02-08T15:14:45+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/novo-nordisk-logo.jpg http://www.pharmajournalist.com/concept-life-sciences-expands-gxp-compliance/ 2018-02-08T15:17:04+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Concept-Life-Sciences-logo.png http://www.pharmajournalist.com/60-pharmaceuticals-60p-receives-priority-review-designation-malaria-drug/ 2018-02-08T15:21:44+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/fda-approves-gileads-biktarvy-treatment-hiv-1-infection/ 2018-02-08T15:31:34+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/biktarvy-tablets-Gilead.jpg https://pharmajournalist.com/wp-content/uploads/2018/02/biktarvy-tablets-Gilead.jpg http://www.pharmajournalist.com/gsk-receives-breakthrough-therapy-designation-fda-meningitis-b-vaccine-bexsero/ 2018-02-08T15:39:25+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/gsk.jpg http://www.pharmajournalist.com/janssen-signs-deal-theravance-biopharma-develop-td-1473/ 2018-02-08T15:45:04+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/Janssen.jpg http://www.pharmajournalist.com/certara-acquires-basecase-life-sciences-data-visualization-company/ 2018-02-09T07:11:13+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Certara_logo.jpg http://www.pharmajournalist.com/acesion-pharma-receives-approval-phase-study-atrial-fibrillation/ 2018-02-09T07:14:25+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Acesion-Pharma.png http://www.pharmajournalist.com/rexahn-pharma-announces-collaboration-zhejiang-haichang-biotechnology/ 2018-02-09T07:29:29+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/rexahn-pharmaceutical-logo.jpg http://www.pharmajournalist.com/astrazenecas-brilinta-reduces-cv-events-heart-attack-survivors/ 2018-02-09T07:32:25+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/vaccibody-expands-human-clinical-trial-hpv-vaccine/ 2018-02-09T07:37:46+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/pharmajet-needle-free-injection.jpg https://pharmajournalist.com/wp-content/uploads/2018/02/pharmajet-needle-free-injection.jpg http://www.pharmajournalist.com/shield-reports-top-line-results-pivotal-phase-iii-study-feraccru/ 2018-02-09T07:43:31+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/clinical-trial.jpg http://www.pharmajournalist.com/novartis-receives-fda-approval-cosentyx-label-update/ 2018-02-09T07:48:12+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/circassia-receives-contract-vizient-niox-vero-asthma-management-products/ 2018-02-09T07:51:47+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/circassia_logo.jpg http://www.pharmajournalist.com/bavarian-nordic-announces-positive-results-pivotal-phase-3-study-imvamune-smallpox-vaccine/ 2018-02-09T08:37:33+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Bavarian-Nordic.jpg https://pharmajournalist.com/wp-content/uploads/2018/02/Bavarian-Nordic.jpg http://www.pharmajournalist.com/ert-expands-respiratory-solutions-support-new-endpoints/ 2018-02-09T08:41:16+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/ert-logo.png http://www.pharmajournalist.com/sanofi-announces-new-safety-data-investigational-avalglucosidase-alfa-patients-pompe-disease/ 2018-02-09T08:43:39+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/sanofi.jpg http://www.pharmajournalist.com/probiogen-teva-sign-license-agreement-hualn-technology/ 2018-02-09T08:46:56+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/TEVA-Pharma.jpg http://www.pharmajournalist.com/selvita-appoints-steffen-heeger-chief-medical-officer/ 2018-02-09T08:50:41+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Selvita-Steffen-Heeger-CMO.jpg https://pharmajournalist.com/wp-content/uploads/2018/02/Selvita-Steffen-Heeger-CMO.jpg http://www.pharmajournalist.com/vetter-introduces-south-koreas-pharma-biotech-community-meet-company-management/ 2018-02-09T08:54:15+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/vetter-Pharma.jpg http://www.pharmajournalist.com/wp-content/uploads/2018/02/vetter-Pharma.jpg http://www.pharmajournalist.com/design-principles-maximising-drug-delivery-efficiency-therapeutic-index-adcs-presented-seattle-genetics-smis-adc-conference/ 2018-02-12T09:28:40+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Antibodies-Antibody-Drug-Conjugates-Banner.jpg http://www.pharmajournalist.com/seventure-partners-joins-panel-microbiome-invest-2018/ 2018-02-12T14:25:49+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Microbiome-Invest-Logo-Kisaco-Research.jpg http://www.pharmajournalist.com/therapeutic-application-botulinum-neurotoxin-pain-pre-clinical-approach/ 2018-02-12T15:39:26+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Pain-Therapeutics-banner-SMi-Pharma-Journalist.jpg http://www.pharmajournalist.com/lakepharma-announces-expansion-new-microbiomanufacturing-center-hopkinton-ma/ 2018-02-13T09:55:43+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/lakepharma-image.jpg https://pharmajournalist.com/wp-content/uploads/2018/02/lakepharma-image.jpg http://www.pharmajournalist.com/teva-announces-launch-generic-version-syprine-united-states/ 2018-02-13T10:02:24+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/TEVA-Pharma.jpg http://www.pharmajournalist.com/applied-therapeutics-initiates-phase-1-trial-001-diabetic-complications/ 2018-02-13T10:07:16+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Applied-Therapeutics-logo.gif http://www.pharmajournalist.com/dnanexus-launches-ngs-clinical-trial-solution/ 2018-02-13T10:09:43+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/DNAnexus-logo.png http://www.pharmajournalist.com/horizon-discovery-enters-license-agreement-us-immuno-oncology-company/ 2018-02-13T10:16:14+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/horizon_logo.png http://www.pharmajournalist.com/challenges-drug-delivery-device-pipelines-pharma-companies/ 2018-02-13T15:41:39+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/Pre-Filled-Syringes-East-Coast-2018-PJ.jpg http://www.pharmajournalist.com/merck-overturns-apecs-study-assessing-verubecestat-mk-8931-prodromal-alzheimers-disease/ 2018-02-14T15:18:05+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/exelixis-declares-results-phase-2-ist-cabozantinib/ 2018-02-14T15:23:37+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Exelixis.jpg https://pharmajournalist.com/wp-content/uploads/2018/02/Exelixis.jpg http://www.pharmajournalist.com/mologen-forays-global-co-development-agreement-oncologie-lead-compound-lefitolimod/ 2018-02-14T15:27:30+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Mologen-AG.jpg http://www.pharmajournalist.com/wp-content/uploads/2018/02/Mologen-AG.jpg http://www.pharmajournalist.com/spinalcyte-cybrocell-dermal-fibroblasts-signalls-positive-phase-1-2-clinical-trial-results/ 2018-02-14T15:31:04+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Fibroblast-cells.jpg https://pharmajournalist.com/wp-content/uploads/2018/02/Fibroblast-cells.jpg http://www.pharmajournalist.com/quidel-seeks-510-k-clearance-quickvue-influenza-ab-test-complying-fdas-class-ii-ridt-requirements/ 2018-02-14T15:38:37+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/quidel-logo.png http://www.pharmajournalist.com/cytobank-associates-fda-enhance-immunotherapy-development/ 2018-02-14T15:39:46+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/astro-declares-positive-results-phase-ii-optima-clinical-trial/ 2018-02-14T15:44:05+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/astro-logo.gif http://www.pharmajournalist.com/phase-ii-condor-trial-suggests-tolerance-inhibitor-durvalumab-patients-metastatic-head-cancer/ 2018-02-14T15:46:01+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/clinical-trials.jpg http://www.pharmajournalist.com/martha-q-curleyphd-appointed-ruth-m-colket-endowed-chair-chop/ 2018-02-14T15:50:37+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Martha-A.Q.-Curley.png https://pharmajournalist.com/wp-content/uploads/2018/02/Martha-A.Q.-Curley.png http://www.pharmajournalist.com/trovagene-declares-activation-2-supplementary-clinical-trial-sites-conduct-phase-1b-2-study/ 2018-02-14T15:55:06+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Trovagene-logo.jpg http://www.pharmajournalist.com/michael-nolte-appointed-ceo-bracket/ 2018-02-14T15:59:16+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Michael-Nolte.jpg https://pharmajournalist.com/wp-content/uploads/2018/02/Michael-Nolte.jpg http://www.pharmajournalist.com/fda-paves-way-marketing-viz-ai-contact-application/ 2018-02-14T16:00:42+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/lynn-lewis-appointed-senior-vp-global-sales-envigo/ 2018-02-14T16:04:58+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Envigo.jpg http://www.pharmajournalist.com/charles-river-laboratories-obtain-mpi-research/ 2018-02-14T16:07:15+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Charles-River.jpeg https://pharmajournalist.com/wp-content/uploads/2018/02/Charles-River.jpeg http://www.pharmajournalist.com/dr-christine-esau-appointed-vp-research-development-arcturus-therapeutics/ 2018-02-14T16:11:12+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Arcturus-Therapeutics.png https://pharmajournalist.com/wp-content/uploads/2018/02/Arcturus-Therapeutics.png http://www.pharmajournalist.com/ec-sanctions-celltrions-herzuma-breast-cancer-patients/ 2018-02-14T16:15:08+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/celltrion-Image.png https://pharmajournalist.com/wp-content/uploads/2018/02/celltrion-Image.png http://www.pharmajournalist.com/pfs-industry-keep-pace-drug-delivery-market/ 2018-02-15T05:00:23+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/PFS-West-Coast-Banner-SMi-Pharma-Journalist.jpg http://www.pharmajournalist.com/facing-uphill-battle-together-pharma-anti-counterfeiting-brand-protection-summit/ 2018-02-15T05:06:13+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Anti-Counterfeiting-IQPC-Banner_Pharma-Journalist.gif http://www.pharmajournalist.com/amgens-blincyto-sbla-assessed-fda-treating-mrd/ 2018-02-15T16:05:44+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/amgen.jpg http://www.pharmajournalist.com/pharmamar-signs-licensing-agreement-seattle-genetics/ 2018-02-15T16:08:17+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/PharmaMar_Image.jpg http://www.pharmajournalist.com/fda-accepts-ortho-dermatologics-jemdel-plaque-psoriasis-treatment/ 2018-02-15T16:14:42+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/valeant-pharma.jpg http://www.pharmajournalist.com/mallinckrodt-affirms-enlisting-first-patient-expressgraft-c9t1-phase-1-study/ 2018-02-15T16:17:03+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/mallinckrodt-pharma.jpg https://pharmajournalist.com/wp-content/uploads/2017/09/mallinckrodt-pharma.jpg http://www.pharmajournalist.com/jj-pharmaceuticals-announce-approval-erleada-fda-nm-crpc-patients/ 2018-02-15T16:21:43+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/Janssen.jpg http://www.pharmajournalist.com/fda-sanctions-breakthrough-treatment-specific-kind-prostate-cancer/ 2018-02-15T16:27:12+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/fda-clearance-sought-roches-factor-ii-factor-v-test-cobas-4800-system/ 2018-02-15T16:30:15+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/sandoz-asserts-fdas-approval-initiation-glatopa/ 2018-02-16T05:25:12+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/sandoz.jpg https://pharmajournalist.com/wp-content/uploads/2017/05/sandoz.jpg http://www.pharmajournalist.com/neurocrine-biosciences-files-nda-opicapone-parkinsons-disease/ 2018-02-16T05:28:54+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/neurocrine-biosciences-logo.png http://www.pharmajournalist.com/irx-therapeutics-commences-phase-2-clinical-trial-cin3-vin3-women/ 2018-02-16T05:32:47+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/IRX-Therapeutics.jpg http://www.pharmajournalist.com/ottr-partners-hemasoft-facilitate-transfusion-medicine/ 2018-02-16T05:35:15+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/ottr.jpg http://www.pharmajournalist.com/bristol-myers-squibb-nektar-therapeutics-collaborate-commercially-nktr-214/ 2018-02-16T05:38:14+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/bristol-myers-squibb.jpg http://www.pharmajournalist.com/fda-concedes-glookos-mobile-insulin-dosing-system/ 2018-02-16T05:44:50+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Glooko-Mobile-App.png http://www.pharmajournalist.com/wp-content/uploads/2018/02/Glooko-Mobile-App.png http://www.pharmajournalist.com/spineology-finishes-enrollment-ide-trial-mesh-fusion-transplant/ 2018-02-16T06:10:46+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Spineology_Logo.jpg http://www.pharmajournalist.com/servier-and-immunoqure-partner-advance-human-interferon-%ce%b1-autoantibody/ 2018-02-16T06:12:08+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Immunoqure.jpg https://pharmajournalist.com/wp-content/uploads/2018/02/Immunoqure.jpg http://www.pharmajournalist.com/astellas-pharma-obtains-universal-cells/ 2018-02-16T06:15:03+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/astellas.jpg http://www.pharmajournalist.com/regentys-collaborates-cook-biotech-curate-unique-ulcerative-colitis-treatment/ 2018-02-16T06:17:24+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/regentys.png http://www.pharmajournalist.com/eisai-asserts-positive-results-phase-3-study-lenvatinib-mesylate/ 2018-02-16T06:41:59+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Eisai.jpg http://www.pharmajournalist.com/citius-patient-mino-lok-phase-3-clinical-trial/ 2018-02-16T06:56:37+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Citius-Pharma.png http://www.pharmajournalist.com/evofem-biosciences-enrollment-phase-3-clinical-trial-amphora/ 2018-02-16T07:09:07+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Evofem-Biosciences.jpg http://www.pharmajournalist.com/dreamed-diabetics-attained-ce-mark-platform-tackling-type-1-diabetes/ 2018-02-16T07:19:28+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/DreaMed-Diabetes.png http://www.pharmajournalist.com/viz-ai-sought-de-novo-fda-clearance-lvo-strokes-cta-imaging/ 2018-02-16T07:27:03+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Viz.ai-logo.jpg http://www.pharmajournalist.com/celgene-corporation-asserted-otezlas-phase-ii-clinical-trial-data/ 2018-02-16T07:43:00+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/celgene-corporation.jpg https://pharmajournalist.com/wp-content/uploads/2018/01/celgene-corporation.jpg http://www.pharmajournalist.com/banyan-biomarkers-attained-fdas-de-novo-request-banyan-bti/ 2018-02-16T08:04:37+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Banyan-Biomarker.jpg https://pharmajournalist.com/wp-content/uploads/2018/02/Banyan-Biomarker.jpg http://www.pharmajournalist.com/aravive-biologics-begins-phase-1-clinical-trial-avb-s6-500/ 2018-02-16T08:23:56+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Aravive-Biologics.jpg http://www.pharmajournalist.com/shawn-m-cross-appointed-ceo-gt-biopharma/ 2018-02-16T08:46:29+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/GTBiopharma-Image.jpg https://pharmajournalist.com/wp-content/uploads/2018/01/GTBiopharma-Image.jpg http://www.pharmajournalist.com/fda-commissioner-scott-gottlieb-statement-influenza-vaccine/ 2018-02-16T08:48:17+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Scott-Gottlieb-FDA.jpg http://www.pharmajournalist.com/intralytix-fda-clearance-phase-iia-clinical-trials-bacteriophages/ 2018-02-16T14:41:24+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Intralytix.jpg https://pharmajournalist.com/wp-content/uploads/2018/02/Intralytix.jpg http://www.pharmajournalist.com/tusker-medical-enlists-first-patient-otter-study/ 2018-02-16T14:45:54+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Tusker-medical.png https://pharmajournalist.com/wp-content/uploads/2018/02/Tusker-medical.png http://www.pharmajournalist.com/merck-kgaa-pfizer-assert-phase-iii-javelin-lung-200-trial-results/ 2018-02-16T14:48:44+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/arrowhead-sought-medsafe-aro-hbv-study/ 2018-02-16T14:50:31+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/arrowhead-pharma-logo.jpg http://www.pharmajournalist.com/arrowhead-pharmaceuticals-orphan-drug-designation-aro-aat/ 2018-02-16T14:51:18+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/arrowhead-pharma-logo.jpg http://www.pharmajournalist.com/arterys-sought-fda-clearance-oncology-ai-suite/ 2018-02-16T14:53:21+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Arterys.jpg http://www.pharmajournalist.com/wp-content/uploads/2018/02/Arterys.jpg http://www.pharmajournalist.com/teva-commercial-availability-qvar-redihaler-inhalation-aerosol/ 2018-02-19T05:58:24+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Teva.jpg https://pharmajournalist.com/wp-content/uploads/2018/02/Teva.jpg http://www.pharmajournalist.com/lead-cell-medica-financing-appointed-kevin-s-boyle-cfo/ 2018-02-19T06:07:12+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Cell-Medica.jpg http://www.pharmajournalist.com/photocure-declares-fda-approved-blue-light-cystoscopy-cysview/ 2018-02-19T06:51:03+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/PhotoCure.jpg http://www.pharmajournalist.com/dermtech-exhibited-pla-high-risk-dna-mutations/ 2018-02-19T07:01:20+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/DermTech.png http://www.pharmajournalist.com/novartis-reports-zero-impact-of-cosentyx-on-moderate-severe-plaque-psoriasis/ 2018-02-19T07:16:20+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/great-point-partners-rebukes-biocrysts-bcrxs-merger-idera/ 2018-02-19T07:27:48+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Idera-Pharmaceuticals.jpg http://www.pharmajournalist.com/abbvie-asserts-new-results-double-blinded-phase-2-celest-study/ 2018-02-19T07:38:39+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Abbvie.jpg https://pharmajournalist.com/wp-content/uploads/2018/02/Abbvie.jpg http://www.pharmajournalist.com/denali-therapeutics-lonza-pharma-biotech-extended-strategic-partnership/ 2018-02-19T07:58:16+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Denali-Therapeutics.jpg https://pharmajournalist.com/wp-content/uploads/2018/02/Denali-Therapeutics.jpg http://www.pharmajournalist.com/roche-set-acquire-shares-flatiron-health-current-12-6/ 2018-02-19T08:00:57+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/senzagen-signs-licensing-agreement-eurofins-biopharma/ 2018-02-19T08:09:51+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/biopharma-product-testing.png http://www.pharmajournalist.com/introducing-launch-smis-injectable-drug-delivery-2018/ 2018-02-19T08:14:21+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Injectable-Drug-Delivery-2018-Banner-SMi-Events-Pharma-Journalist-e1518789305626.jpg http://www.pharmajournalist.com/ground-breaking-research-continuous-fight-amr-stay-updated-smis-event-march/ 2018-02-19T14:09:43+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/20th-Annual-Superbugs-Superdrugs.jpg http://www.pharmajournalist.com/cardax-clinches-deal-hecl-distribution-zanthosyn/ 2018-02-20T13:46:44+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/cardax-inc-logo.png http://www.pharmajournalist.com/recipients-pharmacology-research-grants-declared-avmf/ 2018-02-20T13:51:33+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/AVMF_logo.jpg http://www.pharmajournalist.com/gel-e-sought-two-new-grants-advocate-development-internal-use-hemostats/ 2018-02-20T13:57:19+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/gele-logo.png http://www.pharmajournalist.com/aeras-declared-results-phase-2-tb-vaccine-trial-new-bcg-revaccination-strategies/ 2018-02-20T14:01:01+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/clinical-trial.jpg http://www.pharmajournalist.com/athletico-augments-services-at-athletico-dearborn-heights/ 2018-02-20T14:07:03+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Athlectico-logo.png http://www.pharmajournalist.com/anew-era-tms-facilitates-treatment-medication-resistant-depression/ 2018-02-20T14:13:29+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/treatment-resistante.jpg https://pharmajournalist.com/wp-content/uploads/2018/02/treatment-resistante.jpg http://www.pharmajournalist.com/pantherx-specialty-pharmacy-sought-vipps-accreditation-nabp/ 2018-02-20T14:25:15+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/pantherspecialty-logo.jpg http://www.pharmajournalist.com/photometrics-cairn-research-mizar-imaging-collaborate-hslsfm/ 2018-02-20T14:28:57+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/photometrics-logo.jpg http://www.pharmajournalist.com/genepoc-launches-revogene-instrument-genepoc-gbs-lb-assay-canada/ 2018-02-20T14:37:01+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/GenePOC-revogene.png http://www.pharmajournalist.com/wp-content/uploads/2018/02/GenePOC-revogene.png http://www.pharmajournalist.com/dandrit-biotech-obtains-acquisition-enochian-biopharma/ 2018-02-20T14:40:22+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/dandrit-biotech-logo.jpg http://www.pharmajournalist.com/optimal-research-oncolens-partner-usher-jit-clinical-trials-cancer-patients/ 2018-02-20T14:42:10+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Optimal-research.jpg http://www.pharmajournalist.com/jannsen-pharmaceutical-asserted-remarkable-improvement-tremfya-treated-patients-plaque-psoriasis/ 2018-02-20T14:44:16+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/Janssen.jpg http://www.pharmajournalist.com/leo-pharma-claimed-new-data-exhibiting-long-term-improvements-psoriasis-nail-kyntheum/ 2018-02-20T14:45:42+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/leo-pharma.jpg http://www.pharmajournalist.com/evolus-asserted-presentation-phase-iii-clinical-trial-prabotulinumtoxina-900-kda/ 2018-02-20T14:48:26+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/evolus-logo.png http://www.pharmajournalist.com/saneca-pharma-appoints-new-ceo/ 2018-02-20T14:50:40+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/saneca-pharma-logo.png http://www.pharmajournalist.com/fda-sanctions-imfinzi-treatment-stage-iii-nsclc/ 2018-02-21T05:10:37+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/axiom-foods-secured-first-application-oryzatein-rice-protein/ 2018-02-21T11:49:24+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Axiom.jpg https://pharmajournalist.com/wp-content/uploads/2018/02/Axiom.jpg http://www.pharmajournalist.com/wize-pharma-sought-irb-approval-phase-iv-study/ 2018-02-21T11:52:34+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/wize-pharma-ltd-logo.png http://www.pharmajournalist.com/micromedic-technologies-clinical-study-results-detecting-prostate-cancer-cells/ 2018-02-21T12:00:50+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Micromedic-Technologies.jpg http://www.pharmajournalist.com/wp-content/uploads/2018/02/Micromedic-Technologies.jpg http://www.pharmajournalist.com/alcyone-lifesciences-demarcates-hydrocephalus-business/ 2018-02-21T12:07:39+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/alcyone-lifesciences-inc-logo.png http://www.pharmajournalist.com/catheter-precision-rolls-clinical-trial-vivo-non-invasive-mapping-system/ 2018-02-21T12:11:14+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/clinical-trials.jpg http://www.pharmajournalist.com/fda-quells-ptc-therapeutics-appeal-nda-ataluren/ 2018-02-21T12:15:49+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/PTC-therapeutics-logo.jpg http://www.pharmajournalist.com/kancera-ab-imparts-positive-results-phase-study-kand567/ 2018-02-21T12:20:37+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/kancera-image.png http://www.pharmajournalist.com/wp-content/uploads/2018/02/kancera-image.png http://www.pharmajournalist.com/achieve-declares-preliminary-data-phase-ii-pk-pd-study-cytisine/ 2018-02-21T12:23:43+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/clinical-trials.png http://www.pharmajournalist.com/mylan-n-v-sought-approval-fda-nda-dolutegravir-tablets/ 2018-02-21T12:27:07+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/mylan.jpg http://www.pharmajournalist.com/laura-ames-named-ceo-recovery-centers-amercia/ 2018-02-21T12:33:06+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Recovery-Centers-of-America-logo.png http://www.pharmajournalist.com/impax-declares-launch-generic-version-solodyn/ 2018-02-21T12:36:15+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/impax-lab-logo.jpg http://www.pharmajournalist.com/spencer-fisk-appointed-senior-vp-manufacturing-rubius-therapeutics/ 2018-02-21T12:44:33+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/rubius-therapeutics-logo.png http://www.pharmajournalist.com/qiagen-approves-igra-tb-screening-according-us-cdc/ 2018-02-21T12:46:36+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/qiagen-image.jpg http://www.pharmajournalist.com/fda-extends-hud-nativis-voyager-pediatric-system/ 2018-02-21T12:48:52+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/fda-sanctions-neotracts-indications-urolift-system/ 2018-02-21T12:54:23+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/urolift-system.jpg http://www.pharmajournalist.com/wp-content/uploads/2018/02/urolift-system.jpg http://www.pharmajournalist.com/gsks-fluarix-quadrivalent-exemplifies-63-2-efficacy/ 2018-02-22T06:01:02+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/gsk.jpg https://pharmajournalist.com/wp-content/uploads/2017/10/gsk.jpg http://www.pharmajournalist.com/dr-farideh-bischoff-appointed-vp-clinical-research-imagion-biosystems/ 2018-02-22T06:02:07+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Imagion-Biosystems.jpg http://www.pharmajournalist.com/wp-content/uploads/2018/02/Imagion-Biosystems.jpg http://www.pharmajournalist.com/evofem-biosciences-sought-fdas-fast-track-designation-amphora-vagina-gel/ 2018-02-22T06:23:25+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/evofem-biosciences-logo.jpg http://www.pharmajournalist.com/alabama-fertility-offers-invocell-alabama/ 2018-02-22T07:00:23+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/INVO-Bioscience.jpg http://www.pharmajournalist.com/dr-warren-krackov-appointed-medical-director-and-ufe-specialist-vascular-interventions/ 2018-02-22T07:18:39+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Warren-Krackov.jpg https://pharmajournalist.com/wp-content/uploads/2018/02/Warren-Krackov.jpg http://www.pharmajournalist.com/glenmark-collaborates-scd-ophthalmic-products-u-s-canada/ 2018-02-22T07:36:26+00:00 https://pharmajournalist.com/wp-content/uploads/2017/07/glenmark-pharma.jpg https://pharmajournalist.com/wp-content/uploads/2017/07/glenmark-pharma.jpg http://www.pharmajournalist.com/pharmajet-collaborates-genexine-commercialize-dna-vaccines/ 2018-02-22T07:41:17+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Needle-Free-Injection-Pharmajet.png https://pharmajournalist.com/wp-content/uploads/2018/02/Needle-Free-Injection-Pharmajet.png http://www.pharmajournalist.com/chiron-recovery-executed-a-mat-program-for-opioid-addiction/ 2018-02-22T07:42:32+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Chiron-Recovery.jpg https://pharmajournalist.com/wp-content/uploads/2018/02/Chiron-Recovery.jpg http://www.pharmajournalist.com/fda-monitors-destruction-recall-kratom-products/ 2018-02-22T07:52:10+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/vertex-commences-phase-3-study-vx-659-cf/ 2018-02-22T07:59:37+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/vertex-pharma-logo.png http://www.pharmajournalist.com/biologics-assures-availability-erleada-treatment-non-metastatic-castration-resistant-prostate-cancer/ 2018-02-22T08:11:20+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/McKesson.jpg http://www.pharmajournalist.com/celgene-affirmed-antitrust-clearance-obtaining-juno/ 2018-02-22T08:15:56+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/celgene.jpg http://www.pharmajournalist.com/merck-forays-acquiring-viralytics-augmenting-immuno-oncology-pipeline/ 2018-02-22T08:24:08+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/clovis-oncology-sought-positive-vote-chmp-rucaparib-tablets/ 2018-02-22T08:34:22+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Clovis-Oncology.jpg http://www.pharmajournalist.com/astrazeneca-asserts-availability-flumist-quadrivalent-vaccine-u-s/ 2018-02-22T08:50:41+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/astrazeneca.jpg https://pharmajournalist.com/wp-content/uploads/2017/04/astrazeneca.jpg http://www.pharmajournalist.com/navigate-cardiac-structures-declares-gate-bioprosthesis-treat-tricuspid-regurgitation/ 2018-02-22T08:51:15+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/NaviGate.jpg http://www.pharmajournalist.com/bioprocess-international-european-summit-connecting-science-technology-business-optimise-bioprocessing/ 2018-02-23T12:58:13+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/BioProcess-International-Knect-Banner-PJ.jpg http://www.pharmajournalist.com/pacbridge-capital-partners-hk-acquires-contextual-genomics/ 2018-02-26T06:18:25+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Contextual-genomics.jpg https://pharmajournalist.com/wp-content/uploads/2018/02/Contextual-genomics.jpg http://www.pharmajournalist.com/pfizer-sought-chmp-opinion-mylotarg-bosulif/ 2018-02-26T06:20:22+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/cel-sci-extends-expiration-date-series-dd-series-ee-warrants-issued/ 2018-02-26T06:28:15+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Cell-SCI-1.jpg https://pharmajournalist.com/wp-content/uploads/2018/02/Cell-SCI.jpg http://www.pharmajournalist.com/pfizer-declares-update-emap-sutent-rcc-patients/ 2018-02-26T06:41:33+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Pfizer.jpg https://pharmajournalist.com/wp-content/uploads/2018/02/Pfizer.jpg http://www.pharmajournalist.com/puma-biotechnology-asserts-chmps-negative-opinion-maa-neratinib/ 2018-02-26T06:57:13+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Puma-Biotechnology-logo.jpg http://www.pharmajournalist.com/kadmon-declares-updated-optimistic-results-phase-2-study-kd025-208-cgvhd/ 2018-02-26T07:10:59+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Kadman.png http://www.pharmajournalist.com/mabspace-biosciences-declares-fda-approval-ind-msb2311/ 2018-02-26T07:39:40+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/alfa-scientific-designs-assert-fda-510k-clearance-driven-flow-technology/ 2018-02-26T07:53:39+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Alfa-scientific-designs.jpg https://pharmajournalist.com/wp-content/uploads/2018/02/Alfa-scientific-designs.jpg http://www.pharmajournalist.com/500-special-discount-drug-discovery-conference-4-weeks-time/ 2018-02-26T07:53:56+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/Drug-Discovery-2018-SMi-Banner.jpg http://www.pharmajournalist.com/pfizer-appointed-albert-bourla-board-directors/ 2018-02-26T08:08:51+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/aurinia-appoints-michael-hayden-board-directors/ 2018-02-26T08:17:13+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Aurinia-Pharma-Logo.jpg http://www.pharmajournalist.com/atricure-rolls-atriclip-flex%e2%80%a2v-device-u-s/ 2018-02-26T08:24:42+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/AtriClip-Device.png https://pharmajournalist.com/wp-content/uploads/2018/02/AtriClip-Device.png http://www.pharmajournalist.com/stephen-ostroff-deputy-commissioner-fvmntp-states-draft-report-bisphenol/ 2018-02-26T08:35:23+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Stephen-Ostroff.jpg http://www.pharmajournalist.com/jazz-enrolls-first-patient-phase-2-clinical-trial-evaluating-defibrotide/ 2018-02-26T08:44:46+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Jazz.png http://www.pharmajournalist.com/amgen-sought-chmps-positive-opinion-xgeva-multiple-myeloma/ 2018-02-26T08:50:08+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/amgen.jpg http://www.pharmajournalist.com/hear-medimmune-ipsen-smis-injectable-drug-delivery-2018/ 2018-02-26T09:41:29+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Injectable-Drug-Delivery-2018-Banner-SMi-Events-Pharma-Journalist-e1518789305626.jpg http://www.pharmajournalist.com/lantern-pharma-joins-genomic-englands-discovery-forum-industry-partnership/ 2018-02-27T05:23:07+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/lantern-pharma-logo.png http://www.pharmajournalist.com/merck-asserts-anmats-approval-mavenclad-tablets-treating-multiple-sclerosis/ 2018-02-27T05:50:45+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/explore-innovative-approaches-novel-targets-analgesic-medicine/ 2018-02-27T05:50:58+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Pain-Therapeutics-banner-SMi-Pharma-Journalist.jpg http://www.pharmajournalist.com/first-septic-shock-treatment-proved-saviour-child-levine-childrens-hospital/ 2018-02-27T05:52:42+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Lucas.jpg https://pharmajournalist.com/wp-content/uploads/2018/02/Lucas.jpg http://www.pharmajournalist.com/epds-cardiac-mapping-navigation-system-received-ce-mark-approval/ 2018-02-27T06:06:11+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/EPD.jpg https://pharmajournalist.com/wp-content/uploads/2018/02/EPD.jpg http://www.pharmajournalist.com/american-osteopathic-associations-research-marks-vitamin-d-inefficiency-owing-low-magnesium/ 2018-02-27T06:22:18+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/American-Osteopathic-Association.jpg http://www.pharmajournalist.com/epimab-biotherapeutics-appoints-bin-peng-chief-medical-officer/ 2018-02-27T06:52:31+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Bispecific.jpg http://www.pharmajournalist.com/wp-content/uploads/2018/02/Bispecific.jpg http://www.pharmajournalist.com/genomic-health-launches-oncotype-dx-ar-v7-nuclear-detect-test/ 2018-02-27T06:53:52+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Nucleus-Detect-test.jpg https://pharmajournalist.com/wp-content/uploads/2018/02/Nucleus-Detect-test.jpg http://www.pharmajournalist.com/evidence-based-oncology-imparts-biomarkers-car-t-cell-coverage/ 2018-02-27T07:05:43+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/AJMC.jpg http://www.pharmajournalist.com/neumentum-confirms-type-b-meeting-fda-appointing-new-chief-medical-scientific-officers/ 2018-02-27T07:35:47+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Neumentum.jpg https://pharmajournalist.com/wp-content/uploads/2018/02/Neumentum.jpg http://www.pharmajournalist.com/shionogi-sought-fda-nda-ema-maa-lusutrombopag-s-888711/ 2018-02-27T07:58:53+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Shionogi.jpg http://www.pharmajournalist.com/vertex-appoints-reshma-kewalramani-md-chief-medical-officer/ 2018-02-27T08:22:28+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/vertex-pharma-logo.png http://www.pharmajournalist.com/pharmacyte-declares-completion-6-month-stability-study-encapsulated-cells-clinical-trial/ 2018-02-27T08:33:10+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Pharmacyte.jpg https://pharmajournalist.com/wp-content/uploads/2018/02/Pharmacyte.jpg http://www.pharmajournalist.com/lilly-sought-fda-approval-verzenio-advanced-breast-cancer/ 2018-02-27T08:38:25+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/fda-clearance-sought-access-vasculars-hydropicc-catheter/ 2018-02-27T08:47:34+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Access-vascular.jpg https://pharmajournalist.com/wp-content/uploads/2018/02/Access-vascular.jpg http://www.pharmajournalist.com/longeveron-commenced-treatment-first-left-heart-syndrome-patient-using-mesenchymal-stem-cell-therapy/ 2018-02-28T05:28:15+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Longeveron.png https://pharmajournalist.com/wp-content/uploads/2018/02/Longeveron.png http://www.pharmajournalist.com/abbott-surmodics-venture-agreement-surveil-drug-coated-balloon/ 2018-02-28T05:52:10+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/Abbott1.png http://www.pharmajournalist.com/amgen-sought-positive-chmp-opinion-neulasta-onpro-kit/ 2018-02-28T06:03:37+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/amgen.jpg http://www.pharmajournalist.com/beacon-discovery-proclaims-multi-year-gpcr-drug-discovery-partnership-takeda/ 2018-02-28T06:28:59+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/aridis-pharmaceuticals-enters-jv-shenzhen-hepalink-pharmaceutical-group/ 2018-02-28T06:55:16+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Aridis-Pharmaceutical.jpg https://pharmajournalist.com/wp-content/uploads/2018/02/Aridis-Pharmaceutical.jpg http://www.pharmajournalist.com/aldeyra-therapeutics-forays-agreement-johnson-johnson/ 2018-02-28T07:08:19+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/aldeyra-therapeutics-logo.png http://www.pharmajournalist.com/celltex-therapeutics-initiates-wellness-protocol-clinical-trial-mexico/ 2018-02-28T07:25:27+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Celltex-Therapeutics.jpg https://pharmajournalist.com/wp-content/uploads/2018/02/Celltex-Therapeutics.jpg http://www.pharmajournalist.com/sierra-oncology-signs-supply-agreement-prostate-cancer-study/ 2018-02-28T07:45:42+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Sierra-Oncology.png http://www.pharmajournalist.com/fda-approves-ground-breaking-treatment-obstructive-sleep-disorders/ 2018-02-28T08:10:29+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Meridian-PM-oral-device.jpg https://pharmajournalist.com/wp-content/uploads/2018/02/Meridian-PM-oral-device.jpg http://www.pharmajournalist.com/alung-enrolls-pivotal-trial-hemolung-ras-us-market/ 2018-02-28T08:31:55+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Alung.png http://www.pharmajournalist.com/enyo-pharma-assures-phase-ib-trial-chronic-hbv-afflicted-patients/ 2018-02-28T08:38:46+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/ENYO-Pharma.jpg http://www.pharmajournalist.com/invicro-appoints-edward-hogan-senior-vp-clinical-operations/ 2018-02-28T08:46:45+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Ed_Hogan.jpg https://pharmajournalist.com/wp-content/uploads/2018/02/Ed_Hogan.jpg http://www.pharmajournalist.com/dr-sarah-schlesinger-appointed-medicines-companys-board-directors/ 2018-02-28T08:52:02+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/The-Medicines-Company.jpg http://www.pharmajournalist.com/cmic-holdings-median-technologies-venture-agreement-ensuring-clinical-trial-services/ 2018-02-28T08:59:07+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/CMIC.png http://www.pharmajournalist.com/latest-developments-breakthroughs-antibiotic-resistance/ 2018-03-01T05:52:14+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/20th-Annual-Superbugs-Superdrugs.jpg http://www.pharmajournalist.com/orthospin-successfully-finishes-fih-case-robotic-external-fixation-system/ 2018-03-01T05:52:27+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Orthospin.jpg https://pharmajournalist.com/wp-content/uploads/2018/03/Orthospin.jpg http://www.pharmajournalist.com/spruce-biosciences-rolls-study-congenital-adrenal-hyperplasia/ 2018-03-01T06:12:32+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Spruce-Biosciences.jpg https://pharmajournalist.com/wp-content/uploads/2018/03/Spruce-Biosciences.jpg http://www.pharmajournalist.com/second-genome-initiates-4-collaborations-assessing-effect-gut-microbiota/ 2018-03-01T06:25:11+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Second-Genome.jpg https://pharmajournalist.com/wp-content/uploads/2018/03/Second-Genome.jpg http://www.pharmajournalist.com/mabvax-therapeutics-affirms-positive-results-phase-1-clinical-trial-reviewing-mvt-1075/ 2018-03-01T06:42:34+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/MabVax-Therapeutics-1.png http://www.pharmajournalist.com/sangamo-seeks-mhra-authorization-cta-phase-1-2-clinical-trial-assessing-sb-fix/ 2018-03-01T07:04:29+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Sangamo-Therapeutics.jpg http://www.pharmajournalist.com/bioatla-enlists-first-patient-phase-1-2-ba3011-001-clinical-trial-cab-axl-adc-therapeutic/ 2018-03-01T07:45:23+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/BioAtla.png http://www.pharmajournalist.com/maia-pharmaceuticals-sought-approval-fda-nda-sincalide-injection/ 2018-03-01T07:56:36+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/kinetix-group-care-delivery-services-associates-pts-diagnostics/ 2018-03-01T08:04:58+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/TKG.jpg http://www.pharmajournalist.com/apnea-sciences-corporation-launched-snorerx-approved-fda/ 2018-03-01T08:16:11+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/SnoreRx.png https://pharmajournalist.com/wp-content/uploads/2018/03/SnoreRx.png http://www.pharmajournalist.com/blink-health-appointed-odonnell-head-engineering/ 2018-03-01T08:28:00+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Blink-Health.png http://www.pharmajournalist.com/fda-finalizes-booz-allen-spot-300m-award-optimize-drm/ 2018-03-01T08:35:30+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/concert-pharmaceuticals-proclaims-facilitation-candidate-ctp-692-schizophrenia/ 2018-03-01T08:44:27+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/concert-pharmaceuticals.jpg https://pharmajournalist.com/wp-content/uploads/2017/05/concert-pharmaceuticals.jpg http://www.pharmajournalist.com/sonex-health-samsung-neurologica-claim-strategic-partnership/ 2018-03-01T08:49:23+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Sonex-Health.jpg http://www.pharmajournalist.com/mark-breedlove-spearhead-new-cook-medical-business-divisions/ 2018-03-01T08:54:52+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Breedlove_Mark.jpg https://pharmajournalist.com/wp-content/uploads/2018/03/Breedlove_Mark.jpg http://www.pharmajournalist.com/acclarent-received-fda-clearance-aera-eustachian-tube-balloon-dilation-system/ 2018-03-02T10:11:42+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Acclarent.jpg https://pharmajournalist.com/wp-content/uploads/2018/02/AERA-with-Cap.jpeg http://www.pharmajournalist.com/fda-clearance-received-endomags-magseed-marker/ 2018-03-05T05:05:44+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Magseed-marker.jpg http://www.pharmajournalist.com/wp-content/uploads/2018/02/Magseed-marker.jpg http://www.pharmajournalist.com/fda-approves-jazz-pharmaceuticals-nda-for-solriamfetol-in-osa-patients/ 2018-03-05T05:54:24+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/jazz-pharmaceuticals.jpg https://pharmajournalist.com/wp-content/uploads/2017/04/jazz-pharmaceuticals.jpg http://www.pharmajournalist.com/mylan-set-introduce-viable-hiv-treatments-symfi-lo-cimduo/ 2018-03-05T06:16:00+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/mylan.jpg http://www.pharmajournalist.com/fda-evaluate-sbla-dupixent-asthama-patients/ 2018-03-05T06:32:15+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/regeneron.jpg https://pharmajournalist.com/wp-content/uploads/2017/08/regeneron.jpg http://www.pharmajournalist.com/ageless-forever-declares-offer-gainswave/ 2018-03-05T06:53:26+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Ageless-forever.jpg https://pharmajournalist.com/wp-content/uploads/2018/03/Ageless-forever.jpg http://www.pharmajournalist.com/ionis-pharmaceuticals-asserted-presentation-optimistic-top-line-data-phase-1-2-study-ionis-httrx/ 2018-03-05T07:23:17+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/ionis-pharma-logo.jpg http://www.pharmajournalist.com/jhl-biotech-affirmed-dhas-approval-clinical-trial-application-jhls-jhl1922/ 2018-03-05T07:40:52+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/JHL-Biotech.jpg http://www.pharmajournalist.com/csa-medical-completes-treatments-rejuvenair-safety-feasibility-study-chronic-bronchitis-patients/ 2018-03-05T08:00:20+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/CSA-Medical.jpg http://www.pharmajournalist.com/michbio-endorse-governor-rick-snyder-signing-legislation-pave-way-interchangeable-biologic-medicines/ 2018-03-05T08:10:48+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/MichBio.jpg http://www.pharmajournalist.com/biogen-abbvie-retracts-zinbryta-relapsing-multiple-sclerosis/ 2018-03-05T08:19:05+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/abbvie.jpg https://pharmajournalist.com/wp-content/uploads/2018/02/Abbvie.jpg http://www.pharmajournalist.com/fda-clears-1-0mm-coronary-balloon-cardiovascular-systems/ 2018-03-05T08:32:34+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/six-leading-pharma-firms-participate-pharmaceutical-microbiology-event-san-diego/ 2018-03-05T08:39:02+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Pharmaceutical-Microbiology-West-Coast_PJ.jpg http://www.pharmajournalist.com/christiana-stamoulis-appointed-president-unum-therapeutics/ 2018-03-05T08:40:38+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Unum-Therapeutics.png http://www.pharmajournalist.com/meiragtx-declares-emas-extension-prime-designation-a002/ 2018-03-05T08:49:04+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/MeriaGTx.jpg http://www.pharmajournalist.com/aimmune-therapeutics-declares-results-phase-3-palisade-trial-ar101-peanut-allergy-patients/ 2018-03-05T08:55:20+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Aimmune-Therapeutics-logo.png http://www.pharmajournalist.com/future-parenteral-drug-delivery/ 2018-03-05T10:49:36+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/Pre-Filled-Syringes-East-Coast-2018-PJ.jpg http://www.pharmajournalist.com/micurx-receives-funding-carb-x-polymyxin-antibiotic-mrx-8/ 2018-03-06T05:45:18+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/MicuRx.jpg http://www.pharmajournalist.com/glenmark-pharmaceuticals-presents-new-data-ryaltris-treating-sar-aaaai-wao/ 2018-03-06T06:14:29+00:00 https://pharmajournalist.com/wp-content/uploads/2017/07/glenmark-pharma.jpg https://pharmajournalist.com/wp-content/uploads/2017/07/glenmark-pharma.jpg http://www.pharmajournalist.com/lyric-finishes-enrollment-phase-2-prromote-study-lp101-enteral-feeding-intolerance/ 2018-03-06T06:25:21+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Lyric-Pharmaceuticals.png http://www.pharmajournalist.com/aequus-ehave-venture-collaboration-agreement-bioinformatics-platform/ 2018-03-06T06:43:07+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Ehave.png http://www.pharmajournalist.com/trovagene-confirms-enrollment-first-patient-cycle-1-treatment-pcm-075/ 2018-03-06T06:52:11+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Trovagene-logo.jpg http://www.pharmajournalist.com/benitec-biopharma-initiates-phase-2-oncology-study-australia/ 2018-03-06T07:03:38+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Benitec-biopharma.jpg http://www.pharmajournalist.com/mybiotics-signs-second-option-agreement-ferring-holding-validation/ 2018-03-06T07:09:40+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Ferring-Pharmaceuticals-Singapore.jpg https://pharmajournalist.com/wp-content/uploads/2018/02/Ferring-Pharmaceuticals-Singapore.jpg http://www.pharmajournalist.com/vanda-pharmaceuticals-hetlioz-symptoms-jet-lag-disorder/ 2018-03-06T07:19:23+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Vanda-Pharmaceuticals.jpg http://www.pharmajournalist.com/prometic-receives-rare-pediatric-disease-designation-fda/ 2018-03-06T07:23:44+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Prometic-Life-Sciences.jpg https://pharmajournalist.com/wp-content/uploads/2018/01/Prometic-Life-Sciences.jpg http://www.pharmajournalist.com/fda-approves-ind-application-moleacs-phase-1-study-mlc1501/ 2018-03-06T07:38:44+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Moleac.jpg http://www.pharmajournalist.com/sinovac-biotech-plans-enhance-corporate-governance/ 2018-03-07T05:09:55+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Sinovac.jpg http://www.pharmajournalist.com/glycomimetics-unveils-design-phase-3-clinical-trial-gmi-1271-relapsed-aml/ 2018-03-07T05:45:06+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/GlycoMimetics.png http://www.pharmajournalist.com/city-hope-scientists-doctors-proclaim-new-drug-combat-chronic-myelogenous-leukemia/ 2018-03-07T06:07:29+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/City-Of-hope.jpg http://www.pharmajournalist.com/magenta-therapeutics-heidelberg-pharma-sign-agreement/ 2018-03-07T06:20:09+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Magenta-Therapeutics.jpg http://www.pharmajournalist.com/sagent-pharmaceuticals-asserted-nationwide-recall-methylprednisolone-sodium-succinate-injection-usp-40mg-125mg-1g/ 2018-03-07T07:23:42+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Sagent-1.jpg https://pharmajournalist.com/wp-content/uploads/2018/03/1fgc-1.jpg http://www.pharmajournalist.com/contego-medical-commences-enrollment-performance-trial/ 2018-03-07T08:10:32+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Contego-Medical.png http://www.pharmajournalist.com/fda-sanctions-afia-detecting-antibodies-babesia-microti-imugen-babesia-microti-nat/ 2018-03-07T08:18:16+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/fda-sanctions-trogarzo-hiv-treatment-untreated-patients/ 2018-03-07T08:24:52+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/theratechnologies-states-fda-approval-innovative-therapy-trogarzo-injection/ 2018-03-07T08:31:20+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Thera.jpg http://www.pharmajournalist.com/fda-authorization-extended-23andme-direct-consumer-genetic-test-cancer-risk/ 2018-03-07T08:40:12+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/23andMe.png http://www.pharmajournalist.com/introducing-2nd-annual-hpapi-conference-may-2018/ 2018-03-07T09:04:09+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/HPAPI-Banner-SMi-Pharma-Journalist.jpg http://www.pharmajournalist.com/discover-novel-based-vial-based-technology-presented-roche-may/ 2018-03-07T09:05:57+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Injectable-Drug-Delivery-2018-Banner-SMi-Events-Pharma-Journalist-e1518789305626.jpg http://www.pharmajournalist.com/forendo-pharma-appoints-david-colpman-non-executive-director-board-directors/ 2018-03-07T09:31:28+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Forendo-Pharma-1.png http://www.pharmajournalist.com/citius-pharmaceuticals-conveys-progress-hemorroid-treatment-program/ 2018-03-07T11:27:39+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Citius-Pharma.png http://www.pharmajournalist.com/apexigen-pediatric-brain-tumor-consortium-collaborate-evaluate-apx005m-brain-tumor-children/ 2018-03-07T11:41:21+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Apexigen.png http://www.pharmajournalist.com/biohaven-enrolls-first-patient-phase-3-clinical-trial-assess-rimegepant-zydis-odt-treat-migraine/ 2018-03-07T11:52:52+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Biohaven-Pharma-Logo.png http://www.pharmajournalist.com/ligand-signs-license-agreement-roivant-sciences/ 2018-03-07T12:11:24+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Ligand-Pharmaceuticals-logo.png http://www.pharmajournalist.com/veloxis-submits-snda-fda-seeking-new-indication-envarsus-xr/ 2018-03-08T05:55:37+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/Veloxis-Pharma-Logo.jpg http://www.pharmajournalist.com/perrigo-receives-final-approval-fda-otc-equivalent-mucinex-dm/ 2018-03-08T06:07:34+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/perrigo-logo.jpg http://www.pharmajournalist.com/zydus-partners-medicure-launch-nda-product-zypitamag/ 2018-03-08T06:21:58+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Zydus.jpg https://pharmajournalist.com/wp-content/uploads/2018/03/Zydus.jpg http://www.pharmajournalist.com/fda-commissioner-scott-gottlieb-vows-commit-market-review-essure/ 2018-03-08T06:43:58+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Scott-Gottlieb-FDA.jpg http://www.pharmajournalist.com/pcma-conveys-response-scott-gottliebs-comments-biosimilars/ 2018-03-08T06:52:53+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/PCMA.png http://www.pharmajournalist.com/mym-nutraceuticals-appoints-dr-charith-adkar-new-chief-science-officer/ 2018-03-08T07:11:59+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/MYM-Nutraceuticals-logo.png http://www.pharmajournalist.com/fda-clearance-granted-premier-biotechs-oral-fluid-drug-testing-device-oraltox/ 2018-03-08T07:22:06+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/OralTox.jpg https://pharmajournalist.com/wp-content/uploads/2018/03/OralTox.jpg http://www.pharmajournalist.com/compugen-licenses-selexis-cell-line-based-protein-expression-platform/ 2018-03-08T07:29:35+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/selexis-logo.jpg http://www.pharmajournalist.com/fda-ce-mark-approvals-granted-orthofixs-physiostim-bone-growth-stimulators/ 2018-03-08T07:36:32+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Orthofix_PhysioStim_Device.jpg https://pharmajournalist.com/wp-content/uploads/2018/03/Orthofix_PhysioStim_Device.jpg http://www.pharmajournalist.com/leica-biosystems-announced-release-bond-iii-ihc-ish-stainer/ 2018-03-08T07:45:59+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Leica.jpg https://pharmajournalist.com/wp-content/uploads/2018/03/Leica.jpg http://www.pharmajournalist.com/crossroads-extremity-systems-launches-dynaforce-active-stabilization/ 2018-03-08T07:51:35+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/DynaFORCE-Active-Stabilization.jpg https://pharmajournalist.com/wp-content/uploads/2018/03/DynaFORCE-Active-Stabilization.jpg http://www.pharmajournalist.com/isolatefibromyalgia-test-ascertain-fibromyalgia-iquity/ 2018-03-08T08:02:53+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/IQuity.jpg http://www.pharmajournalist.com/wuxi-nextcode-reveals-genomics-partnership-google-cloud/ 2018-03-08T08:11:27+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Wuxi-NextCODE.jpg http://www.pharmajournalist.com/soin-neuroscience-secures-irb-approval-commence-clinical-case-series-studying-spinal-cord-stimulator-alogrithms/ 2018-03-09T05:55:30+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Amol-Soin.jpg https://pharmajournalist.com/wp-content/uploads/2018/03/Amol-Soin.jpg http://www.pharmajournalist.com/american-diabetes-association-issues-new-guidance-hemoglobin-a1c-targets-glycemic-control-pharmacologic-therapy-nonpregnant-adults-type-2-diabetes-mellitus/ 2018-03-09T06:09:58+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/ADA.png http://www.pharmajournalist.com/cdi-labs-collaborates-discerning-zika-dengue-virus/ 2018-03-09T06:27:10+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Zika-virus.jpg https://pharmajournalist.com/wp-content/uploads/2018/03/Zika-virus.jpg http://www.pharmajournalist.com/johns-hopkins-study-unveils-ai-driven-mobile-app-sweetch-alleviates-blood-sugar-levels/ 2018-03-09T06:47:19+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Sweetch.png https://pharmajournalist.com/wp-content/uploads/2018/03/Sweetch.png http://www.pharmajournalist.com/spinal-singularity-treats-first-patient-connected-catheter/ 2018-03-09T06:58:59+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Connected-Catheter.png http://www.pharmajournalist.com/roche-instigates-new-cobas-m-511-analyzer-hematology-testing/ 2018-03-09T07:23:52+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/prokaryotics-recieves-2-5-million-sbir-grant-endorse-novel-antibiotic-program/ 2018-03-09T07:33:26+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Prokaryotics-Inc-1.jpg http://www.pharmajournalist.com/wuxi-biologics-and-adagene-declare-manufacturing-and-strategic-development-partnership/ 2018-03-09T07:37:55+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/wuxi-biologics-logo.png http://www.pharmajournalist.com/ortho-clinical-diagnostics-institutes-vitros-c-peptide-assay/ 2018-03-09T07:53:38+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Ortho-Clinical-Diagnostics.png http://www.pharmajournalist.com/tyber-medical-asserts-launch-tyfix/ 2018-03-09T08:02:28+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/tyfix-screw.jpg https://pharmajournalist.com/wp-content/uploads/2018/03/tyfix-screw.jpg http://www.pharmajournalist.com/invivo-therapeutics-receives-fda-approval-trial-neuro-spinal-scaffold/ 2018-03-09T08:09:55+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/InVivo.png http://www.pharmajournalist.com/therapeuticsmd-concedes-fda-acceptance-nda-pdufa-date-tx-001hr/ 2018-03-09T08:16:25+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/THERAPEUTICSMD.jpg http://www.pharmajournalist.com/wp-content/uploads/2018/03/THERAPEUTICSMD.jpg http://www.pharmajournalist.com/eyenuk-receives-health-canada-approval-eyeart/ 2018-03-09T08:23:02+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Eyenuk.jpg https://pharmajournalist.com/wp-content/uploads/2018/03/Eyenuk.jpg http://www.pharmajournalist.com/tango-therapeutics-enhances-board-directors-adding-oncology-experts/ 2018-03-09T08:27:28+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Tango-Therapeutics.jpg http://www.pharmajournalist.com/janssen-pharmaceutical/ 2018-03-12T05:49:01+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/Janssen.jpg https://pharmajournalist.com/wp-content/uploads/2017/09/Janssen.jpg http://www.pharmajournalist.com/abbotts-heartmate-3-heart-pump-displays-enhanced-survival-lower-rates-stroke-pump-thrombosis/ 2018-03-12T06:01:07+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Abbott.png http://www.pharmajournalist.com/define-flair-clinical-trial-signals-philips-ifr-cost-friendly-ffr/ 2018-03-12T06:18:33+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Royal-Philips.jpg https://pharmajournalist.com/wp-content/uploads/2018/03/Royal-Philips.jpg http://www.pharmajournalist.com/regeneron-sanofi-declare-plans-make-praluent-accessible-patients-high-risk/ 2018-03-12T06:44:06+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/sanofi.jpg https://pharmajournalist.com/wp-content/uploads/2017/10/sanofi.jpg http://www.pharmajournalist.com/hear-astrazeneca-smis-hpapi-2018/ 2018-03-12T07:00:58+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/HPAPI-Banner-SMi-Pharma-Journalist.jpg http://www.pharmajournalist.com/smis-pharma-microbiology-west-coast-2018-chair-speakers-announced/ 2018-03-12T07:06:22+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Pharma-Microbiology-Banner-SMi-Pharma-Journalist.jpg http://www.pharmajournalist.com/amgen-declared-data-two-new-studies-suggest-barriers-access-pcsk9-inhibitors/ 2018-03-12T07:07:07+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/amgen.jpg http://www.pharmajournalist.com/fda-sanctions-pivotal-clinical-trial-technology-treat-overactive-bladder/ 2018-03-12T07:24:39+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/cti-biopharma-declares-publication-pacritinib-phase-3-persist-2-clinical-trial-jama-oncology/ 2018-03-12T07:33:16+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/CTI-Biopharma.png http://www.pharmajournalist.com/rmat-designation-granted-fda-amniofix-injectable-treatment-osteoarthritis/ 2018-03-12T07:50:13+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/MiMedx-Group-Inc-logo.jpg http://www.pharmajournalist.com/canon-medical-systems-initiates-new-version-aplio-i900-premium-cardiovascular-ultrasound/ 2018-03-12T08:04:18+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Canon-Medical-systems.png http://www.pharmajournalist.com/pfizer-declares-optimistic-result-fda-advisory-committee-meeting-xeljanz-uc/ 2018-03-12T08:11:42+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Pfizer.jpg https://pharmajournalist.com/wp-content/uploads/2018/02/Pfizer.jpg http://www.pharmajournalist.com/mina-therapeutics-declares-publication-pre-clinical-data-endorsing-therapeutic-potential-mtl-cebpa/ 2018-03-12T08:23:54+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/MiNA.jpg http://www.pharmajournalist.com/amc-institute-accreditation-granted-malachite-management/ 2018-03-12T08:28:48+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/AMC-Institute.png http://www.pharmajournalist.com/ncce-japan-use-guardant360-assay-sole-liquid-biopsy-lc-scrum-japan/ 2018-03-13T05:12:18+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Guardant-heallth.jpg https://pharmajournalist.com/wp-content/uploads/2018/03/Guardant-heallth.jpg http://www.pharmajournalist.com/acute-malaria-witnesses-failure-lungs-owing-hemozin/ 2018-03-13T05:50:55+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Society-for-experimental-biology.jpg http://www.pharmajournalist.com/intec-pharma-associates-lts-manufacture-accordion-pill-carbidopa-levodopa/ 2018-03-13T06:04:25+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Intec-Pharma.jpg https://pharmajournalist.com/wp-content/uploads/2018/03/Intec-Pharma.jpg http://www.pharmajournalist.com/research-childrens-hospital-colorado-signals-optimistic-outcomes-surgical-intervention-type-2-diabetes/ 2018-03-13T06:26:57+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Childrens-hospital-of-Colorado.jpg https://pharmajournalist.com/wp-content/uploads/2018/03/Childrens-hospital-of-Colorado.jpg http://www.pharmajournalist.com/myr-pharma-gmbh-completes-myr-202-clinical-trial-myrcludex-b-hdv-patients/ 2018-03-13T06:44:39+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/MYR-Pharma.jpg https://pharmajournalist.com/wp-content/uploads/2018/03/MYR-Pharma.jpg http://www.pharmajournalist.com/pulsante-therapy-clinched-prestigious-forfait-innovation-package-fast-track-medical-innovation-cluster-headache-france/ 2018-03-13T07:09:54+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Autonomic-technolgies.jpg http://www.pharmajournalist.com/cantex-pharmaceuticals-cx-01-product-severe-myeloid-leukemia-studies-reveal-immense-respite-rates/ 2018-03-13T07:31:04+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Cantex-Pharmaceuticals.jpg https://pharmajournalist.com/wp-content/uploads/2018/03/Cantex-Pharmaceuticals.jpg http://www.pharmajournalist.com/cadent-therapeutics-initiates-phase-1-clinical-study-cad-1883/ 2018-03-13T08:06:02+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Cadent-Therapeutics.png http://www.pharmajournalist.com/check-cap-introduces-eu-post-approval-study-using-advanced-c-scan/ 2018-03-13T08:32:09+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Check-Cap.jpg http://www.pharmajournalist.com/bioventrix-announces-first-patient-treated-alive-pivotal-clinical-trial/ 2018-03-13T08:41:46+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/BioVentrix.jpg http://www.pharmajournalist.com/wp-content/uploads/2018/03/BioVentrix.jpg http://www.pharmajournalist.com/merrimack-accentuates-sherloc-study-mm-121-non-small-cell-lung-cancer/ 2018-03-13T09:42:56+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Merrimack-Pharma.jpg http://www.pharmajournalist.com/connexient-rolls-medinav-3-0-navigator-edition/ 2018-03-13T09:51:14+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Connexient.jpg https://pharmajournalist.com/wp-content/uploads/2018/03/Connexient.jpg http://www.pharmajournalist.com/astro-imparts-clinical-guidelines-usage-whole-breast-radiation-therapy-breast-cancer/ 2018-03-13T10:16:05+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/astro-logo.gif http://www.pharmajournalist.com/illumina-appoints-dr-phil-febbo-chief-medical-officer/ 2018-03-13T10:23:01+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Dr.-Febbo.jpg https://pharmajournalist.com/wp-content/uploads/2018/03/Dr.-Febbo.jpg http://www.pharmajournalist.com/introducing-smis-6th-annual-conference-pharmaceutical-freeze-drying-technology-june-2018/ 2018-03-13T11:55:32+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Freeze-Drying.jpg http://www.pharmajournalist.com/boehringer-ingelheim-vanderbilt-university-expand-partnership-develop-novel-treatment-approaches-cancer/ 2018-03-14T11:15:35+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/Boehringer-Ingelheim.jpg http://www.pharmajournalist.com/parexel-cha-partner-enhance-early-phase-clinical-research-korea/ 2018-03-14T16:24:48+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/parexel-clinical.jpg http://www.pharmajournalist.com/future-digitally-connected-device-changing-paradigm-disease-management/ 2018-03-15T09:37:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/Pre-Filled-Syringes-East-Coast-2018-PJ.jpg http://www.pharmajournalist.com/recipharm-completes-blow-fill-seal-expansion-kaysersberg-facility/ 2018-03-15T11:16:12+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/recipharm.jpg http://www.pharmajournalist.com/ionis-akcea-partner-commercialize-inotersen-hattr/ 2018-03-15T11:23:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/ionis-pharma1.jpg http://www.pharmajournalist.com/bio-techne-launches-mimex-gi-accessible-3-d-cell-culturing-platform-gastrointestinal-tract/ 2018-03-15T11:28:22+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Bio-Techne-Logo.jpg http://www.pharmajournalist.com/researchers-computationally-find-needle-haystack-treat-rare-diseases/ 2018-03-15T11:37:57+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Bio_Misagh_2_PTK6.jpg https://pharmajournalist.com/wp-content/uploads/2018/03/Bio_Misagh_2_PTK6.jpg http://www.pharmajournalist.com/medisca-signs-licensing-agreement-torrey-hills-technologies-promill-cleaning-tool/ 2018-03-16T06:43:47+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Medisca-ProMil.png https://pharmajournalist.com/wp-content/uploads/2018/03/Medisca-ProMil.png http://www.pharmajournalist.com/proteostasis-therapeutics-announces-fda-grants-orphan-drug-designation-pti-428-cystic-fibrosis/ 2018-03-16T06:49:52+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/certara-launches-qps-immuno-oncology-simulator-consortium/ 2018-03-16T07:01:50+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Certara_logo.jpg http://www.pharmajournalist.com/dalton-announces-drug-development-gmp-manufacturing-agreement-oryn/ 2018-03-16T07:07:26+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/dalton-image.jpg https://pharmajournalist.com/wp-content/uploads/2018/03/dalton-image.jpg http://www.pharmajournalist.com/novartis-expands-alliance-science-37-advance-virtual-clinical-trials-program/ 2018-03-16T07:11:26+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/dr-reddys-laboratories-announces-launch-levocetirizine-dihydrochloride-tablets-usp-5-mg-u-s-market/ 2018-03-16T09:35:20+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/dr-reddy-logo.png http://www.pharmajournalist.com/x-chem-appoints-christelle-huguet-ph-d-chief-scientific-officer/ 2018-03-16T09:38:26+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Christelle-Huguet-Chief-Scientific-Officer.jpg https://pharmajournalist.com/wp-content/uploads/2018/03/Christelle-Huguet-Chief-Scientific-Officer.jpg http://www.pharmajournalist.com/sartorius-stedim-biotech-launches-new-ambr-250-high-throughput-bioreactor-system-perfusion-culture/ 2018-03-16T09:43:45+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Perfusion-system-3-quarter-operator_2909.jpg http://www.pharmajournalist.com/wp-content/uploads/2018/03/Perfusion-system-3-quarter-operator_2909.jpg http://www.pharmajournalist.com/antimicrobial-resistance-research-funding-incentives-get-updates-smi-event-london/ 2018-03-16T11:35:03+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/20th-Annual-Superbugs-Superdrugs.jpg http://www.pharmajournalist.com/sanofi-joins-speaker-line-smis-launch-injectable-drug-delivery-2018/ 2018-03-19T06:57:03+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Injectable-Drug-Delivery-2018-Banner-SMi-Events-Pharma-Journalist-e1518789305626.jpg http://www.pharmajournalist.com/smis-hpapi-2018-conference-exclusive-interview-released-hpapi-project-services/ 2018-03-19T07:06:22+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/HPAPI-Banner-SMi-Pharma-Journalist.jpg http://www.pharmajournalist.com/chronic-pain-therapeutic-opportunities-exploring-cntx-6970s-case-study-role-big-data-drug-discovery-development/ 2018-03-19T07:11:22+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Pain-Therapeutics-banner-SMi-Pharma-Journalist.jpg http://www.pharmajournalist.com/navigating-injection-technologies-reliable-incorporation-drug-packaging/ 2018-03-19T07:16:38+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/PFS-West-Coast-Banner-SMi-Pharma-Journalist.jpg http://www.pharmajournalist.com/intezyne-partners-exosome-diagnostics-139-companion-diagnostic/ 2018-03-19T13:05:04+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Image-NIH.jpg https://pharmajournalist.com/wp-content/uploads/2018/03/Image-NIH.jpg http://www.pharmajournalist.com/mylan-adds-growing-oncology-portfolio-launch-generic-mutamycin-injection/ 2018-03-21T10:51:04+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/mylan.jpg http://www.pharmajournalist.com/nexcelom-bioscience-announces-strategic-growth-investment-ampersand-capital-partners/ 2018-03-21T10:53:44+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/nexcelom-bioscience-logo.png http://www.pharmajournalist.com/ardelyx-knight-collaborate-bring-tenapanor-patients-canada/ 2018-03-21T10:56:52+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/ardelyx-logo.png http://www.pharmajournalist.com/mallinckrodt-completes-sale-recothrom-preveleak-baxter/ 2018-03-21T10:58:38+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/mallinckrodt-pharma.jpg http://www.pharmajournalist.com/intezyne-partners-exosome-diagnostics-139-companion-diagnostic-2/ 2018-03-21T11:00:55+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/intezyne-logo.jpg http://www.pharmajournalist.com/lundbeck-acquire-prexton-therapeutics/ 2018-03-21T11:02:38+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/lundbeck-logo.jpg http://www.pharmajournalist.com/ionis-akcea-partner-commercialize-inotersen-hattr-2/ 2018-03-21T11:04:34+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/ionis-pharma1.jpg http://www.pharmajournalist.com/fda-grants-priority-review-snda-xtandi-enzalutamide-non-metastatic-crpc/ 2018-03-21T11:10:48+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/thermo-fisher-scientific-invest-new-pharma-service-facility-germany/ 2018-03-21T11:16:10+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/thermo-fisher-scientific.jpg http://www.pharmajournalist.com/smi-13th-annual-admet-conference-2018-brochure-released/ 2018-03-22T13:36:55+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/ADMET-Banner-SMi-Pharma-Journalist.jpg http://www.pharmajournalist.com/invitation-zivaabarahm-ceo-microrite-chairing-2nd-annual-pharmaceutical-microbiology-west-coast-conference-2018/ 2018-03-23T05:32:55+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Pharma-Microbiology-Banner-SMi-Pharma-Journalist.jpg http://www.pharmajournalist.com/aldevron-selects-aes-begins-construction-cleanrooms-30-million-gmp-plasmid-facility/ 2018-03-23T05:37:19+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/manufacturing-facility-aldevron.jpg http://www.pharmajournalist.com/wp-content/uploads/2018/03/manufacturing-facility-aldevron.jpg http://www.pharmajournalist.com/vtv-therapeutics-announces-completion-phase-1b-study-evaluating-ttp399-treatment-type-1-diabetes/ 2018-03-23T05:41:54+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/clinical-trial.jpg http://www.pharmajournalist.com/biomedical-group-brings-californias-regenerative-medicine-research-national-stage/ 2018-03-23T05:44:20+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/biocom-logo.png http://www.pharmajournalist.com/curevac-receives-u-s-patent-covering-entire-process-pharmaceutical-manufacturing-rna/ 2018-03-23T05:47:31+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Curevac-logo.png http://www.pharmajournalist.com/fda-approves-genentechs-lucentis-ranibizumab-injection-0-3-mg-prefilled-syringe-diabetic-macular-edema-diabetic-retinopathy/ 2018-03-23T05:50:55+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/Genentech-Image.jpg http://www.pharmajournalist.com/saladax-receives-approval-sell-new-line-psychiatry-tests-european-market/ 2018-03-23T05:55:13+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Saladax-Image.jpg https://pharmajournalist.com/wp-content/uploads/2018/03/Saladax-Image.jpg http://www.pharmajournalist.com/symbiotix-biotherapies-announces-license-agreement-harvard-university/ 2018-03-23T05:58:03+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Symbiotix-Biotherapies-logo.png http://www.pharmajournalist.com/bioasis-appoints-deborah-rathjen-chair-board-directors/ 2018-03-23T06:02:22+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Bioasis-Deborah-Rathjen.jpg https://pharmajournalist.com/wp-content/uploads/2018/03/Bioasis-Deborah-Rathjen.jpg http://www.pharmajournalist.com/horizon-discoverys-bioproduction-cell-line-used-part-successful-drug-ind-filing/ 2018-03-23T06:07:52+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/horizon-discovery-logo.png http://www.pharmajournalist.com/merck-announces-appointment-jennifer-zachary-general-counsel/ 2018-03-23T06:10:11+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/bicycle-therapeutics-promotes-michael-skynner-chief-operating-officer/ 2018-03-23T06:32:41+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/Bicycle-Therapeutics.jpg http://www.pharmajournalist.com/elligo-health-research-raises-16m-improve-access-clinical-trials/ 2018-03-23T06:35:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/clinical-trials.png http://www.pharmajournalist.com/piedmont-healthcare-expands-use-glytecs-software-insulin-therapy-management/ 2018-03-23T06:38:02+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Piedmont-Healthcare-Logo.jpg http://www.pharmajournalist.com/kalytera-initiates-program-develop-novel-cannabinoid-based-compound-treatment-acute-chronic-pain/ 2018-03-23T06:41:33+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Kalytera-Logo.png http://www.pharmajournalist.com/mhra-grants-uk-patients-early-access-akcea-therapeutics-volanesorsen-fcs/ 2018-03-23T06:47:13+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Akcea-Logo.jpg http://www.pharmajournalist.com/seattle-genetics-announces-fda-approval-adcetris-brentuximab-vedotin/ 2018-03-23T06:55:09+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Seattle-Genetics.jpg https://pharmajournalist.com/wp-content/uploads/2018/03/Seattle-Genetics.jpg http://www.pharmajournalist.com/regeneron-alnylam-discover-new-treatments-nonalcoholic-steatohepatitis/ 2018-03-23T06:59:23+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/regeneron.jpg http://www.pharmajournalist.com/prothena-celgene-develop-new-therapies-neurodegenerative-diseases/ 2018-03-23T07:04:30+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/celgene-corporation.jpg http://www.pharmajournalist.com/smis-highly-potent-active-pharmaceutical-ingredients-2018-conference-hosting-2-workshops/ 2018-03-26T08:01:57+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/HPAPI-Banner-SMi-Pharma-Journalist.jpg http://www.pharmajournalist.com/teva-announces-launch-generic-version-aloxi-united-states/ 2018-03-26T14:01:44+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/TEVA-Pharma.jpg http://www.pharmajournalist.com/shire-nanomedsyn-enter-research-agreement-potential-lysosomal-storage-disorder-treatment/ 2018-03-26T14:04:40+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/shire-pharmaceuticals.jpg http://www.pharmajournalist.com/astellas-seattle-genetics-receive-fda-breakthrough-therapy-designation-enfortumab-vedotin-locally-advanced-metastatic-urothelial-cancer/ 2018-03-26T14:07:42+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/astellas.jpg http://www.pharmajournalist.com/3p-biopharmaceuticals-intervacc-complete-manufacturing-agreement/ 2018-03-26T14:12:29+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/3P-biopharmaceuticals.jpg http://www.pharmajournalist.com/wp-content/uploads/2018/03/3P-biopharmaceuticals.jpg http://www.pharmajournalist.com/pharmacyte-biotech-files-patent-applications-broaden-protection-cancer-therapy-u-s-worldwide/ 2018-03-26T14:15:45+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/PharmaCyte-Biotech-logo.png http://www.pharmajournalist.com/forma-therapeutics-collaborates-arpeggio-biosciences-explore-translational-utility-drug-candidates/ 2018-03-26T14:18:32+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Forma_Logo.jpg http://www.pharmajournalist.com/acorda-files-maa-inbrija-levodopa-inhalation-powder/ 2018-03-26T14:20:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/Acorda-Therapeutics-logo.jpg http://www.pharmajournalist.com/setpoint-medical-announces-u-s-pilot-trial-evaluate-first-bioelectronic-device-treat-rheumatoid-arthritis/ 2018-03-26T14:25:09+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/SetPoint-Medical-Bioelectronic-Device.jpg https://pharmajournalist.com/wp-content/uploads/2018/03/SetPoint-Medical-Bioelectronic-Device.jpg http://www.pharmajournalist.com/flex-pharma-reports-positive-topline-data-exploratory-phase-2-trial-flx-787-multiple-sclerosis/ 2018-03-26T14:28:41+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Flex-Pharma-Logo.jpg http://www.pharmajournalist.com/pfizer-reports-top-line-results-study-chantix-champix-varenicline-adolescent-smokers/ 2018-03-26T14:31:06+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/fda-approves-inclusion-data-safety-outcomes-trial-tresiba-label/ 2018-03-26T14:35:45+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/novo-nordisk-logo.jpg http://www.pharmajournalist.com/novaquest-capital-management-acquires-cutispharma/ 2018-03-26T14:39:59+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/cutispharma-logo.png http://www.pharmajournalist.com/sandoz-receives-positive-chmp-opinion-proposed-biosimilar-infliximab/ 2018-03-26T14:44:22+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/sandoz.jpg http://www.pharmajournalist.com/smithers-rapra-announce-inaugural-extractables-leachables-china-taking-place-beijing-11-12-september/ 2018-03-27T09:51:05+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/EL-China_Pharma-Journalist.png http://www.pharmajournalist.com/syngene-international-signs-rd-agreement-gsk/ 2018-03-27T14:39:33+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/gsk.jpg http://www.pharmajournalist.com/arrowhead-begins-dosing-phase-1-2-study-aro-hbv-treatment-chronic-hepatitis-b/ 2018-03-27T14:43:04+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/arrowhead-pharma-logo.jpg http://www.pharmajournalist.com/teva-announces-launch-generic-version-lialda-united-states/ 2018-03-27T14:45:48+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/TEVA-Pharma.jpg http://www.pharmajournalist.com/viiv-healthcare-gains-chmp-positive-opinion-juluca-dolutegravir-rilpivirine-europe/ 2018-03-27T14:51:57+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/ViiV-healthcare-Juluca.jpg http://www.pharmajournalist.com/wp-content/uploads/2018/03/ViiV-healthcare-Juluca.jpg http://www.pharmajournalist.com/gsk-reaches-agreement-novartis-acquire-full-ownership-consumer-healthcare-business/ 2018-03-27T14:56:01+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/gsk.jpg http://www.pharmajournalist.com/facility-remodelling-completed-abzenas-new-adc-gmp-manufacturing-suite/ 2018-03-27T15:02:42+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/ADC-GMP-Manufacturing-Suite-Abzena.jpg http://www.pharmajournalist.com/wp-content/uploads/2018/03/ADC-GMP-Manufacturing-Suite-Abzena.jpg http://www.pharmajournalist.com/samsara-sciences-announces-multi-year-supply-agreement-lonza/ 2018-03-27T15:08:31+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Organovo-logo.jpg http://www.pharmajournalist.com/tissue-engineering-regenerative-medicine-bioengineered-tissue-shows-sustained-benefit-surgical-techniques/ 2018-03-27T15:31:09+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/IDTechEX-logo.png http://www.pharmajournalist.com/cphi-p-mec-china-2018-build-lucrative-pharma-business-partnerships-china/ 2018-03-28T07:38:43+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/CPhI-China-Banner-PJ.gif http://www.pharmajournalist.com/wp-content/uploads/2018/03/1.jpg http://www.pharmajournalist.com/wp-content/uploads/2018/03/2.jpg https://pharmajournalist.com/wp-content/uploads/2018/03/3.jpg http://www.pharmajournalist.com/wp-content/uploads/2018/03/4.jpg http://www.pharmajournalist.com/wp-content/uploads/2018/03/5.jpg http://www.pharmajournalist.com/smis-pre-filled-syringes-east-coast-conference-april-boston-attendee-list-released/ 2018-03-28T09:55:24+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/Pre-Filled-Syringes-East-Coast-2018-PJ.jpg http://www.pharmajournalist.com/ppd-expands-gmp-biologics-testing-capacity/ 2018-03-28T13:38:11+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/PPD-office_wikipedia.jpg http://www.pharmajournalist.com/forma-therapeutics-appoints-frances-duffy-warren-head-regulatory-affairs/ 2018-03-28T13:41:24+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Frances-Duffy-Warren-Forma-Therapeutics.jpg https://pharmajournalist.com/wp-content/uploads/2018/03/Frances-Duffy-Warren-Forma-Therapeutics.jpg http://www.pharmajournalist.com/acerus-expands-urology-franchise-acquiring-canadian-rights-stendra-metuchen/ 2018-03-28T13:45:25+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Acerus-Pharma-Logo.jpg http://www.pharmajournalist.com/breckenridge-pharmaceutical-announces-final-approval-anda-entecavir-tablets-baraclude/ 2018-03-28T13:51:01+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Breckenridge-pharma-logo.jpg http://www.pharmajournalist.com/clinipace-worldwide-names-ian-fraser-svp-operations-europe-middle-east/ 2018-03-28T13:55:30+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Clinipace-Image.jpg https://pharmajournalist.com/wp-content/uploads/2018/03/Clinipace-Image.jpg http://www.pharmajournalist.com/reliable-incorporation-drug-packaging-navigating-injection-technologies/ 2018-03-29T07:02:33+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/PFS-West-Coast-Banner-SMi-Pharma-Journalist.jpg http://www.pharmajournalist.com/pharmabcine-announces-fda-orphan-drug-designation-granted-ttac-0001-glioblastoma-multiforme/ 2018-04-02T04:17:37+00:00 https://pharmajournalist.com/wp-content/uploads/2018/04/PharmABcine-Logo.png http://www.pharmajournalist.com/pfizer-announces-positive-topline-results-phase-3-attr-act-study-tafamidis-patients-transthyretin-cardiomyopathy/ 2018-04-02T04:19:33+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/great-time-pain-research-exclusive-interview-neil-singla-lotus-clinical-research-llc/ 2018-04-02T06:05:53+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Pain-Therapeutics-banner-SMi-Pharma-Journalist.jpg http://www.pharmajournalist.com/aditlys-creates-natural-tissue-growing-implant-treat-patients-suffering-chronic-kidney-disease/ 2018-04-02T08:25:03+00:00 https://pharmajournalist.com/wp-content/uploads/2018/04/Aditlys-logo.png http://www.pharmajournalist.com/martin-pharmaceuticals-receives-fda-orphan-drug-designation-livantra/ 2018-04-02T08:29:25+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/abide-celgene-enter-worldwide-license-agreement-abx-1772/ 2018-04-02T08:31:29+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/celgene-corporation.jpg http://www.pharmajournalist.com/eagle-pharmaceuticals-announces-new-patent-eagle-biologics/ 2018-04-02T08:35:45+00:00 https://pharmajournalist.com/wp-content/uploads/2018/04/eagle-pharmaceuticals-logo.png http://www.pharmajournalist.com/synlogic-doses-first-patient-phase-1b-2a-trial-synb1020-treatment-hyperammonemia-patients-cirrhosis/ 2018-04-02T13:22:55+00:00 https://pharmajournalist.com/wp-content/uploads/2018/04/synlogic-logo.jpeg http://www.pharmajournalist.com/dr-reddys-laboratories-promius-pharma-announce-filing-nda-migraine-candidate/ 2018-04-02T13:24:37+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/dr-reddy-logo.png http://www.pharmajournalist.com/pharmacyte-ships-clinical-trial-cells-austrianova-encapsulation/ 2018-04-02T13:26:44+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/PharmaCyte-Biotech-logo.png http://www.pharmajournalist.com/spinalcyte-announces-mri-evidence-disc-regeneration-following-phase-1-phase-2-clinical-trial-cybrocell-dermal-fibroblasts/ 2018-04-03T15:14:58+00:00 https://pharmajournalist.com/wp-content/uploads/2018/04/Fibroblast-cells.jpg https://pharmajournalist.com/wp-content/uploads/2018/04/Fibroblast-cells.jpg http://www.pharmajournalist.com/puma-pint-pharma-commercialize-nerlynx-neratinib-latin-america/ 2018-04-03T15:18:19+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Puma-Biotechnology-logo.jpg http://www.pharmajournalist.com/hear-boehringer-ingelheim-janssen-smis-6th-annual-conference-pharmaceutical-freeze-drying-technology/ 2018-04-04T08:59:03+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Freeze-Drying.jpg http://www.pharmajournalist.com/q-state-biosciences-and-vertex-pharma-enter-into-multi-year-drug-discovery-collaboration/ 2018-04-04T14:18:15+00:00 https://pharmajournalist.com/wp-content/uploads/2018/04/q-state-biosciences-logo.jpg http://www.pharmajournalist.com/compugen-announces-license-agreement-with-medimmune-for-antibody-products/ 2018-04-04T14:22:39+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/compugen-logo.jpg http://www.pharmajournalist.com/fda-accepts-bla-for-moxetumomab-pasudotox-in-hairy-cell-leukaemia/ 2018-04-04T14:25:47+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/alkermes-receives-refusal-to-file-letter-from-fda-for-alks-5461/ 2018-04-04T14:28:39+00:00 https://pharmajournalist.com/wp-content/uploads/2018/04/Alkermes-logo.jpg http://www.pharmajournalist.com/the-national-institutes-of-health-announce-biobanking-medical-project/ 2018-04-05T15:12:12+00:00 https://pharmajournalist.com/wp-content/uploads/2018/04/bio-banking-2018-banner.jpg http://www.pharmajournalist.com/boehringer-ingelheim-and-ose-announce-global-immuno-oncology-partnership/ 2018-04-06T06:27:40+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/Boehringer-Ingelheim.jpg http://www.pharmajournalist.com/accelovance-and-linical-merge-organizations-to-form-a-best-in-class-cro-with-increased-global-reach/ 2018-04-06T06:32:26+00:00 https://pharmajournalist.com/wp-content/uploads/2018/04/accelovance_logo.png http://www.pharmajournalist.com/cardiva-medical-announces-fda-approval-of-vascade-vascular-closure-system-for-use-in-femoral-vein-closure/ 2018-04-06T06:42:03+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/ubiquigent-and-forma-enter-an-exclusive-rd-collaboration-to-develop-novel-dub-inhibitors/ 2018-04-06T06:43:34+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Forma_Logo.jpg http://www.pharmajournalist.com/ferring-acquires-innovative-biotechnology-company-and-microbiome-pioneer-rebiotix/ 2018-04-06T06:45:29+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Ferring-Pharmaceuticals-Singapore.jpg http://www.pharmajournalist.com/agilent-technologies-signs-agreement-to-acquire-lasergen/ 2018-04-06T06:49:32+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/agilent-logo.png http://www.pharmajournalist.com/myokardia-begins-dosing-in-phase-2-maverick-hcm-clinical-trial-of-mavacamten/ 2018-04-06T06:53:54+00:00 https://pharmajournalist.com/wp-content/uploads/2018/04/myokardia-logo.png http://www.pharmajournalist.com/proteostasis-triple-combination-program-secures-fda-fast-track-designation-for-cystic-fibrosis/ 2018-04-06T06:57:56+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/inception-neuroscience-program-acquired-by-roche/ 2018-04-06T07:00:28+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Roche-Logo.jpeg http://www.pharmajournalist.com/phasebio-announces-completion-of-dosing-in-first-cohort-of-phase-1-clinical-trial-of-pb2452/ 2018-04-06T07:05:11+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/clinical-trial.jpg http://www.pharmajournalist.com/stemline-therapeutics-announces-start-of-rolling-bla-submission-for-sl-401/ 2018-04-06T07:08:00+00:00 https://pharmajournalist.com/wp-content/uploads/2018/04/Stemline-logo.png http://www.pharmajournalist.com/aradigm-announces-the-ema-has-completed-its-validation-of-the-maa-submission/ 2018-04-06T07:11:39+00:00 https://pharmajournalist.com/wp-content/uploads/2018/04/Aradigm-logo.jpg http://www.pharmajournalist.com/eidos-therapeutics-completes-64m-series-b-financing/ 2018-04-06T07:42:22+00:00 https://pharmajournalist.com/wp-content/uploads/2018/04/eidos-therapeutics-logo.png http://www.pharmajournalist.com/abbvie-announces-global-resolution-of-humira-adalimumab-patent-disputes-with-samsung-bioepis/ 2018-04-06T08:45:40+00:00 https://pharmajournalist.com/wp-content/uploads/2018/04/abbvie-logo.jpg http://www.pharmajournalist.com/hear-from-regulatory-and-pharmaceutical-industry-leaders-this-june/ 2018-04-09T08:50:44+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Freeze-Drying.jpg http://www.pharmajournalist.com/allele-receives-tissue-bank-license-for-manufacturing-and-distribution-of-cgmp-compliant-ipscs/ 2018-04-09T13:30:34+00:00 https://pharmajournalist.com/wp-content/uploads/2018/04/Allele-Biotech.png http://www.pharmajournalist.com/wp-content/uploads/2018/04/Allele-Biotech.png http://www.pharmajournalist.com/protalex-initiates-fourth-cohort-dosing-of-phase-1-2-study-of-prtx-100-in-immune-thrombocytopenia/ 2018-04-09T13:43:41+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/clinical-trials.png http://www.pharmajournalist.com/lonza-opens-worlds-largest-dedicated-cell-and-gene-therapy-manufacturing-facility-in-texas/ 2018-04-13T06:24:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/lonza.jpg http://www.pharmajournalist.com/alexion-to-acquire-wilson-therapeutics/ 2018-04-13T06:25:57+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Alexion-Pharma-Logo.png http://www.pharmajournalist.com/amgen-announces-rhode-island-will-be-location-of-first-us-next-generation-biomanufacturing-plant/ 2018-04-13T06:28:09+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/amgen.jpg http://www.pharmajournalist.com/ionis-and-astrazeneca-advance-new-drug-for-nash/ 2018-04-13T06:30:22+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/ionis-pharma1.jpg http://www.pharmajournalist.com/argenx-to-receive-third-preclinical-milestone-payment-from-collaboration-with-leo-pharma/ 2018-04-13T06:35:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/argenx-logo.jpg http://www.pharmajournalist.com/sanofi-to-invest-e350-million-in-canadian-vaccine-facility/ 2018-04-13T06:37:47+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/sanofi.jpg http://www.pharmajournalist.com/gsk-signs-strategic-agreement-to-transfer-rare-disease-gene-therapy-portfolio-to-orchard-therapeutics/ 2018-04-13T06:39:15+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/gsk.jpg http://www.pharmajournalist.com/milliporesigma-helps-accelerate-global-access-to-affordable-vaccines/ 2018-04-13T06:43:32+00:00 https://pharmajournalist.com/wp-content/uploads/2018/04/MilliporeSigma-Oxford-University-partnership.jpg http://www.pharmajournalist.com/wp-content/uploads/2018/04/MilliporeSigma-Oxford-University-partnership.jpg http://www.pharmajournalist.com/novartis-drug-afinitor-disperz-receives-fda-approval-to-treat-tsc-associated-partial-onset-seizures/ 2018-04-13T06:46:05+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/zealand-and-roche-diabetes-care-enter-phase-3-study-collaboration-for-treatment-of-chi-with-dasiglucagon/ 2018-04-13T06:50:20+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Roche-Logo.jpeg http://www.pharmajournalist.com/inovio-awarded-up-to-56-million-from-cepi-to-advance-dna-vaccines-against-lassa-fever-and-mers/ 2018-04-13T06:53:27+00:00 https://pharmajournalist.com/wp-content/uploads/2018/04/Inovio-Pharmaceuticals.jpg http://www.pharmajournalist.com/novartis-enters-agreement-to-acquire-avexis-inc-for-usd-8-7-bn/ 2018-04-13T06:55:48+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/pfizer-joins-the-trinetx-global-health-research-network/ 2018-04-13T06:58:56+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/lsne-announces-expansion-of-its-current-capabilities-and-qc-laboratory-space/ 2018-04-13T07:03:32+00:00 https://pharmajournalist.com/wp-content/uploads/2018/04/LSNEs-New-Lab-Space.jpg http://www.pharmajournalist.com/wp-content/uploads/2018/04/LSNEs-New-Lab-Space.jpg http://www.pharmajournalist.com/promethera-biosciences-acquires-baliopharm-ag/ 2018-04-13T07:07:00+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/promethera-biosciences-logo.png http://www.pharmajournalist.com/halo-pharma-simplifies-topical-drug-product-development-and-manufacturing/ 2018-04-13T07:14:39+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/halo-pharma.jpg http://www.pharmajournalist.com/veracyte-announces-precision-medicine-collaboration-with-loxo-oncology/ 2018-04-13T07:16:30+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/veracyte-logo.jpg http://www.pharmajournalist.com/evotec-forms-collaboration-with-petra-pharma-on-indigo-platform/ 2018-04-13T07:19:15+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/evotec.png http://www.pharmajournalist.com/charles-river-laboratories-and-pathoquest-expand-strategic-biologics-partnership/ 2018-04-13T07:29:36+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/charles-river-lab.png http://www.pharmajournalist.com/bioascent-establishes-integrated-drug-discovery-services-offering/ 2018-04-13T07:36:41+00:00 https://pharmajournalist.com/wp-content/uploads/2018/04/BioAscent-Drug-Discovery.jpg http://www.pharmajournalist.com/wp-content/uploads/2018/04/BioAscent-Drug-Discovery.jpg http://www.pharmajournalist.com/gustave-roussy-and-protagen-ag-collaborate-to-improve-the-risk-profiling-of-cancer-patients-undergoing-immunotherapy/ 2018-04-13T07:41:00+00:00 https://pharmajournalist.com/wp-content/uploads/2018/04/Gustave-Roussy.jpg https://pharmajournalist.com/wp-content/uploads/2018/04/Gustave-Roussy.jpg http://www.pharmajournalist.com/bristol-myers-squibb-and-harvard-announce-new-fibrosis-research-collaboration/ 2018-04-13T07:46:50+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/bristol-myers-squibb.jpg http://www.pharmajournalist.com/smis-2nd-annual-highly-potent-active-pharmaceutical-ingredients-conference-hosts-2-interactive-workshops/ 2018-04-16T07:36:15+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/HPAPI-Banner-SMi-Pharma-Journalist.jpg http://www.pharmajournalist.com/smis-launch-injectable-drug-delivery-2018-hosts-2-interactive-workshops/ 2018-04-16T07:43:59+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Injectable-Drug-Delivery-2018-Banner-SMi-Events-Pharma-Journalist-e1518789305626.jpg http://www.pharmajournalist.com/discover-the-future-of-pharmaceutical-freeze-drying-at-smis-6th-annual-conference-this-june/ 2018-04-16T07:46:53+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Freeze-Drying.jpg http://www.pharmajournalist.com/past-attendee-list-released-in-advance-of-8th-annual-biobanking-conference/ 2018-04-17T11:07:58+00:00 https://pharmajournalist.com/wp-content/uploads/2018/04/bio-banking-2018-banner.jpg http://www.pharmajournalist.com/sobi-receives-approval-from-health-canada-for-once-daily-dosing-of-orfadin-nitisinone-for-the-treatment-of-ht-1/ 2018-04-17T15:06:29+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/sobi.jpg http://www.pharmajournalist.com/cardurion-pharma-licenses-clinical-stage-heart-failure-candidate-from-astellas/ 2018-04-17T15:11:20+00:00 https://pharmajournalist.com/wp-content/uploads/2018/04/Cardurion-Pharma-Logo.png http://www.pharmajournalist.com/phoremost-and-plexxikon-collaborate-to-identify-novel-drug-targets/ 2018-04-17T15:14:42+00:00 https://pharmajournalist.com/wp-content/uploads/2018/04/PhoreMost-Logo.jpg http://www.pharmajournalist.com/shire-announces-sale-of-oncology-business-to-servier-for-2-4-billion/ 2018-04-17T15:17:42+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/shire-pharmaceuticals.jpg http://www.pharmajournalist.com/samdi-tech-expands-small-molecule-compound-libraries-through-partnership-with-enamine/ 2018-04-17T15:25:15+00:00 https://pharmajournalist.com/wp-content/uploads/2018/04/samdi-tech-logo.jpg http://www.pharmajournalist.com/kinderpharm-llc-and-worldwide-clinical-trials-form-strategic-alliance/ 2018-04-20T09:22:33+00:00 https://pharmajournalist.com/wp-content/uploads/2018/04/kinder-pharm-logo.jpg http://www.pharmajournalist.com/sterling-invests-6m-in-pilot-plant-facility/ 2018-04-20T09:27:27+00:00 https://pharmajournalist.com/wp-content/uploads/2018/04/sterling-pharma-solutions.jpg http://www.pharmajournalist.com/wp-content/uploads/2018/04/sterling-pharma-solutions.jpg http://www.pharmajournalist.com/probiogen-signs-second-contract-development-agreement-with-tizona-therapeutics-for-immuno-oncology-antibody-project/ 2018-04-20T09:30:36+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/clinical-trials.jpg http://www.pharmajournalist.com/biogo-introduces-bioproduction-agility-to-accelerate-biotech-innovation/ 2018-04-20T09:35:00+00:00 https://pharmajournalist.com/wp-content/uploads/2018/04/bioGO-Adaptive-Bioproduction-Platform.jpg http://www.pharmajournalist.com/wp-content/uploads/2018/04/bioGO-Adaptive-Bioproduction-Platform.jpg http://www.pharmajournalist.com/sinovac-announces-preliminary-results-of-phase-iii-trial-on-sipv/ 2018-04-20T09:37:46+00:00 https://pharmajournalist.com/wp-content/uploads/2018/04/Sinovac-Biotech-Logo.jpg http://www.pharmajournalist.com/astellas-announces-sale-of-certain-agensys-research-facilities-to-kite/ 2018-04-20T09:40:10+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/astellas.jpg http://www.pharmajournalist.com/phoenixmd-announces-manufacturing-collaboration-with-wuxi-sta-to-advance-pmd-026-toward-ind/ 2018-04-20T09:45:45+00:00 https://pharmajournalist.com/wp-content/uploads/2018/04/Phoenix-MD.jpg http://www.pharmajournalist.com/wp-content/uploads/2018/04/Phoenix-MD.jpg http://www.pharmajournalist.com/almac-group-expands-us-specialised-commercial-packaging-capabilities/ 2018-04-20T09:48:51+00:00 https://pharmajournalist.com/wp-content/uploads/2018/04/SAPS-Line_Almac-Group.jpg http://www.pharmajournalist.com/wp-content/uploads/2018/04/SAPS-Line_Almac-Group.jpg http://www.pharmajournalist.com/novadigm-therapeutics-announces-initiation-of-phase-2a-clinical-trial-of-ndv-3a-in-staphylococcus-aureus/ 2018-04-20T09:54:39+00:00 https://pharmajournalist.com/wp-content/uploads/2018/04/novadigm-logo.png http://www.pharmajournalist.com/synlogic-doses-first-subject-in-phase-1-2a-trial-of-synb1618-for-treatment-of-phenylketonuria/ 2018-04-20T09:57:45+00:00 https://pharmajournalist.com/wp-content/uploads/2018/04/synlogic-logo.jpeg http://www.pharmajournalist.com/evotec-and-bayer-advance-third-endometriosis-programme-into-phase-i-clinical-development/ 2018-04-20T09:59:13+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/evotec.png http://www.pharmajournalist.com/merck-announces-first-phase-three-studies-for-pcv-15-v114-its-investigational-pneumococcal-disease-vaccine/ 2018-04-20T10:03:20+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/sempre-health-and-novo-nordisk-partner-to-improve-medication-costs-for-patients-with-diabetes/ 2018-04-20T10:06:42+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/novo-nordisk-logo.jpg http://www.pharmajournalist.com/ges-new-factory-in-a-box-accelerates-the-production-of-viral-vector-based-therapeutics/ 2018-04-20T10:10:09+00:00 https://pharmajournalist.com/wp-content/uploads/2018/04/KUBio-BSL2.jpg http://www.pharmajournalist.com/wp-content/uploads/2018/04/KUBio-BSL2.jpg http://www.pharmajournalist.com/sandoz-and-pear-therapeutics-to-develop-and-commercialize-prescription-digital-therapeutics/ 2018-04-20T10:31:37+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/sandoz.jpg http://www.pharmajournalist.com/fda-approves-tagrisso-as-1st-line-treatment-for-egfr-mutated-non-small-cell-lung-cancer/ 2018-04-20T10:34:59+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/artificial-antimicrobial-peptides-could-help-overcome-drug-resistant-bacteria/ 2018-04-20T10:42:08+00:00 https://pharmajournalist.com/wp-content/uploads/2018/04/MIT-Antimicrobial-Peptide_0.jpg http://www.pharmajournalist.com/wp-content/uploads/2018/04/MIT-Antimicrobial-Peptide_0.jpg http://www.pharmajournalist.com/advent-international-enters-into-exclusive-negotiations-to-acquire-zentiva/ 2018-04-20T10:45:13+00:00 https://pharmajournalist.com/wp-content/uploads/2018/04/Zentiva.png http://www.pharmajournalist.com/wp-content/uploads/2018/04/Zentiva.png http://www.pharmajournalist.com/fda-grants-breakthrough-therapy-designation-for-roches-hemlibra-in-haemophilia-a-without-inhibitors/ 2018-04-20T10:49:06+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/novartis-renews-commitment-to-malaria-elimination-investing-usd-100-million-to-research-and-develop-next-generation-antimalarials/ 2018-04-20T10:50:52+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/boehringer-ingelheim-and-lilly-announce-an-academic-collaboration-with-university-of-oxford/ 2018-04-20T10:53:35+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/Boehringer-Ingelheim.jpg http://www.pharmajournalist.com/future-of-pfs-injection-devices-from-cross-industry-expertise-perspectives-discussion-this-june-in-san-diego/ 2018-04-26T12:14:55+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/PFS-West-Coast-Banner-SMi-Pharma-Journalist.jpg http://www.pharmajournalist.com/speaker-interview-with-pau-aceves-released-smis-13th-annual-admet-conference/ 2018-04-27T06:33:54+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/ADMET-Banner-SMi-Pharma-Journalist.jpg http://www.pharmajournalist.com/innovus-pharma-announces-the-launch-of-its-hemorrhoid-drug-xyralid-in-canada/ 2018-04-27T07:12:27+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/drug-discovery.jpg http://www.pharmajournalist.com/juniper-pharmaceuticals-licenses-intravaginal-ring-ivr-platform-to-dare-bioscience/ 2018-04-27T07:15:05+00:00 https://pharmajournalist.com/wp-content/uploads/2018/04/juniper_pharma_logo.png http://www.pharmajournalist.com/freenome-and-biognosys-announce-collaboration-to-improve-early-cancer-detection-and-treatment/ 2018-04-27T07:18:39+00:00 https://pharmajournalist.com/wp-content/uploads/2018/04/freenome-logo.jpg http://www.pharmajournalist.com/lsne-announces-acquisition-of-psc-biotechs-parenteral-manufacturing-facility/ 2018-04-27T07:30:38+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/drug.jpg http://www.pharmajournalist.com/parexel-announces-appointment-of-peyton-howell-as-chief-commercial-and-strategy-officer/ 2018-04-27T07:58:26+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/parexel-clinical.jpg http://www.pharmajournalist.com/adc-bio-secures-1-14m-investment-from-downing-llp/ 2018-04-27T08:02:35+00:00 https://pharmajournalist.com/wp-content/uploads/2018/04/adcbio-logo.png http://www.pharmajournalist.com/grand-river-aseptic-manufacturing-expands-pharmaceutical-manufacturing-capacity-with-major-equipment-purchase/ 2018-04-27T08:06:53+00:00 https://pharmajournalist.com/wp-content/uploads/2018/04/Grand-River.jpg http://www.pharmajournalist.com/q-therapeutics-announces-joint-venture-with-reprocell/ 2018-04-27T08:09:56+00:00 https://pharmajournalist.com/wp-content/uploads/2018/04/REPROCELL-logo.png http://www.pharmajournalist.com/noramco-and-spi-pharma-sign-agreement-to-develop-ready-to-implement-patient-friendly-formulations-for-pharmaceutical-manufacturers/ 2018-04-27T08:13:26+00:00 https://pharmajournalist.com/wp-content/uploads/2018/04/Noramco-Logo.jpg http://www.pharmajournalist.com/amri-expands-nmr-spectroscopy-capabilities-in-europe/ 2018-04-27T08:16:50+00:00 https://pharmajournalist.com/wp-content/uploads/2018/04/AMRI-Logo.png http://www.pharmajournalist.com/zoetis-to-expand-animal-vaccine-research-and-manufacturing-in-suzhou-china/ 2018-04-27T09:05:13+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/zoetis-logo.jpg http://www.pharmajournalist.com/immune-therapeutics-files-new-drug-application-for-lodonol-in-kenya-to-target-hiv-epidemic/ 2018-04-27T09:09:56+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/immune-therapeutics-logo.jpg http://www.pharmajournalist.com/concert-pharmaceuticals-completes-enrollment-in-phase-2a-trial-of-ctp-543-in-alopecia-areata/ 2018-04-27T09:12:10+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/concert-pharmaceuticals.jpg http://www.pharmajournalist.com/adc-therapeutics-announces-the-termination-of-its-adct-502-program-targeting-her2-expressing-solid-tumors/ 2018-04-27T09:19:04+00:00 https://pharmajournalist.com/wp-content/uploads/2018/04/ADC_Therapeutics_Logo.png http://www.pharmajournalist.com/abbvie-submits-bla-to-fda-for-investigational-treatment-risankizumab-for-moderate-to-severe-plaque-psoriasis/ 2018-04-27T09:20:55+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Abbvie.jpg http://www.pharmajournalist.com/once-daily-trelegy-ellipta-gains-expanded-indication-in-the-us-for-the-treatment-of-patients-with-copd/ 2018-04-27T09:23:30+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/gsk.jpg http://www.pharmajournalist.com/astrazeneca-reports-results-from-the-arctic-trial-in-third-line-non-small-cell-lung-cancer/ 2018-04-27T09:25:58+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/zymeworks-and-celgene-expand-bispecific-antibody-collaboration/ 2018-04-27T09:28:33+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/celgene.jpg http://www.pharmajournalist.com/boehringer-ingelheim-rd-pushes-to-transcend-disease-boundaries/ 2018-04-27T09:32:58+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/boehringer-ingelheim.jpg http://www.pharmajournalist.com/novartis-launches-focalview-app-providing-opportunity-for-patients-to-participate-in-ophthalmology-clinical-trials-from-home/ 2018-04-27T09:34:14+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/over-20-presentations-on-developments-in-the-field-of-analgesic-medicine-at-the-smi-event-in-london/ 2018-05-01T14:44:35+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Pain-Therapeutics-banner-SMi-Pharma-Journalist.jpg http://www.pharmajournalist.com/discover-the-next-generation-of-injectable-drug-devices-in-just-2-weeks/ 2018-05-02T07:26:23+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Injectable-Drug-Delivery-2018-Banner-SMi-Events-Pharma-Journalist-e1518789305626.jpg http://www.pharmajournalist.com/5-benefits-of-risk-based-monitoring-rbm-within-clinical-trials/ 2018-05-03T16:35:09+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/Clinical-Operations-in-Oncology-Trials-East-Coast-Pharma-Journalist.jpg http://www.pharmajournalist.com/merck-kgaa-darmstadt-germany-to-develop-abituzumab-in-metastatic-colorectal-cancer-with-sfj-pharmaceuticals-group/ 2018-05-04T10:06:40+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/bavarian-nordic-receives-fda-orphan-drug-designation-for-bn-brachyury-for-the-treatment-of-chordoma/ 2018-05-04T10:10:55+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/Bavarian-Nordic-logo.png http://www.pharmajournalist.com/abbvie-submits-application-to-ema-for-investigational-treatment-risankizumab-for-moderate-to-severe-plaque-psoriasis/ 2018-05-04T10:14:55+00:00 https://pharmajournalist.com/wp-content/uploads/2018/04/abbvie-logo.jpg http://www.pharmajournalist.com/novartis-receives-fda-approval-of-tafinlar-mekinist-for-adjuvant-treatment-of-braf-v600-mutant-melanoma/ 2018-05-04T10:17:51+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/agc-biologics-enters-into-commercial-manufacturing-agreement-with-horizon-pharma-plc/ 2018-05-04T10:22:20+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/AGC-Biologics.jpg http://www.pharmajournalist.com/innomar-strategies-enhances-commercialization-expertise-with-acquisition-of-therapeutic-products/ 2018-05-04T10:25:06+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/Innomar-Strategies-logo.png http://www.pharmajournalist.com/bactevo-enters-drug-discovery-agreement-with-boehringer-ingelheim/ 2018-05-04T10:26:59+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/boehringer-ingelheim.jpg http://www.pharmajournalist.com/exelixis-and-invenra-enter-into-collaboration-to-discover-and-develop-novel-biologics-to-treat-cancer/ 2018-05-04T10:29:22+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Exelixis.jpg http://www.pharmajournalist.com/united-therapeutics-to-acquire-steadymed/ 2018-05-04T10:51:47+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/United-Therapeutics-logo.jpg http://www.pharmajournalist.com/ferring-signs-global-agreement-to-commercialise-novel-gene-therapy-for-bladder-cancer-patients/ 2018-05-04T10:55:19+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Ferring-Pharmaceuticals-Singapore.jpg http://www.pharmajournalist.com/acadia-pharma-announces-appointment-of-elena-ridloff-as-svp-investor-relations/ 2018-05-04T10:59:59+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/Elena_Ridloff.jpg https://pharmajournalist.com/wp-content/uploads/2018/05/Elena_Ridloff.jpg http://www.pharmajournalist.com/abbott-expands-cardiac-arrhythmias-portfolio-with-fda-clearance-of-advanced-mapping-catheter/ 2018-05-04T11:10:51+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/Abbott1.png http://www.pharmajournalist.com/menogenix-awarded-nih-grant-to-fund-phase-ib-iia-clinical-trial/ 2018-05-04T11:13:02+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/clinical-trials.jpg http://www.pharmajournalist.com/sylentis-announces-the-clinical-results-of-tivanisiran-for-the-treatment-of-dry-eye-syndrome/ 2018-05-04T11:15:27+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/pharmamar1.jpg http://www.pharmajournalist.com/onkure-close-7m-series-a-financing-to-support-development-of-epigenetics-drug/ 2018-05-04T11:18:30+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/Onkure-Therapeutics-logo.png http://www.pharmajournalist.com/cirius-therapeutics-reaches-enrollment-target-in-phase-2b-emminence-trial-in-nash/ 2018-05-04T11:20:40+00:00 https://pharmajournalist.com/wp-content/uploads/2017/02/abzena-clinical.jpg http://www.pharmajournalist.com/janssen-to-acquire-benevir-biopharm-to-advance-immunotherapy-regimens/ 2018-05-04T11:41:14+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/Janssen.jpg http://www.pharmajournalist.com/bioniz-therapeutics-announces-positive-phase-1b-clinical-study-results-for-investigational-agent-bnz-1/ 2018-05-04T11:51:25+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/Bionz-Therapeutics-logo.png http://www.pharmajournalist.com/upsher-smith-launches-doxazosin-tablets-usp/ 2018-05-04T11:54:33+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/Doxazosin-Tablets.jpg http://www.pharmajournalist.com/wp-content/uploads/2018/05/Doxazosin-Tablets.jpg http://www.pharmajournalist.com/haselmeier-and-common-sensing-enter-connected-injectable-medicine-collaboration/ 2018-05-04T12:04:37+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/haselmeierLogo.png http://www.pharmajournalist.com/biogen-and-neurimmune-announce-option-exercise-for-alzheimers-disease-investigational-treatment-aducanumab/ 2018-05-04T12:05:47+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/Biogen-logo.jpg http://www.pharmajournalist.com/introducing-the-launch-of-smis-cell-gene-therapy-2018/ 2018-05-08T08:43:34+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/Cell-Gene-Therapy-2018-Banner_Pharma-Journalist.jpg http://www.pharmajournalist.com/new-speakers-and-sponsor-announced-in-lead-up-to-8th-annual-biobanking-conference/ 2018-05-09T08:57:37+00:00 https://pharmajournalist.com/wp-content/uploads/2018/04/bio-banking-2018-banner.jpg http://www.pharmajournalist.com/lilly-announces-agreement-to-acquire-armo-biosciences/ 2018-05-11T07:16:01+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lilly.jpg http://www.pharmajournalist.com/lodo-therapeutics-corporation-forms-multi-target-strategic-collaboration-with-genentech/ 2018-05-11T07:17:37+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/Genentech-Image.jpg http://www.pharmajournalist.com/proposed-acquisition-of-shire-plc-by-takeda/ 2018-05-11T07:19:32+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/shire-pharmaceuticals.jpg http://www.pharmajournalist.com/lannett-acquires-portfolio-of-generic-products-from-endo-international/ 2018-05-11T07:21:02+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/lannett-logo.jpg http://www.pharmajournalist.com/lonza-to-invest-in-portsmouth-nh-usa-site-including-mid-scale-biologics/ 2018-05-11T07:22:59+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/lonza.jpg http://www.pharmajournalist.com/moderna-and-merck-expand-mrna-cancer-vaccines-collaboration/ 2018-05-11T07:24:37+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/schreiner-medipharm-equips-syringes-for-pfizer-epoetin-product-with-needle-trap/ 2018-05-11T07:29:13+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/SMP_Needle-Trap_Pfizer-Epoetin.jpg https://pharmajournalist.com/wp-content/uploads/2018/05/SMP_Needle-Trap_Pfizer-Epoetin.jpg http://www.pharmajournalist.com/vbi-vaccines-announces-positive-final-phase-1-study-results-of-preventative-cmv-vaccine/ 2018-05-11T07:32:34+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/VBI-Vaccines-Logo.png http://www.pharmajournalist.com/fda-approves-new-uses-for-two-drugs-administered-together-for-the-treatment-of-braf-positive-anaplastic-thyroid-cancer/ 2018-05-11T07:39:06+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/xtalpi-announces-strategic-research-collaboration-with-pfizer/ 2018-05-11T07:45:12+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/Xtalpi-inc-logo.png http://www.pharmajournalist.com/fda-approves-janssens-darzalex-daratumumab-to-treat-multiple-myeloma/ 2018-05-11T07:51:56+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/Janssen.jpg http://www.pharmajournalist.com/index-pharmaceuticals-develops-oral-formulation-of-cobitolimod/ 2018-05-11T08:32:23+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/InDex-Pharmaceuticals-logo.png http://www.pharmajournalist.com/acelrx-resubmits-new-drug-application-for-dsuvia/ 2018-05-11T08:43:31+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/AcelRx-Pharma-logo.jpg http://www.pharmajournalist.com/provention-bio-selects-intravacc-as-product-development-and-manufacturing-partner-for-coxsackievirus-b-vaccine/ 2018-05-11T08:54:02+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/provention-Bio-Logo.jpg http://www.pharmajournalist.com/scientists-identify-cause-of-resistance-to-breakthrough-breast-and-ovarian-cancer-drug/ 2018-05-11T08:58:51+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/ovarian-cancer-drug.jpg http://www.pharmajournalist.com/fda-seeks-permanent-injunctions-against-two-stem-cell-clinics/ 2018-05-11T09:06:55+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/wave-life-sciences-highlights-progress-on-hepatic-collaboration-with-pfizer/ 2018-05-11T09:18:47+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/Wave-Life-Sciences-logo.png http://www.pharmajournalist.com/procella-therapeutics-and-smartwise-enter-collaboration-with-astrazeneca-to-develop-novel-cardiovascular-and-catheter-based-therapies/ 2018-05-11T09:20:58+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/astrazeneca.jpg http://www.pharmajournalist.com/miragen-announces-new-interim-data-from-phase-1-clinical-trial-of-cobomarsen-in-mycosis-fungoides/ 2018-05-11T09:23:22+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/miRagen-Therapeutics-logo.jpg http://www.pharmajournalist.com/smis-pre-filled-syringes-west-coast-conference-and-exhibition-attendee-list-released/ 2018-05-14T09:12:03+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/PFS-West-Coast-Banner-SMi-Pharma-Journalist.jpg http://www.pharmajournalist.com/wp-content/uploads/2018/05/600x314_PFS-WC_3WK_PR.jpg http://www.pharmajournalist.com/updates-on-keytruda-and-future-potential-therapies-advancements-in-immuno-oncology/ 2018-05-14T09:12:24+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/Immuno-Oncology-Banner-SMi-Pharma-Journalist.jpg http://www.pharmajournalist.com/explore-the-latest-developments-in-atmps-at-smis-cell-gene-therapy-2018/ 2018-05-17T09:13:48+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/Cell-Gene-Therapy-2018-Banner_Pharma-Journalist.jpg http://www.pharmajournalist.com/novartis-and-amgen-announce-fda-approval-of-aimovig-erenumab-aooe/ 2018-05-18T08:06:19+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/catalent-biologics-and-valerius-biopharma-to-collaborate-on-manufacture-of-specialty-biosimilars/ 2018-05-18T08:27:53+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/Catalent-Logo.png http://www.pharmajournalist.com/tedor-pharma-announces-recapitalization-and-new-management/ 2018-05-18T08:32:34+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/Tedor-Pharma-Logo.png http://www.pharmajournalist.com/cambrex-completes-pilot-plant-expansion-at-its-high-point-nc-facility/ 2018-05-18T08:34:44+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/cambrex.jpeg http://www.pharmajournalist.com/lillys-galcanezumab-meets-primary-endpoint-in-phase-3-study/ 2018-05-18T08:37:37+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lilly.jpg http://www.pharmajournalist.com/fujifilm-to-merge-toyama-chemical-ri-pharma/ 2018-05-18T09:08:46+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/Fujifilm.jpg http://www.pharmajournalist.com/qpsi-announces-strategic-alliance-with-supply-chain-wizard/ 2018-05-18T09:12:30+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/QPSI-Logo.jpg http://www.pharmajournalist.com/fda-approves-first-epoetin-alfa-biosimilar-for-the-treatment-of-anemia/ 2018-05-18T09:15:17+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/medigene-significantly-expands-tcr-alliance-with-bluebird-bio-in-cancer-immunotherapy/ 2018-05-18T09:20:47+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/bluebird-bio-inc.jpg http://www.pharmajournalist.com/novartis-announces-fda-approval-of-gilenya-as-the-first-disease-modifying-therapy-for-pediatric-relapsing-multiple-sclerosis/ 2018-05-18T09:23:13+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/lyrica-pregabalin-oral-solution-cv-phase-3-trial-in-pediatric-epilepsy-meets-primary-endpoint/ 2018-05-18T09:28:58+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/emulate-and-astrazeneca-form-strategic-agreement-to-work-side-by-side-on-organs-on-chips-technology/ 2018-05-18T09:31:15+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/biolamina-and-novo-nordisk-partner-to-advance-stem-cell-based-therapies-for-three-common-medical-conditions/ 2018-05-18T09:32:57+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/novo-nordisk-logo.jpg http://www.pharmajournalist.com/lilly-to-acquire-aurka-pharma/ 2018-05-18T09:34:39+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lilly.jpg http://www.pharmajournalist.com/zymeworks-and-daiichi-sankyo-expand-immuno-oncology-collaboration-focused-on-bispecific-antibodies/ 2018-05-18T09:36:46+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/Daiichi-Pharma.jpg http://www.pharmajournalist.com/amneal-announces-fda-approval-and-launch-of-generic-welchol-colesevelam-hcl-tablets-625-mg/ 2018-05-18T09:40:13+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/drug-discovery.jpg http://www.pharmajournalist.com/albireo-enrolls-first-patient-in-phase-3-pfic-trial-of-a4250/ 2018-05-18T09:43:14+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/clinical-trial.jpg http://www.pharmajournalist.com/ucb-announces-briviact-brivaracetam-now-approved-by-fda-to-treat-partial-onset-focal-seizures-in-pediatric-epilepsy-patients/ 2018-05-18T10:27:56+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/ucb-pharma.jpg http://www.pharmajournalist.com/nih-funds-three-national-cryo-em-service-centers-and-training-for-new-microscopists/ 2018-05-18T10:30:28+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/beta-galactosidase.jpg https://pharmajournalist.com/wp-content/uploads/2018/05/beta-galactosidase.jpg http://www.pharmajournalist.com/mabxience-and-amneal-enter-into-an-agreement-for-bevacizumab-biosimilar-in-the-united-states/ 2018-05-24T13:23:15+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/mABxience-Logo.png http://www.pharmajournalist.com/centogene-announces-drug-development-collaboration-with-orphazyme-in-neuronopathic-gaucher-disease/ 2018-05-24T13:33:05+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/Centogene-AG-Logo.png http://www.pharmajournalist.com/evotec-and-celgene-enter-into-strategic-oncology-partnership/ 2018-05-24T13:35:48+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/evotec.png http://www.pharmajournalist.com/fda-to-review-zynquista-sotagliflozin-as-potential-treatment-for-type-1-diabetes/ 2018-05-24T13:39:20+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/sanofi.jpg http://www.pharmajournalist.com/amgen-enters-groundbreaking-collaboration-to-improve-symptom-management-during-cancer-treatment/ 2018-05-24T13:41:49+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/amgen.jpg http://www.pharmajournalist.com/mit-team-develops-single-injection-vaccine-for-the-polio-virus/ 2018-05-24T13:46:02+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/MIT-Polio-Vaccine.jpg https://pharmajournalist.com/wp-content/uploads/2018/05/MIT-Polio-Vaccine.jpg http://www.pharmajournalist.com/lokelma-approved-in-the-us-for-the-treatment-of-adults-with-hyperkalaemia/ 2018-05-24T13:49:39+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/astrazeneca.jpg http://www.pharmajournalist.com/harmony-biosciences-receives-breakthrough-therapy-and-fast-track-designations-for-pitolisant/ 2018-05-24T13:52:21+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/Harmony-Biosciences-Logo.png http://www.pharmajournalist.com/bicycle-therapeutics-expands-strategic-partnership-with-astrazeneca/ 2018-05-24T13:55:04+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/Bicycle-Therapeutics.jpg http://www.pharmajournalist.com/epigen-to-license-its-lpa1-receptor-small-molecule-program-to-novo-nordisk/ 2018-05-24T14:01:19+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/novo-nordisk-logo.jpg http://www.pharmajournalist.com/takeda-divests-techpool-to-joint-venture-partners-in-china/ 2018-05-24T14:03:38+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/viiv-healthcare-receives-eu-marketing-authorisation-for-juluca-to-treat-hiv-1-infection/ 2018-05-24T14:09:18+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/ViiV-healthcare-Juluca.jpg http://www.pharmajournalist.com/dova-pharmaceuticals-announces-u-s-fda-approval-of-doptelet-avatrombopag/ 2018-05-24T14:10:58+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/ppd-evidera-join-newdigs-initiative-at-mit-as-a-strategic-partner/ 2018-05-24T14:32:20+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/PPD-office_wikipedia.jpg http://www.pharmajournalist.com/avenue-therapeutics-announces-positive-topline-phase-3-data-for-intravenous-tramadol-in-the-management-of-postoperative-pain/ 2018-05-24T14:33:56+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/clinical-trials.jpg http://www.pharmajournalist.com/thermo-fisher-scientific-installs-first-glacios-cryo-electron-microscope-for-drug-discovery-and-development/ 2018-05-24T14:36:25+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/thermo-fisher-scientific.jpg http://www.pharmajournalist.com/inmune-bio-initiates-phase-i-clinical-trial-of-inb03/ 2018-05-24T14:39:25+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/inmunebio-PNG-logo.png http://www.pharmajournalist.com/berg-announces-fda-orphan-drug-designation-of-bpm-31510-for-the-treatment-of-patients-with-epidermolysis-bullosa/ 2018-05-24T14:42:48+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/berg-logo.png http://www.pharmajournalist.com/calling-all-microbiologists-5-great-reasons-to-be-in-san-diego/ 2018-05-25T08:46:58+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Pharma-Microbiology-Banner-SMi-Pharma-Journalist.jpg http://www.pharmajournalist.com/probiogen-announces-further-development-milestone-for-use-of-its-glymaxx-cancer-cell-killing-enhancement-antibody-technology-with-merus-n-v/ 2018-05-25T08:53:43+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/ProBioGen-Logo.png http://www.pharmajournalist.com/sotio-starts-phase-i-ii-trial-of-dcvac-in-combination-with-oncos-102-the-targovax-adenovirus-based-immunotherapy/ 2018-05-25T08:56:38+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/Sotio-Logo.jpg http://www.pharmajournalist.com/lunaphore-and-vitro-sign-collaboration-agreement-to-develop-ish-protocols-for-rna-dna-targets/ 2018-05-25T08:59:54+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/Lunaphore_Logo.jpg http://www.pharmajournalist.com/samsung-biologics-receives-an-additional-fda-approval-for-its-world-largest-plants-production/ 2018-05-25T09:08:45+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/Samsung-BioLogics.jpg https://pharmajournalist.com/wp-content/uploads/2018/05/Samsung-BioLogics.jpg http://www.pharmajournalist.com/avara-pharmaceutical-services-acquires-major-sterile-manufacturing-facility-and-development-center-in-canada/ 2018-05-25T09:14:37+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/Tim-Tyson.jpg https://pharmajournalist.com/wp-content/uploads/2018/05/Tim-Tyson.jpg http://www.pharmajournalist.com/fda-approves-a-new-treatment-for-pku-a-rare-and-serious-genetic-disease/ 2018-05-25T09:16:52+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/global-device-week-5-high-caliber-events-join-forces-to-boost-medical-innovation-at-medical-fair-china/ 2018-05-28T07:21:06+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/2..jpg http://www.pharmajournalist.com/wp-content/uploads/2018/05/1.Banner.jpg http://www.pharmajournalist.com/wp-content/uploads/2018/05/2..jpg http://www.pharmajournalist.com/wp-content/uploads/2018/05/3..jpg https://pharmajournalist.com/wp-content/uploads/2018/05/logo2.png https://pharmajournalist.com/wp-content/uploads/2018/05/logo3.png https://pharmajournalist.com/wp-content/uploads/2018/05/logo4.jpg http://www.pharmajournalist.com/from-manufacturing-to-patient-access-smis-cell-gene-therapy-2018/ 2018-05-30T10:09:33+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/Cell-Gene-Therapy-2018-Banner_Pharma-Journalist.jpg http://www.pharmajournalist.com/machines-are-now-intelligent-robots-are-stealing-jobs-and-your-next-meeting-might-be-led-by-a-bot-how-will-ai-disrupt-your-life/ 2018-05-30T10:58:03+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/AI-IN-HEALTHCARE-SUMMIT-Pharma-Journalist.png http://www.pharmajournalist.com/exploring-the-future-through-ocular-gene-editing-and-strategic-drug-delivery-at-ophthalmic-drugs-2018/ 2018-05-31T07:42:01+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/Ophthalmic-Drugs_SMi_Banner_Pharma-Journalist.jpg http://www.pharmajournalist.com/fda-expedites-review-of-novartis-drug-promacta-for-first-line-severe-aplastic-anemia-saa/ 2018-06-01T07:18:52+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/daiichi-sankyo-announces-launch-of-immune-mediated-inflammatory-diseases-consortium-for-drug-development/ 2018-06-01T07:24:44+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/Daiichi-Pharma.jpg http://www.pharmajournalist.com/aptar-pharma-and-propeller-health-partner-to-develop-digital-medicine-platform-across-therapeutic-areas/ 2018-06-01T07:28:41+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/Aptar-Pharma-Logo.jpg http://www.pharmajournalist.com/fda-grants-priority-review-to-astellas-new-drug-application-for-gilteritinib/ 2018-06-01T07:31:03+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/astellas.jpg http://www.pharmajournalist.com/beactica-signs-three-year-extension-agreement-with-sanofi/ 2018-06-01T07:33:42+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Sanofi.jpg http://www.pharmajournalist.com/syndax-and-nektar-announce-immuno-oncology-clinical-trial-collaboration/ 2018-06-01T07:38:12+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/Syndax-Pharmaceuticals-logo.jpg http://www.pharmajournalist.com/forma-therapeutics-and-hitgen-initiate-multiyear-research-collaboration/ 2018-06-01T07:57:13+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Forma_Logo.jpg http://www.pharmajournalist.com/cloud-pharmaceuticals-forms-drug-design-collaboration-with-gsk/ 2018-06-01T07:59:23+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/gsk.jpg http://www.pharmajournalist.com/ipsen-and-md-anderson-announce-bench-to-bedside-cancer-drug-development-partnership/ 2018-06-01T08:03:42+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/Ipsen-Group-Image.jpg http://www.pharmajournalist.com/evotec-and-celgene-expand-ipsc-collaboration-to-include-additional-cell-lines/ 2018-06-01T08:06:02+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/evotec.png http://www.pharmajournalist.com/braeburn-resubmits-new-drug-application-for-cam2038-for-opioid-use-disorder/ 2018-06-01T08:09:14+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/braeburn-logo.jpg http://www.pharmajournalist.com/luye-pharma-acquires-astrazenecas-signature-products-seroquel-and-seroquel-xr/ 2018-06-01T08:12:05+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/clinigen-signs-agreement-with-nordic-pharma-for-aprotinin/ 2018-06-01T08:27:21+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/Clinigen-Group-Plc-logo.jpg http://www.pharmajournalist.com/five-prime-therapeutics-announces-collaboration-with-roche-to-develop-companion-diagnostics-for-targeted-immuno-oncology-investigational-drug-candidates/ 2018-06-01T08:34:48+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/five-prime-therapeutics-inc-lo.png http://www.pharmajournalist.com/pfizer-announces-fda-approves-xeljanz-tofacitinib-for-the-treatment-of-moderately-to-severely-active-ulcerative-colitis/ 2018-06-01T08:41:00+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/fda-accepts-larotrectinib-new-drug-application-and-grants-priority-review/ 2018-06-01T09:37:16+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/bayer.jpg http://www.pharmajournalist.com/pharmaceutical-microbiology-west-coast-conference-exhibition-takes-place-in-less-than-a-week/ 2018-06-01T10:01:02+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Pharmaceutical-Microbiology-West-Coast_PJ.jpg http://www.pharmajournalist.com/shuwen-biotech-and-bliss-biopharmaceutical-partner-on-companion-diagnostics-for-cancer-drugs/ 2018-06-01T10:26:49+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/Shuwen-Biotech-Logo.png http://www.pharmajournalist.com/arrowhead-completes-enrollment-in-single-dose-portion-of-phase-1-2-study-of-aro-hbv/ 2018-06-01T10:40:05+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/arrowhead-pharma-logo.jpg http://www.pharmajournalist.com/nih-begins-testing-ebola-treatment-in-early-stage-trial/ 2018-06-01T10:50:12+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/ebola-nih.jpg https://pharmajournalist.com/wp-content/uploads/2018/06/ebola-nih.jpg http://www.pharmajournalist.com/ingestible-bacteria-on-a-chip-could-help-diagnose-disease/ 2018-06-01T10:54:17+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/MIT-Ingestible-Sensor.jpg https://pharmajournalist.com/wp-content/uploads/2018/06/MIT-Ingestible-Sensor.jpg http://www.pharmajournalist.com/official-programme-released-for-smis-8th-annual-orphan-drugs-and-rare-diseases-conference/ 2018-06-04T08:57:35+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/300x250_ODRD-.jpg http://www.pharmajournalist.com/internationally-recognised-biobanks-sign-up-to-8th-annual-biobanking-conference/ 2018-06-05T10:14:44+00:00 https://pharmajournalist.com/wp-content/uploads/2018/04/bio-banking-2018-banner.jpg http://www.pharmajournalist.com/celltrion-launches-bio-cdmo-business-for-the-development-of-new-drugs/ 2018-06-08T07:05:13+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/celltrion-Image.png http://www.pharmajournalist.com/blueprint-medicines-and-cstone-pharmaceuticals-announce-exclusive-collaboration-and-license-agreement/ 2018-06-08T07:07:57+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/Blueprint-Medicines-and-CStone-Pharmaceuticals.jpg http://www.pharmajournalist.com/wp-content/uploads/2018/06/Blueprint-Medicines-and-CStone-Pharmaceuticals.jpg http://www.pharmajournalist.com/sensei-biotherapeutics-reports-new-data-from-phase-1-clinical-trial-of-sns-301/ 2018-06-08T07:09:58+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/clinical-trial.jpg http://www.pharmajournalist.com/vetter-strikes-out-on-new-pathways-to-further-develop-the-injection-process/ 2018-06-08T07:13:17+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/Vetter-Innovation-Challenge.jpg http://www.pharmajournalist.com/wp-content/uploads/2018/06/Vetter-Innovation-Challenge.jpg http://www.pharmajournalist.com/ge-healthcare-flexfactory-helps-xph-scale-up-industrialization-of-tcr-t-cell-immunotherapy-drugs/ 2018-06-08T07:16:57+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/GE-Healthcare-FlexFactory.jpg http://www.pharmajournalist.com/wp-content/uploads/2018/06/GE-Healthcare-FlexFactory.jpg http://www.pharmajournalist.com/biogen-enters-exclusive-option-agreement-to-acquire-tms-phase-2-asset-for-acute-stroke/ 2018-06-08T07:19:50+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/Biogen-logo.jpg http://www.pharmajournalist.com/inflarx-opens-new-research-facility-in-ann-arbor/ 2018-06-08T07:24:17+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/inflarx-logo.png http://www.pharmajournalist.com/ppd-and-neogenomics-forming-global-strategic-alliance-for-pathology-and-molecular-testing-solutions/ 2018-06-08T07:28:07+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/PPD-office_wikipedia.jpg http://www.pharmajournalist.com/alcami-to-become-industry-leading-platform-cdmo-following-acquisition-by-madison-dearborn-partners/ 2018-06-08T07:30:26+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/alcami-logo.jpg http://www.pharmajournalist.com/hookipa-and-gilead-enter-into-a-collaboration-and-license-agreement-to-develop-immunotherapies-against-hiv-and-hepatitis-b/ 2018-06-08T07:34:36+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/gilead1.jpg http://www.pharmajournalist.com/chugais-hemlibra-receives-priority-review-status-from-fda-for-hemophilia-a-without-inhibitors/ 2018-06-08T07:36:33+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Roche-Logo.jpeg http://www.pharmajournalist.com/fda-approves-mylan-and-biocons-fulphila-pegfilgrastim-jmdb-the-first-biosimilar-to-neulasta/ 2018-06-08T07:40:25+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/mylan-1.jpg http://www.pharmajournalist.com/virpax-pharmaceuticals-licenses-liposome-drug-delivery-technology-from-lipocure/ 2018-06-08T07:43:36+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/Virpax-Pharmaceuticals-Logo.jpg http://www.pharmajournalist.com/ec-approves-roches-perjeta-for-post-surgery-treatment-of-her2-positive-early-breast-cancer-at-high-risk-of-recurrence/ 2018-06-08T07:47:30+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/third-novartis-phase-iii-trial-shows-kisqali-combination-therapy-significantly-improves-pfs-in-hr-her2-advanced-breast-cancer/ 2018-06-08T07:50:22+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/mercks-keytruda-pembrolizumab-showed-overall-response-rate-of-nearly-40-percent-as-first-line-therapy/ 2018-06-08T07:52:58+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/fda-approves-genentechs-rituxan-rituximab-for-pemphigus-vulgaris/ 2018-06-08T07:55:26+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/Genentech-Image.jpg http://www.pharmajournalist.com/ironwood-pharmaceuticals-announces-fda-orphan-drug-designation-for-olinciguat-for-the-treatment-of-sickle-cell-disease/ 2018-06-08T07:58:58+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/Ironwood-Pharmaceuticals-Logo.png http://www.pharmajournalist.com/chimerix-receives-orphan-drug-designation-from-the-fda-for-brincidofovir-for-the-treatment-of-smallpox/ 2018-06-08T08:09:29+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/Chimerix-Logo.jpg http://www.pharmajournalist.com/fda-and-ema-accept-regulatory-submissions-for-review-of-talazoparib/ 2018-06-08T08:12:08+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/blackthorn-therapeutics-initiates-phase-1-study-of-btrx-335140-an-investigational-kappa-opioid-receptor-kor-antagonist/ 2018-06-08T08:15:13+00:00 https://pharmajournalist.com/wp-content/uploads/2017/02/abzena-clinical.jpg http://www.pharmajournalist.com/strategic-competitive-intelligence-and-the-role-of-the-microbiome-in-immuno-oncology/ 2018-06-12T16:25:14+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/Immuno-Oncology-Banner-SMi-Pharma-Journalist.jpg http://www.pharmajournalist.com/wp-content/uploads/2018/06/Immuno-Oncology-SMi.jpg http://www.pharmajournalist.com/explore-new-strategies-for-treating-retinal-vascular-disease-at-smis-2nd-annual-ophthalmic-drugs-2018/ 2018-06-13T06:42:38+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/Ophthalmic-Drugs_SMi_Banner_Pharma-Journalist.jpg http://www.pharmajournalist.com/exclusive-speaker-interview-for-smis-inaugural-cell-gene-therapy-2018/ 2018-06-13T09:31:16+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/Cell-Gene-Therapy-2018-Banner_Pharma-Journalist.jpg http://www.pharmajournalist.com/smis-13th-annual-industry-leading-cold-chain-distribution-conference-returns-to-london-uk-this-december/ 2018-06-13T10:12:46+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/Cold-Chain-Distribution-SMi-Banner-Pharma-Journalist.jpg http://www.pharmajournalist.com/new-speakers-from-roche-and-imperial-college-london-announced-for-smis-admet-event/ 2018-06-15T07:37:04+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/ADMET-Banner-SMi-Pharma-Journalist.jpg http://www.pharmajournalist.com/nordic-nanovector-announces-betalutin-has-been-granted-fast-track-designation-in-the-us-for-follicular-lymphoma/ 2018-06-15T08:19:59+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/nordic-nanovector-logo.jpg http://www.pharmajournalist.com/eisai-to-launch-center-for-genetics-guided-dementia-discovery-in-cambridge-massachusetts/ 2018-06-15T08:22:37+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/eisai-logo.jpg http://www.pharmajournalist.com/janssens-tremfya%e2%96%bc-guselkumab-receives-its-first-two-positive-health-technology-assessments-in-europe/ 2018-06-15T08:27:13+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/Janssen.jpg http://www.pharmajournalist.com/asterias-biotherapeutics-announces-first-patient-dosed-in-first-in-human-clinical-study-of-immunotherapy-ast-vac2-in-non-small-cell-lung-cancer/ 2018-06-15T08:32:18+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/Asterias-Biotherapeutics.jpg http://www.pharmajournalist.com/abcellera-announces-collaboration-with-denali-therapeutics-to-discover-new-antibodies-to-treat-neurodegenerative-diseases/ 2018-06-15T08:36:09+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/AbCellera-Logo.jpg http://www.pharmajournalist.com/translate-bio-announces-agreement-with-sanofi-pasteur-to-develop-vaccines-for-infectious-diseases-using-novel-mrna-technology/ 2018-06-15T08:40:16+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/Translate-Bio-Logo.png http://www.pharmajournalist.com/alcamis-extended-workbench-supports-commercial-supply-of-flexion-therapeuticss-zilretta/ 2018-06-15T08:46:05+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/alcami-logo.jpg http://www.pharmajournalist.com/wuxi-sta-first-cdmo-to-support-the-approval-of-an-innovative-drug-in-china-through-the-mah-pilot/ 2018-06-15T08:51:21+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/wuxi-apptec-logo.png http://www.pharmajournalist.com/catalent-appoints-paul-hegwood-as-new-president-of-clinical-supply-services/ 2018-06-15T08:57:34+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/Catalent-Logo.png http://www.pharmajournalist.com/thermo-fisher-scientific-opens-u-s-precision-medicine-science-center/ 2018-06-15T09:02:25+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/thermo-fisher-scientific.jpg http://www.pharmajournalist.com/cambrex-expands-generic-api-research-and-development-capabilities-at-milan-italy-site/ 2018-06-15T09:07:19+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/cambrex-logo.png http://www.pharmajournalist.com/amri-secures-seven-year-nih-contract-from-the-national-institute-of-allergy-and-infectious-diseases/ 2018-06-15T09:09:46+00:00 https://pharmajournalist.com/wp-content/uploads/2018/04/AMRI-Logo.png http://www.pharmajournalist.com/microbiotica-enters-into-microbiome-collaboration-with-genentech/ 2018-06-15T09:17:16+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/Microbiotica-Logo.png http://www.pharmajournalist.com/biomarin-receives-milestone-payments-from-pfizer-for-talazoparib/ 2018-06-15T09:19:57+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/Biomarin-Pharma-Logo.jpg http://www.pharmajournalist.com/alexion-and-complement-announce-partnership-to-co-develop-pre-clinical-complement-inhibitor-for-neurodegenerative-disorders/ 2018-06-15T09:22:19+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Alexion-Pharma-Logo.png http://www.pharmajournalist.com/icon-enhances-endpoint-adjudication-services-using-ag-mednet-advanced-technology/ 2018-06-15T09:36:25+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/ICON-plc-logo.jpg http://www.pharmajournalist.com/acerus-announces-approval-of-natesto-in-south-korea/ 2018-06-15T09:39:17+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/Acerus-Pharma-Logo.jpg http://www.pharmajournalist.com/pharmacolog-ab-and-heliometrics-partner-to-provide-critcal-drug-diversion-solutions/ 2018-06-15T09:44:21+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/Pharmacolog-Image.jpg http://www.pharmajournalist.com/labcorp-expands-drug-development-solutions-with-acquisition-of-sciformix/ 2018-06-15T09:46:40+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/LabCorp-Logo.jpg http://www.pharmajournalist.com/prana-to-commence-phase-1-clinical-trial-of-pbt434-for-treatment-of-parkinsonian-diseases/ 2018-06-15T09:54:00+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/Prana-Biotechnology-Logo.png http://www.pharmajournalist.com/seattle-genetics-announces-first-patient-dosed-in-phase-2-trial-of-tisotumab-vedotin-for-women-with-recurrent-or-metastatic-cervical-cancer/ 2018-06-15T09:57:06+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Seattle-Genetics.jpg http://www.pharmajournalist.com/latest-updates-on-smis-13th-annual-industry-leading-cold-chain-distribution-conference/ 2018-06-20T07:01:53+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/Cold-Chain-Distribution-SMi-Banner-Pharma-Journalist.jpg http://www.pharmajournalist.com/agenda-released-for-usa-biosimilars-conference-this-november/ 2018-06-20T07:17:51+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/300x250.jpg http://www.pharmajournalist.com/india-upgrading-to-the-new-medical-device-regulations/ 2018-06-20T07:25:39+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/300px-W-X-250px-H2..gif http://www.pharmajournalist.com/join-leading-experts-and-local-stakeholders-at-chinas-first-two-day-conference-dedicated-solely-to-extractables-and-leachables/ 2018-06-20T09:42:38+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/EL-China_Pharma-Journalist.png http://www.pharmajournalist.com/registration-opens-for-the-9th-annual-biosimilars-and-biobetters-2018-conference/ 2018-06-20T12:21:15+00:00 https://pharmajournalist.com/wp-content/uploads/2018/04/Biosimilars-Biobetters_Banner_Pharma-Journalist.jpg http://www.pharmajournalist.com/lyophilization-usa-conference-official-agenda-published/ 2018-06-21T06:27:36+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/Lyophilization-USA_SMi_Pharma-Journalist.jpg http://www.pharmajournalist.com/superbugs-superdrugs-usa-conference-returns-to-new-jersey-this-november/ 2018-06-22T08:15:18+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/Superbugs-Superdrugs-USA_SMi_Pharma-Journalist.jpg http://www.pharmajournalist.com/merck-signs-exclusive-agreement-with-histocyte-laboratories-to-distribute-pathology-technology/ 2018-06-22T11:03:47+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/sanofi-completes-its-acquisition-of-ablynx-following-the-expiration-of-the-squeeze-out-procedure/ 2018-06-22T11:09:17+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Sanofi.jpg http://www.pharmajournalist.com/immunogen-announces-fda-fast-track-designation-for-mirvetuximab-soravtansine-in-patients-with-platinum-resistant-ovarian-cancer/ 2018-06-22T11:22:02+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/Immunogen-Logo.png http://www.pharmajournalist.com/maat-pharma-and-lutech-sign-licensing-agreement-on-microbiome-therapy-for-graft-vs-host-disease/ 2018-06-22T11:27:45+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/MaaT-Pharma-Logo.png http://www.pharmajournalist.com/aquinnah-pharmaceuticals-receives-3-4m-grant-from-ninds-to-advance-new-therapies-for-als/ 2018-06-22T11:29:57+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/Aquinnah-Pharma-Logo.png http://www.pharmajournalist.com/novacap-to-expand-its-pharmaceutical-offering-in-the-u-s-with-the-acquisition-of-pci-synthesis/ 2018-06-22T11:32:03+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/Novacap-logo.png http://www.pharmajournalist.com/neptune-announces-multi-year-agreement-with-canopy-growth-to-provide-extracted-cannabis-products/ 2018-06-22T11:35:55+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/Neptune-Logo.png http://www.pharmajournalist.com/grifols-expands-its-nat-solutions-portfolio-with-new-fda-approvals-for-two-assays/ 2018-06-22T11:38:36+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/grifols.png http://www.pharmajournalist.com/celltrion-completes-resubmission-to-fda-for-proposed-trastuzumab-biosimilar/ 2018-06-22T11:41:03+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/celltrion-Image.png http://www.pharmajournalist.com/comprehend-joins-veevas-technology-partner-program/ 2018-06-22T11:47:15+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/Veeva-CRM.jpg http://www.pharmajournalist.com/syneos-health-and-elligo-announce-strategic-collaboration/ 2018-06-22T11:49:54+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/Syneos-Health-Logo.png http://www.pharmajournalist.com/enamine-and-tbd-biodiscovery-collaborate-to-provide-gmp-based-services/ 2018-06-22T11:57:32+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/Enamine-Logo.jpg http://www.pharmajournalist.com/juniper-pharma-services-expands-laboratory-facilities-to-meet-with-growing-demand/ 2018-06-22T11:59:35+00:00 https://pharmajournalist.com/wp-content/uploads/2018/04/juniper_pharma_logo.png http://www.pharmajournalist.com/pacira-pharmaceuticals-and-nuance-biotech-announce-license-agreement-for-exparel-in-china/ 2018-06-22T12:02:09+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/Pacira-Pharma-Logo.png http://www.pharmajournalist.com/crownbio-enters-partnership-with-pierre-fabre-to-accelerate-discovery-and-development-of-immuno-oncology-agents/ 2018-06-22T12:04:02+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/crownbio-logo.jpg http://www.pharmajournalist.com/sharp-selects-werum-it-solutions-as-strategic-mes-partner/ 2018-06-22T12:06:04+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/sharp-clinical-services.jpg http://www.pharmajournalist.com/meiragtx-announces-mhra-grants-mia-imp-license-for-cgmp-manufacturing-facility-in-london-uk/ 2018-06-22T12:07:21+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/MeiraGTx-Logo.jpg http://www.pharmajournalist.com/samsung-biologics-receives-health-canada-approval/ 2018-06-22T12:08:09+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/Samsung-BioLogics.jpg https://pharmajournalist.com/wp-content/uploads/2018/06/Samsung-BioLogics.jpg http://www.pharmajournalist.com/record-breaking-medical-fair-asia-the-comprehensive-sourcing-and-knowledge-sharing-platform-for-the-healthcare-industry/ 2018-06-26T06:52:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/Medical-Fair-Asia-Press-Photo-PJ.jpg http://www.pharmajournalist.com/your-latest-ophthalmology-news-for-smis-ophthalmic-drugs-2018/ 2018-06-26T11:11:28+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/Ophthalmic-Drugs_SMi_Banner_Pharma-Journalist.jpg http://www.pharmajournalist.com/be-the-part-of-indias-largest-pharma-expo/ 2018-06-29T07:02:22+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/IPE-Banner_Pharma-Journalist.jpg http://www.pharmajournalist.com/aquinox-announces-topline-results-of-phase-3-leadership-301-clinical-trial-in-interstitial-cystitis-bladder-pain-syndrome/ 2018-06-29T08:50:14+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/clinical-trial.jpg http://www.pharmajournalist.com/fda-grants-priority-review-to-roches-baloxavir-marboxil-for-the-treatment-of-influenza/ 2018-06-29T08:52:54+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/abbvie-and-calibr-announce-collaboration-for-next-generation-t-cell-therapies/ 2018-06-29T08:58:34+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Abbvie.jpg http://www.pharmajournalist.com/boehringer-ingelheim-to-invest-230-million-euro-in-biologics-rd/ 2018-06-29T09:01:59+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/boehringer-ingelheim.jpg http://www.pharmajournalist.com/fda-approves-first-drug-comprised-of-an-active-ingredient-derived-from-marijuana-to-treat-rare-severe-forms-of-epilepsy/ 2018-06-29T09:04:58+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/novaliqs-novatears-treatment-for-evaporative-dry-eye-disease-is-now-available-across-australia-and-new-zealand/ 2018-06-29T09:18:35+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/Novaliq-AFT-blue.jpg https://pharmajournalist.com/wp-content/uploads/2018/06/Novaliq-AFT-blue.jpg